syndrome	score	normalized_score
DRAVET SYNDROME	2.8321857	100.0
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	71.34665216338038
BIRDSHOT CHORIORETINOPATHY	2.00826446	70.90864345512372
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	70.6168384368299
CHILDHOOD ABSENCE EPILEPSY	1.52074085	53.69495545436869
PITUITARY APOPLEXY	1.38049451	48.74307888780032
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.320621654	46.62906298834854
PERIPHERAL CONE DYSTROPHY	1.25	44.13552402301868
DIGEORGE SYNDROME; DGS	1.226615373	43.30984980963642
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	43.04926594326071
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	42.14744817050661
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1581403600000002	40.89210534464601
TURCOT SYNDROME WITH POLYPOSIS	1.111111	39.231572986192255
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.07818681	38.069071883245506
RETINITIS PIGMENTOSA 75; RP75	1.0666667	37.662315009923255
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	1.0660176190000001	37.63939698586855
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.02930401	36.343097488275575
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.0291128189999998	36.33634683629678
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.01491127	35.83491259065392
MOWAT-WILSON SYNDROME; MOWS	1.010261329	35.67073052448503
IDIOPATHIC INTRACRANIAL HYPERTENSION	1.00826446	35.60022423670877
EHLERS-DANLOS SYNDROME, TYPE I	1.0	35.30841921841495
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	35.30841921841495
BROWN SYNDROME	1.0	35.30841921841495
STRABISMUS, SUSCEPTIBILITY TO	1.0	35.30841921841495
LEBER CONGENITAL AMAUROSIS 17	1.0	35.30841921841495
MYOCLONIC EPILEPSY OF LAFORA	0.9427052199999999	33.28543110714809
CRANIOPHARYNGIOMA	0.7988433730000001	28.205896703736627
LAFORA DISEASE	0.7819456599999999	27.60926516930016
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.77869296	27.494417474108424
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	27.2092716236792
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	26.43113987899875
MENINGIOMA	0.735725	25.977286729468336
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7214750139999999	25.474142249923794
EARLY MYOCLONIC ENCEPHALOPATHY	0.720372604	25.435217895493224
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.6918247399999999	24.427237945590925
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.68775935	24.283695451184574
ROLANDIC EPILEPSY	0.6114546000000001	21.589495349828226
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.61096717	21.572284967048596
COG4-CDG	0.596351694	21.05623561336391
TSH-SECRETING PITUITARY ADENOMA	0.595264119	21.017835059332445
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684000000001	20.972085269691178
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.5893574	20.809278148675066
MUCOPOLYSACCHARIDOSIS TYPE 2	0.588586973	20.78207558918188
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.58524564	20.664098402869556
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.5797020500000001	20.46836300317455
SPINOCEREBELLAR ATAXIA TYPE 10	0.5755583	20.322053741038236
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.5683460090000001	20.06739914688504
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.558844	19.731898229695886
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	19.615790023938047
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.550180064	19.425988345326363
PLACENTAL INSUFFICIENCY	0.53522694	18.898017174509427
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.8311451470149
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	18.608490255423575
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	18.41404551968467
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.519276729	18.33484043789925
INHALATIONAL ANTHRAX	0.5172414	18.26297618831985
PERSISTENT PLACOID MACULOPATHY	0.5133333	18.12498735517237
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.512980369	18.112525919469192
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	18.084799312417967
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.507604834	17.92272427616593
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.90286032444836
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.5027009	17.74957411867449
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.502332303	17.736559541275838
RESTRICTIVE DERMOPATHY	0.50189394	17.721081636702
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.501086973	17.692588907570574
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	17.654209609207474
PAROXYSMAL HEMICRANIA	0.5	17.654209609207474
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.5	17.654209609207474
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	17.654209609207474
CREST SYNDROME	0.5	17.654209609207474
PAPILLARY TUMOR OF THE PINEAL REGION	0.5	17.654209609207474
PINEOCYTOMA	0.5	17.654209609207474
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.5	17.654209609207474
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.47239697999999997	16.67959060735318
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.46848267400000004	16.541382650156027
PINEOBLASTOMA	0.464368929	16.39613281713837
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.4519231	15.956690269285662
NELSON SYNDROME	0.4519231	15.956690269285662
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.44294439900000004	15.639666530340863
CONGENITAL MYASTHENIC SYNDROME	0.44294439900000004	15.639666530340863
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.43686985	15.425183807686055
JUVENILE GLAUCOMA	0.43124969999999996	15.226745195415681
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.425810594	15.034698960594284
DUANE RETRACTION SYNDROME 1	0.42514088	15.011052417925844
ACUTE BILIRUBIN ENCEPHALOPATHY	0.422764019	14.927129213313941
DUANE-RADIAL RAY SYNDROME; DRRS	0.41791163	14.755799028291117
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.4095316	14.459913415988224
NON-DISTAL MONOSOMY 20Q	0.401688479	14.182985211739469
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.37351413	13.188193486041538
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.368045154	12.995092588738089
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	12.872034132507624
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.364298264	12.862795825852801
LEBER HEREDITARY OPTIC NEUROPATHY	0.3581731	12.64652596755926
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.357688054	12.629399760051044
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.623383417266739
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	12.623383417266739
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.355925534	12.567167965010203
CENTRALOPATHIC EPILEPSY	0.3547009	12.523928074349078
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34778265999999997	12.279655956175471
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.347573019	12.272253863862105
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.347573019	12.272253863862105
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34726515999999996	12.261383849229942
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34605429	12.21862994365094
OROFACIODIGITAL SYNDROME TYPE 3	0.3455281	12.200051006542402
PROLACTINOMA	0.345264119	12.190730254728706
NON-FUNCTIONING PITUITARY ADENOMA	0.345264119	12.190730254728706
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.34410233	12.149709321673363
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.34180758	12.068685326671904
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34173636	12.06617066105517
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.34037525	12.018112018572793
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.018112018572793
SPINOCEREBELLAR ATAXIA TYPE 42	0.33457833	11.813431937037178
ELSAHY-WATERS SYNDROME; ESWS	0.333878554	11.788723952670194
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	11.76946130333191
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	11.76946130333191
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.76946130333191
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	0.333333	11.76946130333191
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.33194444	11.720433444741989
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32399069	11.43959910538352
XQ21 MICRODELETION SYNDROME	0.318999003	11.263350528180407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.63777046822883
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.2991457	10.562361782986192
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.29177275	10.302034573509781
OPTIC ATROPHY 1; OPA1	0.28798984	10.168466001364246
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.28798984	10.168466001364246
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.2849752	10.062023828451643
RETINAL CAPILLARY MALFORMATION	0.283056	9.99425991028766
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.282337273	9.968882796068069
NARP SYNDROME	0.278387673	9.829428663523016
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27616419000000003	9.750920993633999
MARFAN SYNDROME; MFS	0.27066968	9.556918531154226
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.26912256	9.50229216961303
WILLIAMS-BEUREN SYNDROME; WBS	0.26769956	9.452048289065226
RETINOSCHISIS OF FOVEA	0.2652089	9.36410702165469
SLC35A2-CDG	0.26463345400000005	9.34378893304913
ALLAN-HERNDON-DUDLEY SYNDROME	0.26322136	9.293930126121321
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.26013600000000003	9.184990941801592
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.2599044	9.176813511910606
HYPEREKPLEXIA 1; HKPX1	0.25925926	9.154034638336038
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25847458	9.126328827943732
CATARACT 7; CTRCT7	0.25826446	9.118909822897558
UVEAL MELANOMA	0.25826446	9.118909822897558
NEOVASCULAR GLAUCOMA	0.25826446	9.118909822897558
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.257686639	9.098507876796354
TRICHOTHIODYSTROPHY	0.25696008400000003	9.07285436827112
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.256097019	9.042380907438377
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.256035929	9.040223916108324
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.02588958061613
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.25549451	9.021107267083512
OPTIC ATROPHY 9; OPA9	0.25549451	9.021107267083512
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.255418049	9.01840755004165
PALLISTER-HALL SYNDROME	0.252439494	8.913239481436545
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	8.84636745394202
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.250541419	8.846221453628552
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.250541419	8.846221453628552
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.25	8.827104804603737
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	8.827104804603737
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	8.827104804603737
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	8.827104804603737
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24444441	8.630945703878105
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.244048764	8.616976069048015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	8.581540186436222
RETINITIS PUNCTATA ALBESCENS	0.2366153	8.354512205891018
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.21172531165594
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.230957884	8.15475779007005
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	7.977201141860153
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.22359056300000002	7.89462933168542
POLYARTERITIS NODOSA	0.2208333	7.7972747337859944
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.21720738000000003	7.669249230373559
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.215610734	7.612874184062153
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.213878854	7.551724238986165
PITUITARY CARCINOMA	0.21382781	7.549921956035581
USHER SYNDROME TYPE 3	0.21096707000000003	7.448913748840694
CRI-DU-CHAT SYNDROME	0.21070892000000002	7.439798880419459
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2098612	7.409867227279624
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20900901000000002	7.3797777455058835
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.20847458000000002	7.360907867022985
RETINITIS PIGMENTOSA 18	0.2083333	7.355919493555807
SLC39A8-CDG	0.206728199	7.29924591455991
JUVENILE MYOCLONIC EPILEPSY	0.2042519	7.211811711357768
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.20416972	7.208910065466399
USHER SYNDROME TYPE 1	0.20250361400000003	7.150082496356084
PREECLAMPSIA/ECLAMPSIA 1	0.202435359	7.147672520202331
LINEAR VERRUCOUS NEVUS SYNDROME	0.20178674900000002	7.124771126413074
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.201086973	7.100063142046088
TRANSALDOLASE DEFICIENCY	0.20054555400000001	7.080946493021273
ROMANO-WARD SYNDROME	0.200541419	7.080800492707804
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.200541419	7.080800492707804
EPISODIC ATAXIA, TYPE 4	0.2	7.0616838436829905
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.0616838436829905
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	7.0616838436829905
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	7.0616838436829905
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.0616838436829905
NEPHROSIS-DEAFNESS-URINARY TRACT-DIGITAL MALFORMATIONS SYNDROME	0.2	7.0616838436829905
HELLP SYNDROME	0.2	7.0616838436829905
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.0616838436829905
MALARIA	0.2	7.0616838436829905
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.0616838436829905
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.0616838436829905
CARPENTER SYNDROME	0.2	7.0616838436829905
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.2	7.0616838436829905
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.0616838436829905
BENIGN SCHWANNOMA	0.2	7.0616838436829905
UNILATERAL POLYMICROGYRIA	0.19630751000000002	6.931307858803186
ADNP SYNDROME	0.19161293899999998	6.765549977884571
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.431003235416378
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.400915519063598
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.400915519063598
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.17785471399999997	6.279768801883293
RIFT VALLEY FEVER	0.17547247900000004	6.195655849826515
USHER SYNDROME TYPE 2	0.17493106000000003	6.176539200801699
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17489919300000004	6.175414027406466
MUCOLIPIDOSIS TYPE II	0.17407441	6.146292243478244
MACULAR CORNEAL DYSTROPHY	0.173611	6.129929968928238
CEREBROOCULONASAL SYNDROME	0.17269110000000001	6.097449754089218
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.17266915000000002	6.096674734287374
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.017598139839488
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.16971255000000002	5.992281862026209
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.16876496	5.95882395705903
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.16876496	5.95882395705903
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.168435409	5.947188032197182
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.167753973	5.923127604238662
SPINOCEREBELLAR ATAXIA TYPE 13	0.167753973	5.923127604238662
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.167208419	5.90386495490038
POSTENCEPHALITIC PARKINSONISM	0.167208419	5.90386495490038
DERMATOLEUKODYSTROPHY	0.166667	5.884748305875565
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	5.884748305875565
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	5.884748305875565
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.166667	5.884748305875565
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.166667	5.884748305875565
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.161921074	5.71717716108799
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.158117219	5.582869054101926
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.156639614	5.5306971573227
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.4691630566456135
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15390714399999997	5.4342179610609564
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.150545654	5.315529062942447
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.24165135075712
JOUBERT SYNDROME 5	0.14769169000000001	5.214760105596183
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.145189303	5.12640477635347
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.144984523	5.119174318265925
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14464788399999998	5.107288127328656
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.14394397299999998	5.082434142648202
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.14353632000000002	5.0680405596285585
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.044054844285103
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.044054844285103
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.139244154	4.916490963145531
XP21 MICRODELETION SYNDROME	0.13708058299999998	4.840098691268724
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.13248749999999998	4.677924191199749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.63714346132035
CONE-ROD DYSTROPHY 2	0.13071191	4.615230915119724
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13015824999999998	4.595682055735257
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.129721224	4.58025135851791
RETINITIS PIGMENTOSA 58	0.1291667	4.5606719926592385
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.12824465	4.528115864718899
LISSENCEPHALY, X-LINKED, 2	0.12822341900000003	4.527366231670474
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.127020933	4.484908351878198
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.12677254400000001	4.476138128936955
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.126768409	4.475992128623487
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.126718313	4.474223318054321
GLYCOGEN STORAGE DISEASE II	0.12622699	4.456875479598672
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.125620063	4.4354458466476965
HURLER SYNDROME	0.125545554	4.432815051640152
PHENYLKETONURIA	0.125541419	4.432669051326683
THORACOLARYNGOPELVIC DYSPLASIA	0.125	4.413552402301868
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.125	4.413552402301868
ADENOHYPOPHYSITIS	0.125	4.413552402301868
PANHYPOPHYSITIS	0.125	4.413552402301868
SHEEHAN SYNDROME	0.125	4.413552402301868
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	4.413552402301868
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.125	4.413552402301868
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	4.413552402301868
CENTRAL PRECOCIOUS PUBERTY	0.125	4.413552402301868
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.12480951000000001	4.406826501524954
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.12437784399999999	4.391585057434616
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.122614673	4.329330276612865
SCHINZEL-GIEDION SYNDROME	0.12072416000000001	4.262579251071002
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.11953011	4.220419233103253
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.11934559	4.213904123589071
COG8-CDG	0.11905982899999999	4.2038143544047974
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.191067132356469
W SYNDROME	0.11869880399999999	4.191067132356469
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.171804483018185
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.117676519	4.154971865015772
FOVEAL HYPOPLASIA 2; FVH2	0.11660550999999998	4.117156230257076
DDOST-CDG	0.11371689900000001	4.015163942110152
BILATERAL POLYMICROGYRIA	0.113135344	3.994630154371586
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.11290198400000002	3.9863905816627776
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.11287940899999999	3.9855934940989206
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11235632999999999	3.9671244014825717
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11235632999999999	3.9671244014825717
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.11219797299999999	3.9615330661404013
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.11205724399999997	3.956564147612212
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	3.9424164171155867
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11165241899999999	3.9422704168021183
GANGLIOCYTOMA	0.11111110000000002	3.923157298619226
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	3.9231537677773027
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	3.9231537677773027
MUCOLIPIDOSIS III ALPHA/BETA	0.11111099999999999	3.9231537677773027
MYOTONIA, POTASSIUM-AGGRAVATED	0.11111099999999999	3.9231537677773027
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.11111099999999999	3.9231537677773027
SUDDEN INFANT DEATH SYNDROME	0.11111099999999999	3.9231537677773027
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10903684000000001	3.849918456971236
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.10887481899999998	3.844197751581049
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10869115400000001	3.837712830765299
TRICHOHEPATOENTERIC SYNDROME 1	0.10822884	3.8213892542427566
OPTIC ATROPHY 5; OPA5	0.10817310000000001	3.8194211629555226
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.10768421900000001	3.8021595476596044
RING CHROMOSOME 7 SYNDROME	0.10679109	3.770624574511481
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.106758864	3.7694867253937474
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.10644866000000001	3.7585339125185193
BECKWITH-WIEDEMANN SYNDROME	0.10615976	3.7483333102063185
MELAS	0.10553470000000001	3.7262634296896566
SALT-AND-PEPPER SYNDROME	0.105439164	3.7228902045512053
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.10525225399999999	3.716290707915091
AICARDI SYNDROME; AIC	0.10491369	3.7043365482708284
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.103270484	3.6463175419606135
CONGENITAL ENTEROVIRUS INFECTION	0.10256786000000001	3.6215089992156946
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.10140257400000001	3.5803645926183445
NOCARDIOSIS	0.10111611900000002	3.5702503193911337
SANJAD-SAKATI SYNDROME	0.100459529	3.547067164416514
ROBERTS SYNDROME	0.09985801400000001	3.5258286206303495
SARCOSINEMIA	0.09974223400000001	3.5217406118532413
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.09921533	3.5031364645333816
SENIOR-LOKEN SYNDROME 3	0.09917356000000001	3.5016616318626284
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.4938776789954127
BOWEN-CONRADI SYNDROME	0.09885792900000001	3.490517200196301
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.09868667000000002	3.4844703156293746
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.4741314455475147
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.09816821	3.466164312601395
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.4645274142864286
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.4645274142864286
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.4645274142864286
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.4645274142864286
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.4645274142864286
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.097738334	3.4509860705814592
LATE-ONSET RETINAL DEGENERATION; LORD	0.09762186000000002	3.4468735577614145
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.09639854	3.4036800623631422
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.095610474	3.375854697663363
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.09481738	3.3478518022317534
TRISOMY 8P	0.094663299	3.342411445690161
RETINAL CONE DYSTROPHY 3B	0.09358764000000001	3.3044316267820997
PRADER-WILLI SYNDROME	0.092858149	3.2786744527380387
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.092677509	3.2722963398904246
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	3.2576218430874784
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.09199607300000001	3.248235911931905
20Q11.2 MICRODUPLICATION SYNDROME	0.09199607300000001	3.248235911931905
AICA-RIBOSIDURIA	0.09145051900000001	3.2289732625936214
STURGE-WEBER SYNDROME	0.09114414900000002	3.218155822197676
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.0909091	3.2098566135688067
ROBERTS SYNDROME; RBS	0.0909091	3.2098566135688067
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.0909091	3.2098566135688067
ULBRIGHT-HODES SYNDROME	0.0909091	3.2098566135688067
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.0909091	3.2098566135688067
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.0909091	3.2098566135688067
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.0909091	3.2098566135688067
RHEUMATOID ARTHRITIS	0.0901315	3.182400786784567
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.089670973	3.1661403064071685
OROFACIODIGITAL SYNDROME TYPE 14	0.089272544	3.152072408246394
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.08882781000000001	3.1363695537337115
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08825100000000001	3.116003304444338
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08772485000000001	3.097425779672569
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08767720999999999	3.095743686581003
AICARDI SYNDROME	0.08723209999999998	3.080027556102694
ADENYLOSUCCINASE DEFICIENCY	0.086621653	3.0584736375160713
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.0429628961123565
NEUROTROPHIC KERATOPATHY	0.08593211	3.0341269642029474
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08522724000000001	3.0092391187484635
8Q12 MICRODUPLICATION SYNDROME	0.08510584400000001	3.0049528178890252
CITRULLINEMIA TYPE I	0.08510170900000001	3.004806817575557
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.08456049399999999	2.9856973714682615
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.084429733	2.981080407262843
TOWNES-BROCKS SYNDROME 1; TBS1	0.08387885400000002	2.961629740592222
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.082959029	2.9291521738846433
WHITE-SUTTON SYNDROME; WHSUS	0.082733894	2.9212030129239053
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.08241761	2.910035524859828
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08239085400000001	2.909090812795221
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.90028842388407
GAUCHER DISEASE TYPE 2	0.08193319000000002	2.892931420422044
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08187854400000001	2.8910019565454346
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.08063971	2.847260686331408
CONE-ROD DYSTROPHY 10	0.0803653	2.837571703013683
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.080122614	2.8290028439872423
USHER SYNDROME	0.07956821	2.809427715138877
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.07883488300000001	2.7835350979986946
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.779120345110139
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.078432963	2.769343938146428
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07829105999999998	2.764333567534077
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.07750898299999999	2.736719664956997
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.7351497114048704
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	2.7160330623800553
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.7160330623800553
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.7160330623800553
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.7160330623800553
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.076504843	2.7012650688830186
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.6943536929799485
HYDROXYKYNURENINURIA	0.076281954	2.693395210631845
SENIOR-LOKEN SYNDROME 4; SLSN4	0.07583329999999999	2.677553947115826
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07550508	2.6659650177599583
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.07524900300000001	2.6569233436917647
LEIGH SYNDROME; LS	0.07498789300000001	2.6477039623496443
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0749364	2.64588582591883
MONOSOMY 18Q	0.074812953	2.6415271074915743
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.073777854	2.6049793980670124
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.073513684	2.5956519729620835
2Q24 MICRODELETION SYNDROME	0.072968019	2.576385404389267
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07279345000000001	2.5702216489547283
PEHO SYNDROME	0.072761414	2.5690905084366467
CONE-ROD DYSTROPHY 8; CORD8	0.0726908	2.5665972397219576
CONE-ROD DYSTROPHY 6; CORD6	0.07216120999999999	2.547898253988077
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.072110964	2.5461241471560285
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.5412936023227575
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.07197001900000001	2.5411476020092896
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.07197001900000001	2.5411476020092896
TAKAYASU ARTERITIS	0.07197001900000001	2.5411476020092896
SPONTANEOUS PERIODIC HYPOTHERMIA	0.07197001900000001	2.5411476020092896
SCLERODERMA	0.07197001900000001	2.5411476020092896
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07154332999999999	2.526081887921402
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07154332999999999	2.526081887921402
ALAND ISLAND EYE DISEASE	0.07150901	2.5248701029738267
CLEFT LIP AND ALVEOLUS	0.07142860000000001	2.5220309529844744
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.07142860000000001	2.5220309529844744
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	2.5220309529844744
RELAPSING POLYCHONDRITIS	0.07142860000000001	2.5220309529844744
PYCNODYSOSTOSIS	0.07142860000000001	2.5220309529844744
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.07142860000000001	2.5220309529844744
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.07057467299999999	2.4918801404865505
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.07044325399999998	2.487239943341285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.070351524	2.484001102046381
FG SYNDROME TYPE 1	0.06955916300000001	2.456024087686058
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.4535008421234523
DISTAL MONOSOMY 12Q	0.06923925399999999	2.4447286066023137
SILVER-RUSSELL SYNDROME	0.0691208	2.4405461831122155
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.069065519	2.438594298389403
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.068980663	2.4355981671682048
NIEMANN-PICK DISEASE, TYPE C2	0.068980663	2.4355981671682048
JOUBERT SYNDROME 2	0.068967284	2.435125775827482
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.4254659572640307
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06856063999999999	2.4207678190028283
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0685241	2.419477649364588
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.068111574	2.4049120084180915
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.06810997	2.4048553737136658
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.3978664252135724
LISSENCEPHALY 8; LIS8	0.067753673	2.392275089871402
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.067753673	2.392275089871402
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.067212254	2.373158440846587
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.067212254	2.373158440846587
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.067212254	2.373158440846587
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.067212254	2.373158440846587
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.067212254	2.373158440846587
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.067212254	2.373158440846587
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.066772329	2.357625384521926
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.066772329	2.357625384521926
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.066772329	2.357625384521926
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.066772329	2.357625384521926
RETINITIS PIGMENTOSA 41	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY	0.0666667	2.353895791508304
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.353895791508304
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.353895791508304
SPINOCEREBELLAR ATAXIA TYPE 40	0.0666667	2.353895791508304
PERRY SYNDROME	0.0666667	2.353895791508304
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0666667	2.353895791508304
KUFOR-RAKEB SYNDROME	0.0666667	2.353895791508304
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0666667	2.353895791508304
CARIBBEAN PARKINSONISM	0.0666667	2.353895791508304
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.353895791508304
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0666667	2.353895791508304
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.0666667	2.353895791508304
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0666667	2.353895791508304
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.353895791508304
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.353895791508304
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.353895791508304
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.0666667	2.353895791508304
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.353895791508304
CHROMOSOME 16P13.2 DELETION SYNDROME	0.066059293	2.332449210516104
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.065913673	2.3273075985095186
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.065832769	2.324451006161072
RETINITIS PIGMENTOSA 20	0.06566456	2.3185118122727615
HADDAD SYNDROME	0.065513739	2.313186561177821
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06522628	2.3030368382977144
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.06483230300000001	2.2891261332193014
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.2885081299577217
LEBER CONGENITAL AMAUROSIS	0.064813963	2.2884785768108356
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	2.2707409334070148
OCULODENTODIGITAL DYSPLASIA	0.064236409	2.2680860580575626
DIETHYLSTILBESTROL SYNDROME	0.06395896000000001	2.2582897724538333
BRONCHOPULMONARY DYSPLASIA	0.06395896000000001	2.2582897724538333
AMISH INFANTILE EPILEPSY SYNDROME	0.06368481000000001	2.2486099693251047
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.06326349	2.233733826140002
XQ12-Q13.3 DUPLICATION SYNDROME	0.06256964999999999	2.2092354325494967
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.0625	2.206776201150934
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0625	2.206776201150934
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0625	2.206776201150934
ARNOLD-CHIARI MALFORMATION TYPE I	0.0625	2.206776201150934
MULTIPLE SYSTEM ATROPHY	0.0625	2.206776201150934
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.0625	2.206776201150934
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.0625	2.206776201150934
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.0625	2.206776201150934
HEREDITARY METHEMOGLOBINEMIA	0.06187790900000001	2.1848111513309316
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.061804412999999996	2.1822161237520543
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.060068830000000004	2.1209354315997007
CHROMOSOME 1P36 DELETION SYNDROME	0.05999273299999999	2.1182485668224365
JOUBERT SYNDROME 3; JBTS3	0.059947150000000005	2.116639103149204
HYPOPLASMINOGENEMIA	0.0596073	2.1046395368778255
PGM3-CDG	0.05944951899999999	2.0990685391851245
YUNIS-VARON SYNDROME	0.059369054	2.0962274472327147
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.059364919	2.096081446919247
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.059364919	2.096081446919247
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.059364919	2.096081446919247
17Q24.2 MICRODELETION SYNDROME	0.059364919	2.096081446919247
MENTAL RETARDATION, X-LINKED 98; MRX98	0.059306853	2.0940312282489106
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.059266440000000004	2.0926043091030366
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.059205240000000006	2.0904434338468696
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0588235	2.0769647978944317
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.05816756299999999	2.053804699317562
CONE-ROD DYSTROPHY 20; CORD20	0.05802111	2.048633675397768
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.0400466678438494
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.05761994399999999	2.034469138093593
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.057594530000000005	2.0335718099275764
JOUBERT SYNDROME 1	0.057328144000000004	2.0241661413656598
JUVENILE ABSENCE EPILEPSY	0.056942849999999996	2.01056201929132
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.056642573	1.9999597130936717
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.056642573	1.9999597130936717
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05657202900000001	1.997468915968328
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.056106379000000005	1.981027550559273
JOUBERT SYNDROME 7	0.056101154	1.9808430640688566
WOLFRAM SYNDROME	0.056097019000000005	1.980697063755389
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.056097019000000005	1.980697063755389
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.05590010399999999	1.973744306384994
CREUTZFELDT-JAKOB DISEASE; CJD	0.05579616	1.9700742080577551
APNEA, OBSTRUCTIVE SLEEP	0.0555984	1.9630916150731217
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.9615804147305738
GITELMAN SYNDROME	0.055555600000000004	1.9615804147305738
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.9615804147305738
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.9615804147305738
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.9615804147305738
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.9615804147305738
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.9615804147305738
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.9615804147305738
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.9615804147305738
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.9615804147305738
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.9615804147305738
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	1.9615804147305738
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.9615804147305738
17P11.2 MICRODUPLICATION SYNDROME	0.054305743999999996	1.917449975119922
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.054031649	1.907772113954251
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.05387693	1.902309230641197
ADULT-ONSET DYSTONIA-PARKINSONISM	0.053718573	1.8967178952990265
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05348399999999999	1.8884354934777046
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.053466803	1.887828294592406
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.053247009	1.8800677158987138
KUFOR-RAKEB SYNDROME	0.053173019	1.8774552459607432
INHERITED CREUTZFELDT-JAKOB DISEASE	0.053173019	1.8774552459607432
INFANTILE MYOFIBROMATOSIS	0.0530914	1.8745734080925553
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0530914	1.8745734080925553
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0526316	1.858338596935928
SPASTIC PARAPLEGIA TYPE 7	0.0526316	1.858338596935928
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0526316	1.858338596935928
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.0526316	1.858338596935928
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0526316	1.858338596935928
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.0526316	1.858338596935928
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0526316	1.858338596935928
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0526316	1.858338596935928
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0526316	1.858338596935928
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0526316	1.858338596935928
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0526316	1.858338596935928
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.052624818999999996	1.8580991705452081
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.05252171	1.8544585547480164
ZELLWEGER SYNDROME	0.052496539	1.8535698065278698
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.052440749999999994	1.8515999851280935
JUVENILE XANTHOGRANULOMA	0.051742760000000006	1.8269550615978327
XP22.13P22.2 DUPLICATION SYNDROME	0.051624879	1.8227928698319462
PRADER-WILLI-LIKE SYNDROME	0.051568462999999995	1.82080091005332
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.8106586019412496
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8071244057195825
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.05078144899999999	1.7930126898105585
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.050513743	1.7835604141352737
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.05044311	1.7810664745606193
ACHROMATOPSIA	0.05038954	1.7791750025430888
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.049793033	1.7581132833203696
CHARGE SYNDROME	0.049612213999999995	1.7517288502657151
ERYTHERMALGIA, PRIMARY	0.0494995	1.747749097101931
DESMOID TUMOR	0.0494995	1.747749097101931
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.7328261349529448
MOHR-TRANEBJAERG SYNDROME	0.04894842	1.7282913334390466
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.04859377	1.7157692025632358
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.048517149999999995	1.7130638714827209
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.048288373	1.7049861172591896
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.047921654	1.6920378490718317
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.047786803	1.687276473431809
BIOTINIDASE DEFICIENCY	0.047750204000000004	1.6859842205968347
9P13 MICRODELETION SYNDROME	0.047677119999999996	1.6834037400866757
NEUROFIBROMATOSIS TYPE 1	0.047184279	1.6660023034506528
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.047042869	1.6610093398889767
CONGENITAL DISORDER OF GLYCOSYLATION	0.047032702999999995	1.6606503944992024
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.046841814	1.6539104056630185
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.046617570000000004	1.6459927045038043
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.046541473	1.6433058397265405
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.046235233	1.6324929894250932
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.04622591300000001	1.6321639149579779
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.046000054	1.6241891907017254
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.046000054	1.6241891907017254
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.62265842949493
GALLOWAY-MOWAT SYNDROME	0.045855562999999995	1.6190874419004373
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	1.6175775479694003
CONE-ROD DYSTROPHY, X-LINKED, 3	0.04575352	1.6154844648781326
YOU-HOOVER-FONG SYNDROME; YHFS	0.045693814000000006	1.613376340400278
CHRISTIANSON SYNDROME	0.04568974	1.6132324939003824
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.045689679000000004	1.61323034008681
AMYLOIDOSIS	0.04554079999999999	1.6079736579419912
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04551705	1.6071350829855544
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0454545	1.6049265413634421
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.04540046	1.6030184743888791
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.04537224	1.6020220707985355
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04532904899999999	1.6004970648640724
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.0452822	1.5988429007321094
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.04514712	1.5940734394640859
GLUTAMINE DEFICIENCY, CONGENITAL	0.044985889	1.5883806277250816
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.587945310224538
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.04497356	1.587945310224538
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5862487406810928
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04478762999999999	1.5813804158392575
WHITE FORELOCK WITH MALFORMATIONS	0.04472363000000001	1.5791206770092798
PSEUDOTRISOMY 13 SYNDROME	0.04470529	1.5784731206008138
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.044567273	1.5735999585055456
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.5692618601951136
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.5640907303500613
CANAVAN DISEASE	0.04428809	1.5637424481028912
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.044216963	1.5612310661691426
OPTIC PATHWAY GLIOMA	0.044080003000000006	1.5563952250729889
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.5542666923288257
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04350680900000001	1.5361566510275089
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.5351500433040108
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.5351500433040108
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.5351500433040108
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.5351500433040108
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	1.5351500433040108
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.5351500433040108
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.5351500433040108
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.5351500433040108
LICHTENSTEIN SYNDROME	0.043478300000000004	1.5351500433040108
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.5351500433040108
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.043320553	1.5295802460975634
DEND SYNDROME	0.043216219	1.5258963774868293
PRADER-WILLI SYNDROME; PWS	0.043153243	1.5236727944781303
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.5145083883447328
49,XYYYY SYNDROME	0.04289368999999999	1.5145083883447328
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.042822559	1.5119968651773081
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.042809413	1.5115327006982626
COFS SYNDROME	0.04280571899999999	1.5114022713976696
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5096661917331198
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.5096661917331198
WEST SYNDROME	0.0426748	1.5067797284620144
ALG13-CDG	0.0426748	1.5067797284620144
ALPERS-HUTTENLOCHER SYNDROME	0.04261669400000001	1.5047280974549093
CHERUBISM	0.04227	1.4924868803624
16P13.11 MICRODELETION SYNDROME	0.042255454	1.4919732840964488
SCHWARTZ-JAMPEL SYNDROME	0.04224055	1.4914470474164176
COG2-CDG	0.04221225399999999	1.490447960386213
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.483728768208949
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.04181266399999999	1.4763390691507265
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.041719814	1.473060682426297
HAMAMY SYNDROME; HMMS	0.041666699999999994	1.47118531104793
49,XXXYY SYNDROME	0.041666699999999994	1.47118531104793
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.47118531104793
HISTIDINEMIA	0.041666699999999994	1.47118531104793
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.47118531104793
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.47118531104793
GYRATE ATROPHY OF CHOROID AND RETINA	0.041540719000000004	1.466737121086375
NORRIE DISEASE	0.041036809	1.4489448555580235
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.040928619000000006	1.4451248376827834
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.4451248376827834
MENTAL RETARDATION, X-LINKED 106; MRX106	0.040905854	1.444321041519276
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.040888704	1.4437155021296801
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.4356918757128105
OSTEOPETROSIS AND RELATED DISORDERS	0.04061194	1.4339434027931148
DOORS SYNDROME	0.040533034	1.4311573566662665
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.040528854	1.4310097674739337
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.040447574	1.4281398991598608
OCULOCUTANEOUS ALBINISM	0.0404459	1.4280807928660892
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04020156	1.4194535337142615
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.040015769	1.412893547199253
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.039858799	1.4073511846345386
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.039817654	1.4058984197257969
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.039661714	1.4003924248328774
OPTIC ATROPHY 8	0.03951446	1.3951931188692888
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.3866357703875138
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.039092333	1.3802884817898768
MARSHALL-SMITH SYNDROME; MRSHSS	0.03905765	1.3790638798861246
LISSENCEPHALY 2; LIS2	0.038809544	1.3703036492275207
COSTELLO SYNDROME; CSTLO	0.038765644	1.3687536096238322
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.03874215	1.3679240736227147
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.038735919	1.3677040668625648
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.038535394	1.360623846098792
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3601262092383275
CEDNIK SYNDROME	0.038492573	1.3591119042794404
1P36 DELETION SYNDROME	0.038423753	1.356681978868829
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.038421223	1.3565926485682063
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.038298733	1.3522677202981428
MYHRE SYNDROME	0.038197682999999996	1.3486998045361218
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.038149659	1.3470041530115768
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.038124033	1.346099339460686
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.3443574692153837
SCLEROSTEOSIS 1; SOST1	0.03801564	1.3422721539763443
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.038007514	1.3419852377617754
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.33759802544021
XIA-GIBBS SYNDROME	0.037591533999999996	1.3272976415352988
13Q12.3 MICRODELETION SYNDROME	0.03740978	1.320880195108675
X-LINKED RETINOSCHISIS	0.0374056	1.320732605916342
CARTILAGE-HAIR HYPOPLASIA	0.03733677999999999	1.3183026805057305
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.037274100000000004	1.3160895487891209
JOUBERT SYNDROME 30; JBTS30	0.037117343000000004	1.3105547069176997
MYOCLONUS AND ATAXIA	0.037037	1.3077179225924345
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3077179225924345
MCLEOD SYNDROME; MCLDS	0.037037	1.3077179225924345
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3077179225924345
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3077179225924345
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3077179225924345
HALLERMANN-STREIFF SYNDROME; HSS	0.03685898	1.3014323178031724
SOTOS SYNDROME	0.036803593	1.299476690387922
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.2993947748553352
MACULAR DYSTROPHY, RETINAL, 2	0.03674451	1.2973905630552403
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.03674451	1.2973905630552403
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.03674451	1.2973905630552403
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.03674451	1.2973905630552403
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.03674451	1.2973905630552403
ACHROMATOPSIA 7; ACHM7	0.03674451	1.2973905630552403
STARGARDT DISEASE	0.03674451	1.2973905630552403
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.036676943000000004	1.2950048790939097
19P13.3 MICRODUPLICATION SYNDROME	0.036415833999999994	1.2857855330602084
BAKER-GORDON SYNDROME; BAGOS	0.036275594	1.2808338803490182
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.036259854	1.2802781258305203
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.2801321255170524
SCHAAF-YANG SYNDROME; SHFYNG	0.036208803	1.2784755957210008
16P13.2 MICRODELETION SYNDROME	0.036208803	1.2784755957210008
ALSTROM SYNDROME; ALMS	0.036110714	1.2750122281882859
SAETHRE-CHOTZEN SYNDROME	0.035953348999999996	1.2694559187979797
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03592458399999999	1.2684402721191619
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.035924053000000004	1.2684215233485574
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.03590774	1.2678455371058472
SECKEL SYNDROME 2; SCKL2	0.03590774	1.2678455371058472
ROWLEY-ROSENBERG SYNDROME	0.03590774	1.2678455371058472
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.03568606999999999	1.260018719817701
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.259318906948792
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.259318906948792
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.035624382999999996	1.2578406493613745
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.035520754	1.2541816731861897
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.035422659999999995	1.2507181291113783
SMITH-MAGENIS SYNDROME; SMS	0.035171673	1.241856174897006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.035146914	1.2409819737455774
DYSOSTEOSCLEROSIS	0.035136919	1.2406290660954895
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.035063313	1.2380301545904986
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.034979513999999996	1.2350713443684147
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.034948963	1.2339926368528729
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.034833984	1.2299329101195589
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.2294409226061696
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.034783003	1.2281328515993848
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03473042	1.226276228991623
22Q11.2 MICRODUPLICATION SYNDROME	0.034535003	1.219376363633218
CONE-ROD DYSTROPHY 17; CORD17	0.03441456	1.2151237116972942
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.034407544	1.214875987828058
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.034152039999999995	1.205854545484076
MEIER-GORLIN SYNDROME 5; MGORS5	0.034152039999999995	1.205854545484076
SECKEL SYNDROME	0.034152039999999995	1.205854545484076
ISOTRETINOIN-LIKE SYNDROME	0.034152039999999995	1.205854545484076
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.03403064399999999	1.2015682446246372
CHROMOSOME 17Q12 DELETION SYNDROME	0.03397144	1.1994778449732302
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0337422	1.191383742951601
POTOCKI-LUPSKI SYNDROME	0.033537613	1.1841600993889632
SPINOCEREBELLAR ATAXIA TYPE 34	0.03350343	1.18295315169482
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	1.18295315169482
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.1823055952863541
DENT DISEASE	0.033485089999999995	1.1823055952863541
PITT-HOPKINS SYNDROME	0.033401602999999995	1.1793578012910664
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.033377719	1.1785144950064539
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.032803653999999995	1.1582451673278342
NETHERTON SYNDROME; NETH	0.032803653999999995	1.1582451673278342
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.1582451673278342
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.158099167014366
TUBEROUS SCLEROSIS-1	0.032799519	1.158099167014366
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.158099167014366
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.158099167014366
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.158099167014366
RETINITIS PIGMENTOSA 11	0.032795210000000005	1.1579470230359543
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.032712354	1.1550215086531932
WILLIAMS SYNDROME	0.03266387999999999	1.1533099683399994
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.03252151	1.1482831086958738
1Q21.1 MICRODELETION SYNDROME	0.032480233	1.1468256830757952
3P25.3 MICRODELETION SYNDROME	0.032453899999999994	1.1458959064725167
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.0324507	1.1457829195310179
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.1389825179895512
MILD CANAVAN DISEASE	0.0322581	1.1389825179895512
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.1389825179895512
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.1389825179895512
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.1389825179895512
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.1389825179895512
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1389825179895512
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.1389825179895512
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.1389825179895512
THROMBOCYTOPENIA 1	0.0322581	1.1389825179895512
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.1389825179895512
COG1-CDG	0.0322581	1.1389825179895512
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.1389825179895512
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.1389825179895512
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.1389825179895512
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.1389825179895512
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.1389825179895512
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	1.1389825179895512
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.1389825179895512
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0322581	1.1389825179895512
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.1389825179895512
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.1389825179895512
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1389825179895512
FETAL ALCOHOL SYNDROME	0.032256224	1.1389162793950975
CARDIOFACIOCUTANEOUS SYNDROME	0.032223134	1.1377479238031603
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.032136004	1.1346715012366597
GIANT CELL ARTERITIS	0.03207396	1.1324808256746723
X-LINKED ADRENOLEUKODYSTROPHY	0.03207396	1.1324808256746723
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.032062944	1.1320918681285623
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.031944440000000004	1.1279076792175036
ACHONDROPLASIA	0.03169233	1.1190060736483485
TYSHCHENKO SYNDROME	0.031676154	1.1184349246590715
TETRASOMY X	0.031589274	1.1153673291973758
PENTASOMY X	0.031589274	1.1153673291973758
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.031589274	1.1153673291973758
DISTAL MONOSOMY 7Q36	0.031585139	1.1152213288839075
C SYNDROME	0.031585139	1.1152213288839075
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.03152996	1.1132730456198547
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.031483779	1.1116424675119292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.03134496	1.1067409880644479
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.03134496	1.1067409880644479
SHORT SYNDROME	0.03130574	1.1053561918627015
CRANIOSYNOSTOSIS 2	0.031295359	1.1049896551627953
COFFIN-LOWRY SYNDROME	0.031254449	1.1035451877325697
CONE-ROD DYSTROPHY 18	0.03125	1.103388100575467
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.03125	1.103388100575467
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.03125	1.103388100575467
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1025728291757138
JOUBERT SYNDROME 23; JBTS23	0.031081414	1.0974355954131114
DOWN SYNDROME	0.03104372	1.0961046798590925
TURNPENNY-FRY SYNDROME; TPFS	0.031010894	1.0949456456898288
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.030987783999999997	1.0941296681216912
DYSTONIA 28, CHILDHOOD-ONSET	0.030831164	1.0885996635037032
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.03082266	1.0882994007066698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.030758713	1.0860415332229096
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	1.0824547980734454
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03063879	1.0818072416649798
WYBURN-MASON SYNDROME	0.030628033	1.0814274289994472
KOOLEN-DE VRIES SYNDROME	0.030586293	1.0799536555812708
RAVINE SYNDROME	0.030535859999999998	1.0781729460748282
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.030468094	1.0757802357380732
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.03046534	1.0756829963515457
BARATELA-SCOTT SYNDROME	0.030387864	1.07294744126418
LOWRY-MACLEAN SYNDROME	0.030302329	1.0699273356263326
7Q11.23 MICRODUPLICATION SYNDROME	0.030220109000000002	1.0670242773981946
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.03019156	1.0660162573379282
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030110103000000003	1.0631401394336537
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.030044874	1.0608370065564556
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02997931	1.0585220453588193
NAVAJO NEUROHEPATOPATHY	0.029957354	1.0577468137064598
RAHMAN SYNDROME	0.029947143999999995	1.0573863147462397
RETINAL CONE DYSTROPHY 4	0.02993567	1.0569811859441278
RETINITIS PIGMENTOSA 4; RP4	0.029833600000000002	1.0533772555945042
ALG12-CDG	0.02979839	1.0521340461538238
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.02979839	1.0521340461538238
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.02979839	1.0521340461538238
COG7-CDG	0.02979839	1.0521340461538238
VASCULAR EHLERS-DANLOS SYNDROME	0.029782214	1.0515628971645468
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.029756709	1.050662355932381
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.0490474900710074
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.029658373000000002	1.047190267220119
ALG1-CDG	0.029658373000000002	1.047190267220119
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.029658373000000002	1.047190267220119
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.029568353999999998	1.0440118386304966
EPILEPSY, PYRIDOXINE-DEPENDENT	0.029568353999999998	1.0440118386304966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.029564549000000002	1.0438774900953705
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02954584	1.0432169048802131
SUSAC SYNDROME	0.02954106	1.0430481306363493
LEBER OPTIC ATROPHY AND DYSTONIA	0.02954106	1.0430481306363493
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	1.0384841643681768
ECHO VIRUS 11 SENSITIVITY	0.0294118	1.0384841643681768
IMMUNE SUPPRESSION	0.0294118	1.0384841643681768
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	1.0384841643681768
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	1.0384841643681768
MYELOPEROXIDASE DEFICIENCY	0.0294118	1.0384841643681768
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	1.0384841643681768
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	1.0384841643681768
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	1.0384841643681768
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	1.0384841643681768
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	1.0384841643681768
MONOMELIC AMYOTROPHY	0.0294118	1.0384841643681768
MYASTHENIA GRAVIS; MG	0.0294118	1.0384841643681768
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	1.0384841643681768
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	1.0384841643681768
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	1.0384841643681768
RAGWEED SENSITIVITY	0.0294118	1.0384841643681768
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	1.0384841643681768
USHER SYNDROME, TYPE IIIA	0.029304010000000002	1.0346782698606238
CAVITARY OPTIC DISC ANOMALIES; CODA	0.029304010000000002	1.0346782698606238
RETINITIS PIGMENTOSA 78; RP78	0.029304010000000002	1.0346782698606238
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.029304010000000002	1.0346782698606238
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.029297874	1.0344616174002996
KEPPEN-LUBINSKY SYNDROME	0.029225429	1.0319036989700217
AURICULOCONDYLAR SYNDROME	0.029116954	1.028073618195304
PROPIONIC ACIDEMIA	0.029116954	1.028073618195304
MUCOPOLYSACCHARIDOSIS, TYPE II	0.029112819	1.027927617881836
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.029004790000000003	1.0241132846620897
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.028864773000000003	1.019169505728385
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.028864773000000003	1.019169505728385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.028864773000000003	1.019169505728385
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.028864773000000003	1.019169505728385
DISTAL MONOSOMY 6P	0.028817884	1.0175139292596527
RENPENNING SYNDROME	0.028813749	1.0173679289461846
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.028762459	1.015556960124472
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.028752319999999998	1.0151989680620164
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0106681917079094
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0106681917079094
EMANUEL SYNDROME	0.028583053	1.009222417866173
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	1.0088109688570208
CONGENITAL LOBAR EMPHYSEMA	0.0285714	1.0088109688570208
HURLER-SCHEIE SYNDROME	0.0285714	1.0088109688570208
SCHEIE SYNDROME	0.0285714	1.0088109688570208
ACRODYSOSTOSIS	0.0285714	1.0088109688570208
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0285714	1.0088109688570208
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	1.0088109688570208
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	1.0088109688570208
CHEILITIS GLANDULARIS	0.0285714	1.0088109688570208
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	1.0088109688570208
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	1.0088109688570208
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0285714	1.0088109688570208
ALPHA-THALASSEMIA	0.0285714	1.0088109688570208
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	1.0088109688570208
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0285714	1.0088109688570208
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	1.0088109688570208
TETRASOMY 9P	0.028509312999999998	1.0066187750330071
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.028509312999999998	1.0066187750330071
STVE-WIEDEMANN SYNDROME	0.028509189999999997	1.0066144320974433
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.02827233	0.9982512799213694
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.02827233	0.9982512799213694
NANOPHTHALMOS	0.02827233	0.9982512799213694
PEHO-LIKE SYNDROME; PEHOL	0.028270504000000002	0.9981868067478767
BETA-UREIDOPROPIONASE DEFICIENCY	0.028270504000000002	0.9981868067478767
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.02822104	0.9964403110996569
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.02822104	0.9964403110996569
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.028177523000000003	0.9949037946205294
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.02794395	0.9866567012184264
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.027807463999999997	0.9818375963129818
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.027799489	0.981556011669715
GIANT AXONAL NEUROPATHY	0.027777800000000002	0.9807902073652869
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9807902073652869
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.027777800000000002	0.9807902073652869
OROFACIODIGITAL SYNDROME XVII	0.027777800000000002	0.9807902073652869
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.9807902073652869
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9807902073652869
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.027777800000000002	0.9807902073652869
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.027621859999999998	0.975284212472367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9735432955543839
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.9733972952409159
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.027327753999999996	0.9648997945297157
BARDET-BIEDL SYNDROME 21; BBS21	0.0273007	0.963944560556181
ALEXANDER DISEASE	0.027274609000000002	0.9630233285903533
TRISOMY 13	0.027198758999999996	0.9603451849926364
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.027178294	0.9596225981933316
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9542806462161009
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.027027	0.9542806462161009
HYPEROPIA, HIGH	0.027027	0.9542806462161009
ACRAL PEELING SKIN SYNDROME	0.027027	0.9542806462161009
BENIGN OCCIPITAL EPILEPSY	0.027027	0.9542806462161009
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.027027	0.9542806462161009
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.027027	0.9542806462161009
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.027027	0.9542806462161009
MICROPHTHALMIA, ISOLATED 1	0.027027	0.9542806462161009
CRANIOECTODERMAL DYSPLASIA	0.027027	0.9542806462161009
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.027027	0.9542806462161009
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9542806462161009
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.026832889	0.947426893653195
RETINITIS PIGMENTOSA 19	0.02677111	0.9452455748223006
RETINITIS PIGMENTOSA 10; RP10	0.02677111	0.9452455748223006
RETINITIS PIGMENTOSA 83; RP83	0.02677111	0.9452455748223006
CHERUBISM	0.02677111	0.9452455748223006
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.02677111	0.9452455748223006
RETINITIS PIGMENTOSA 79	0.02677111	0.9452455748223006
RETINITIS PIGMENTOSA 72; RP72	0.02677111	0.9452455748223006
RETINITIS PIGMENTOSA 14	0.02677111	0.9452455748223006
ZUNICH NEUROECTODERMAL SYNDROME	0.026768409000000003	0.9451502067819919
MAPLE SYRUP URINE DISEASE; MSUD	0.026768409000000003	0.9451502067819919
ZIMMERMANN-LABAND SYNDROME 1	0.026768409000000003	0.9451502067819919
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.026709563000000002	0.9430724475446649
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02665816	0.9412574888715808
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.9356964128446804
GABRIELE-DE VRIES SYNDROME	0.02650013	0.9356776993824945
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.026439254	0.9335282640541542
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02637401	0.9312246015506681
GALACTOSEMIA	0.026369563	0.9310675850104037
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.026286533	0.9281359269626989
LINEAR NEVUS SEBACEUS SYNDROME	0.026219949	0.9257849511774598
MICROSPORIDIOSIS	0.026047279	0.9196882464310161
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.026040463	0.9194475842456233
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.026035464	0.9192710774579507
CROUZON SYNDROME	0.025784609	0.9104137839549151
16P11.2P12.2 MICRODELETION SYNDROME	0.025745114	0.9090192779378838
1P21.3 MICRODELETION SYNDROME	0.025683564	0.9068460447349902
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.025644760000000003	0.905475936835639
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025621114	0.9046410339548003
OCULOCEREBRORENAL SYNDROME OF LOWE	0.025606899	0.9041391247756105
ISOLATED PLAGIOCEPHALY	0.025600384	0.9039090904244027
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.025588783	0.9034994774530498
LYNCH SYNDROME	0.025577909000000003	0.9031155337024689
FAMILIAL COLORECTAL CANCER TYPE X	0.025577909000000003	0.9031155337024689
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.025541419000000003	0.901827129485189
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025541419000000003	0.901827129485189
KEUTEL SYNDROME; KTLS	0.025541419000000003	0.901827129485189
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.025541419000000003	0.901827129485189
TOXIC EPIDERMAL NECROLYSIS	0.025505859999999998	0.9005715974062011
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.025502843	0.9004650719054192
PYRUVATE DEHYDROGENASE DEFICIENCY	0.025484503000000002	0.8998175154969534
DPM1-CDG	0.025304818999999996	0.8934731574981116
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025147104	0.8879044901610794
GORLIN-CHAUDHRY-MOSS SYNDROME	0.025138009999999995	0.8875833953967069
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.025115699	0.886795629255525
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02507556	0.8853783846165172
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.8827104804603738
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.8827104804603738
HOOFT DISEASE	0.025	0.8827104804603738
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.8827104804603738
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.8827104804603738
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.8827104804603738
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.025	0.8827104804603738
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.8827104804603738
MARFANOID HYPERMOBILITY SYNDROME	0.025	0.8827104804603738
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.025	0.8827104804603738
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	0.8827104804603738
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.8827104804603738
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.8827104804603738
OSTEOGENESIS IMPERFECTA, TYPE I	0.025	0.8827104804603738
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.8827104804603738
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.8827104804603738
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.025	0.8827104804603738
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.8827104804603738
ALKAPTONURIA	0.025	0.8827104804603738
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.8827104804603738
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.025	0.8827104804603738
3MC SYNDROME 1	0.02492624	0.8801061314588234
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.024735203	0.8733609169765951
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.024587273	0.8681377425216149
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.024528009	0.8660452243650548
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02451503	0.865586956392019
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.024482939999999998	0.8644539092193
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.024482939999999998	0.8644539092193
SNEDDON SYNDROME	0.024350919000000002	0.8597924564056659
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.024350919000000002	0.8597924564056659
FAMILIAL THROMBOCYTOSIS	0.024350919000000002	0.8597924564056659
AICARDI-GOUTIERES SYNDROME 7	0.024257513	0.8564944382001505
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.024077828999999995	0.8501500802013087
AGEL AMYLOIDOSIS	0.02399786	0.8473265012248314
HAREL-YOON SYNDROME; HAYOS	0.023945533999999997	0.8454789528808084
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.8406758073808508
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0238095	0.8406758073808508
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.8406758073808508
FUNCTIONING GONADOTROPIC ADENOMA	0.0238095	0.8406758073808508
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.8406758073808508
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.8406758073808508
PITUICYTOMA	0.0238095	0.8406758073808508
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.0238095	0.8406758073808508
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.0238095	0.8406758073808508
CRYPTOCOCCOSIS	0.023806919000000003	0.840584676350848
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.023768323	0.8392219126026942
OROFACIODIGITAL SYNDROME TYPE 4	0.023716094	0.8373777891753355
INFANTILE REFSUM DISEASE	0.023590563000000002	0.8329454880024286
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.023590563	0.8329454880024286
HERMANSKY-PUDLAK SYNDROME	0.02358764	0.8328422814930532
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.02358764	0.8328422814930532
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.023541368999999996	0.8312085256273978
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.023518073	0.8303859806932857
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.023295614	0.8225313050623764
CINCA SYNDROME	0.023295554000000003	0.8225291865572233
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.023165603	0.8179408221713711
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.02313799	0.8169658507914929
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.023045009	0.8136828386641456
ISOLATED CEREBELLAR AGENESIS	0.023045008999999998	0.8136828386641454
6Q25 MICRODELETION SYNDROME	0.023029922999999997	0.8131501758518165
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.022952294	0.8104092185763101
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.02276314	0.8037304898474701
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02272724	0.802462917597529
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.022663584	0.8002153248637616
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.022620049	0.7986781728330878
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.022605844	0.7981766167380901
WIEACKER-WOLFF SYNDROME	0.022541333	0.795898835305891
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.7949056447816962
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7949056447816962
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.7949056447816962
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7929054228329732
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.7896224107056257
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.7896224107056257
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.022342309999999997	0.7888716477877844
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.022342309999999997	0.7888716477877844
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.022342309999999997	0.7888716477877844
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.022237358999999998	0.7851659938823925
AYM-GRIPP SYNDROME	0.022081614	0.7796668841312205
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02207863	0.7795615238082728
OPTIC ATROPHY 11; OPA11	0.022068624	0.7792082277655733
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02196784	0.7756497040430645
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7756429954434131
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.02196306	0.7754809297992006
SIALURIA	0.021920273	0.7739701884661023
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.021920273	0.7739701884661023
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.021920273	0.7739701884661023
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.021822154	0.7705057616808106
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.021822154	0.7705057616808106
HUNTINGTON DISEASE; HD	0.021818019	0.7703597613673426
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.021818019	0.7703597613673426
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.021818019	0.7703597613673426
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021756653	0.7681930249135852
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021756653	0.7681930249135852
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.021546533	0.7607740198674119
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.021453503	0.7574892776275227
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.021444369	0.7571667705263818
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.021436594	0.7568922475669586
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.7547075391278192
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.7547075391278192
CEREBROTENDINOUS XANTHOMATOSIS	0.021343319	0.7535988547643608
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.021343319	0.7535988547643608
GAUCHER DISEASE, PERINATAL LETHAL	0.021343308999999998	0.7535985016801687
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.021299298999999997	0.7520445781503662
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7515892760845448
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7512431123425275
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 69	0.0212766	0.7512431123425275
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.7512431123425275
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7512431123425275
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7512431123425275
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 1	0.0212766	0.7512431123425275
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7512431123425275
NEUROFERRITINOPATHY	0.0212766	0.7512431123425275
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.7512431123425275
KURU, SUSCEPTIBILITY TO	0.0212766	0.7512431123425275
PRIMARY BASILAR INVAGINATION	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.7512431123425275
RETINITIS PIGMENTOSA 6	0.0212766	0.7512431123425275
KID SYNDROME	0.021106009999999998	0.745219849108058
JOUBERT SYNDROME WITH OCULAR DEFECT	0.021083012999999998	0.7444078613912921
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.021000979	0.7415113705291287
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7405732611389146
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02097441	0.7405732611389146
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.020937633	0.7392747234053191
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.020937633	0.7392747234053191
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020937633	0.7392747234053191
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.020937633	0.7392747234053191
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.020937633	0.7392747234053191
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.020928259999999997	0.7389437775919847
MENKES DISEASE	0.020903749	0.7380783329285222
SECONDARY SHORT BOWEL SYNDROME	0.02089104	0.7376295982286755
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02089104	0.7376295982286755
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02089104	0.7376295982286755
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.735590890103004
CRANDALL SYNDROME	0.0208333	0.735590890103004
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.735590890103004
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.735590890103004
STICKLER SYNDROME, TYPE III	0.0208333	0.735590890103004
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.735590890103004
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.735590890103004
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.735590890103004
GLAUCOMA - SLEEP APNEA	0.0208333	0.735590890103004
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.735590890103004
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.735590890103004
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.735590890103004
ACROMEGALY	0.0208333	0.735590890103004
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.735590890103004
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.735590890103004
HYPOCHONDROPLASIA	0.0208333	0.735590890103004
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.735590890103004
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.735590890103004
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.735590890103004
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.735590890103004
UNIQUE GREEN PHENOMENON	0.0208333	0.735590890103004
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.735590890103004
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.735590890103004
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.735590890103004
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.735590890103004
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.735590890103004
DERMOIDS OF CORNEA	0.0208333	0.735590890103004
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.735590890103004
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.735590890103004
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.735590890103004
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.735590890103004
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.735590890103004
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.735590890103004
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.735590890103004
PUPIL, EGG-SHAPED	0.0208333	0.735590890103004
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.735590890103004
GAUCHER DISEASE, TYPE I	0.0208333	0.735590890103004
IMINOGLYCINURIA	0.0208333	0.735590890103004
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.735590890103004
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.735590890103004
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.735590890103004
611426 TENTED EYEBROWS	0.0208333	0.735590890103004
APNEA, CENTRAL SLEEP	0.0208333	0.735590890103004
SOMATOMAMMOTROPINOMA	0.0208333	0.735590890103004
ALSTRM SYNDROME	0.020809673	0.7347566580821306
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.020801899999999998	0.7344822057395459
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.020762933	0.733106342567862
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7323266267462616
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7323266267462616
8Q24.3 MICRODELETION SYNDROME	0.020670523	0.7298434915478882
MOEBIUS SYNDROME; MBS	0.020669680000000003	0.7298137265504873
SPINOCEREBELLAR ATAXIA TYPE 7	0.020648064	0.7290504997606618
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.020643039999999998	0.7288731102625085
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.020525164	0.7247110950387186
ANGELMAN SYNDROME	0.020427293	0.721255424741393
STEVENS-JOHNSON SYNDROME	0.02040596	0.7205021902342067
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020365923999999997	0.7190885823623782
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.020304313999999997	0.7169132306543315
RETINITIS PIGMENTOSA 80; RP80	0.020268254	0.7156400090573156
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.020264118999999997	0.7154940087438474
MIRAGE SYNDROME; MIRAGE	0.020222313	0.7140179049700024
SMITH-FINEMAN-MYERS SYNDROME	0.020143928999999998	0.7112502898379861
SIALIDOSIS TYPE 1	0.020139908999999998	0.7111083499927281
GAUCHER DISEASE, TYPE II	0.020066142999999998	0.7085037891406626
TRANSIENT NEONATAL DIABETES MELLITUS	0.019967994000000003	0.7050383031027946
PERMANENT NEONATAL DIABETES MELLITUS	0.019967994000000003	0.7050383031027946
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.019837683000000002	0.7004372276860236
DISTAL MONOSOMY 10Q	0.019744672999999997	0.6971531916145186
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0197227	0.6963773597190325
6Q TERMINAL DELETION SYNDROME	0.019693442999999998	0.6953443412979593
LEUKOCYTE ADHESION DEFICIENCY	0.019676759000000002	0.6947552556317194
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6947270442047637
PITT-HOPKINS-LIKE SYNDROME	0.019610859	0.6924284308052259
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6919849923682617
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.019575272999999997	0.6911719453989192
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.019502879	0.6886158276980214
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.019436834	0.6862838831507411
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.019234638999999998	0.6791446973268735
CONE-ROD DYSTROPHY 16	0.01919311	0.6776783739851521
CONE DYSTROPHY 3	0.01919311	0.6776783739851521
PYRIDOXINE-DEPENDENT EPILEPSY	0.019185074	0.6773946355283129
DYSEQUILIBRIUM SYNDROME	0.019142738999999995	0.6758998536007012
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01913954	0.6757869019676217
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.019099133999999997	0.6743602299806823
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.6737589276013928
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01893494	0.668562799395534
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.018912918999999997	0.6677852726959251
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083000000002	0.6677204464382404
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01890171	0.667389500624906
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.018842653	0.6653042913111241
OROFACIODIGITAL SYNDROME TYPE 6	0.018820813	0.6645331554353938
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.018776583	0.6629714640533634
GAUCHER DISEASE	0.018773830000000002	0.6628742599752552
ZTTK SYNDROME; ZTTKS	0.018710703	0.6606453453952542
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6544962782631096
HYPERPROLINEMIA, TYPE I	0.018481163	0.6525406508478592
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.01846839	0.6520896564091825
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.01846839	0.6520896564091825
MOSAIC TRISOMY 15	0.01846839	0.6520896564091825
ALG11-CDG	0.018461303	0.6518394256421814
ALG3-CDG	0.018442962999999996	0.6511918692337156
MULTIPLE CARBOXYLASE DEFICIENCY	0.018442962999999996	0.6511918692337156
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.018392943999999998	0.6494257774128298
X SMALL RINGS	0.018296724	0.6460284013156341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.018285753	0.6456410326483888
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.018285753	0.6456410326483888
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.018285753	0.6456410326483888
NEONATAL ADRENOLEUKODYSTROPHY	0.018258609000000002	0.6446826209171242
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0182192	0.6432911514241457
XYLOSIDASE DEFICIENCY	0.018209209000000004	0.6429383850077346
SALLA DISEASE	0.018158703	0.6411550979866892
PREECLAMPSIA	0.018022939999999998	0.6363615210683394
FETAL PARVOVIRUS SYNDROME	0.018022939999999998	0.6363615210683394
LOEYS-DIETZ SYNDROME 5	0.01800905	0.6358710871253958
GERODERMA OSTEODYSPLASTICA	0.017901544	0.6320752202089007
CONGENITAL HYPOTHYROIDISM	0.017901544	0.6320752202089007
MPDU1-CDG	0.017897409	0.6319292198954327
BENIGN FAMILIAL INFANTILE EPILEPSY	0.017897408999999996	0.6319292198954325
CHOREOACANTHOCYTOSIS	0.017897408999999996	0.6319292198954325
CURRARINO SYNDROME	0.017786954	0.6280292284506627
WHIM SYNDROME	0.017782819000000002	0.6278832281371945
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.017782819000000002	0.6278832281371945
YUNIS-VARON SYNDROME	0.017704710000000002	0.6251253228204634
COFFIN-SIRIS SYNDROME 1; CSS1	0.017626803	0.6223745498044142
PHELAN-MCDERMID SYNDROME	0.017580212999999997	0.6207295305530283
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.017580212999999997	0.6207295305530283
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.017580212999999997	0.6207295305530283
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01752372	0.6187348520261224
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01752372	0.6187348520261224
STICKLER SYNDROME	0.017505430000000002	0.6180890610386177
MEHMO SYNDROME	0.017498359	0.6178393952063242
HYPEREKPLEXIA 2; HKPX2	0.01748359	0.6173179251628874
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.017404578999999996	0.6145281716520211
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.017374329999999997	0.6134601272790833
TOWNES-BROCKS SYNDROME	0.017374329999999997	0.6134601272790833
EEM SYNDROME	0.017374329999999997	0.6134601272790833
WAARDENBURG SYNDROME TYPE 1	0.017374329999999997	0.6134601272790833
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.017317623	0.6114578927504648
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.017289374	0.6104604652159638
ISOLATED AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123795
RAT-BITE FEVER	0.0172414	0.6087665791123795
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6087665791123795
MELIOIDOSIS	0.0172414	0.6087665791123795
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.0172414	0.6087665791123795
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6087665791123795
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0172414	0.6087665791123795
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0172414	0.6087665791123795
TRANSSEXUALITY	0.0172414	0.6087665791123795
CYCLIC NEUTROPENIA	0.0172414	0.6087665791123795
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6087665791123795
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6087665791123795
269800 SENILE PLAQUE FORMATION	0.0172414	0.6087665791123795
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6087665791123795
X-LINKED AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123795
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6087665791123795
PLAGUE	0.0172414	0.6087665791123795
FELTY SYNDROME	0.0172414	0.6087665791123795
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0172414	0.6087665791123795
COMBINED IMMUNODEFICIENCY DUE TO PARTIAL RAG1 DEFICIENCY	0.0172414	0.6087665791123795
WISKOTT-ALDRICH SYNDROME	0.0172414	0.6087665791123795
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6087665791123795
LAMELLAR ICHTHYOSIS	0.0172414	0.6087665791123795
CERVICAL RIB	0.0172414	0.6087665791123795
NEUROLEPTIC MALIGNANT SYNDROME	0.0172414	0.6087665791123795
IMMUNODEFICIENCY 46; IMD46	0.0172414	0.6087665791123795
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6087665791123795
ALCOHOL DEPENDENCE	0.0172414	0.6087665791123795
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6087665791123795
HIRSCHSPRUNG DISEASE	0.0172414	0.6087665791123795
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.0172414	0.6087665791123795
THUMBS, CONGENITAL CLASPED	0.0172414	0.6087665791123795
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6087665791123795
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	0.0172414	0.6087665791123795
PYOMYOSITIS	0.0172414	0.6087665791123795
CHRONIC GRANULOMATOUS DISEASE	0.0172414	0.6087665791123795
OMENN SYNDROME	0.0172414	0.6087665791123795
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6087665791123795
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6087665791123795
RETICULAR DYSGENESIS	0.0172414	0.6087665791123795
SEVERE COMBINED IMMUNODEFICIENCY	0.0172414	0.6087665791123795
RETICULAR DYSGENESIA	0.0172414	0.6087665791123795
PALMOMENTAL REFLEX	0.0172414	0.6087665791123795
CLASSIC GALACTOSEMIA	0.0172414	0.6087665791123795
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6087665791123795
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6087665791123795
DIASTEMATOMYELIA	0.0172414	0.6087665791123795
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6087665791123795
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6087665791123795
MYOPATHY, CONGENITAL	0.0172414	0.6087665791123795
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6087665791123795
MOTION SICKNESS	0.0172414	0.6087665791123795
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6087665791123795
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6087665791123795
LEGIONELLOSIS	0.0172414	0.6087665791123795
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6087665791123795
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6087665791123795
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6087665791123795
BULLOUS IMPETIGO	0.0172414	0.6087665791123795
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6087665791123795
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6087665791123795
CALCIPHYLAXIS	0.0172414	0.6087665791123795
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6087665791123795
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.0172414	0.6087665791123795
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6087665791123795
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6087665791123795
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6087665791123795
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6087665791123795
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6087665791123795
ACQUIRED PURPURA FULMINANS	0.0172414	0.6087665791123795
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6087665791123795
RADIATION PROCTITIS	0.0172414	0.6087665791123795
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6087665791123795
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6087665791123795
CARDIAC ARRHYTHMIA	0.0172414	0.6087665791123795
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6087665791123795
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6087665791123795
SICKLE CELL ANEMIA	0.0172414	0.6087665791123795
RECOMBINANT 8 SYNDROME	0.017215973	0.6078687919369128
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.01719878	0.6072617342852906
SOTOS SYNDROME 2	0.017198779999999997	0.6072617342852905
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.017098354	0.6037158509768621
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.017021764	0.6010115791489238
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.017021763999999998	0.6010115791489237
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.01698294	0.5996407650811879
PHACE SYNDROME	0.016892593	0.5964507553300619
OROFACIODIGITAL SYNDROME TYPE 2	0.016847064	0.5948431983114666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.016712754	0.5901009245262413
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5901009245262413
FARBER DISEASE	0.016674553999999998	0.5887521429120978
INSULINOMA	0.016670419	0.5886061425986296
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016670419	0.5886061425986296
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016670419	0.5886061425986296
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.016505993	0.5828005204602227
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.016499003999999998	0.582553749918305
JACOBSEN SYNDROME	0.01647257	0.5816204071646855
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.016439163	0.5804408588038559
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.016439163	0.5804408588038559
FUMARASE DEFICIENCY; FMRD	0.016431404	0.5801669007791402
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016347038999999997	0.5771881059917785
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.016334883	0.5767588968477596
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.016334883	0.5767588968477596
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.5755805489731834
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5755805489731834
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.5755805489731834
STERNAL CLEFT	0.016128999999999998	0.5694894935738146
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.5694894935738146
DIPROSOPUS	0.016128999999999998	0.5694894935738146
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.5694894935738146
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.5694894935738146
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.5694894935738146
NARCOLEPSY TYPE 1	0.016128999999999998	0.5694894935738146
ARACHNOIDITIS	0.016128999999999998	0.5694894935738146
ACRORENAL SYNDROME	0.016128999999999998	0.5694894935738146
SILENT SINUS SYNDROME	0.016128999999999998	0.5694894935738146
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.5694894935738146
CENTRAL NEUROCYTOMA	0.016128999999999998	0.5694894935738146
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.5694894935738146
WAARDENBURG SYNDROME	0.016128999999999998	0.5694894935738146
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.5694894935738146
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.5694894935738146
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.5694894935738146
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.5694894935738146
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.5694894935738146
ALKAPTONURIA	0.016128999999999998	0.5694894935738146
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01607346	0.567528463970424
WITTEVEEN-KOLK SYNDROME	0.016047313	0.5666052547331201
FANCONI ANEMIA	0.015858393999999998	0.5599348234827962
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.01579181	0.5575838476975574
CONGENITAL TOXOPLASMOSIS	0.015775823	0.5570193719995126
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.015742659	0.555848403584553
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5541652865488303
RING CHROMOSOME 14 SYNDROME	0.015689494	0.5539712314768059
AMISH LETHAL MICROCEPHALY	0.01567665	0.5535177301403648
DUANE RETRACTION SYNDROME	0.015665603	0.5531276780332589
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.015665603	0.5531276780332589
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.015665603	0.5531276780332589
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.015665603	0.5531276780332589
MUENKE SYNDROME	0.015665603	0.5531276780332589
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.015647262999999998	0.5524801216247931
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.015592539999999998	0.5505479389999038
KNOBLOCH SYNDROME	0.015485348999999997	0.5467631942354626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015471144	0.5462616381404651
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5462549295408136
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5462549295408136
NEURAMINIDASE DEFICIENCY	0.015467008999999999	0.5461156378269969
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.015437559	0.5450758048810147
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.01541902	0.5444212220971245
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.01541902	0.5444212220971245
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.015415903	0.5443111657544207
SEVERE CANAVAN DISEASE	0.015251323	0.538500106119454
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01522724	0.5376497734594169
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5368438234823373
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.015193833	0.5364702250985872
MONOSOMY 22Q13.3	0.015090692999999999	0.5328285147403999
NEMALINE MYOPATHY 2; NEM2	0.01507321	0.5322112176472044
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.015019133	0.5303018442611303
COHEN SYNDROME	0.015014439000000001	0.5301361065413189
LOWE OCULOCEREBRORENAL SYNDROME	0.015014439000000001	0.5301361065413189
1Q41Q42 MICRODELETION SYNDROME	0.015008108999999999	0.5299126042476663
OCULOECTODERMAL SYNDROME; OES	0.014990953	0.5293068530075552
REFSUM DISEASE	0.014925589999999999	0.526998988802182
EPILEPSY, HOT WATER, 1	0.014925589999999999	0.526998988802182
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5269922802025304
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5269922802025304
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5269922802025304
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5269922802025304
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.014863314	0.524800121686936
ADAMS-OLIVER SYNDROME	0.014863009	0.5247893526190743
ADRENOLEUKODYSTROPHY	0.014829979	0.5236231155322901
DONNAI-BARROW SYNDROME	0.014785572999999998	0.5220552098684771
HSD10 DISEASE	0.014785572999999998	0.5220552098684771
RENPENNING SYNDROME 1; RENS1	0.014755289	0.5209859297008667
NEURONAL CEROID LIPOFUSCINOSIS	0.014705769	0.5192374567811708
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.014668233000000001	0.5179121199573884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.014668233000000001	0.5179121199573884
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5175811741440541
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.014648279	0.5172075757603041
DESMOSTEROLOSIS	0.014633569999999999	0.5166882242220204
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.014607759000000001	0.515776878613574
MARSHALL SYNDROME	0.014578629999999999	0.5147483796701607
CROUZON DISEASE	0.014578629999999999	0.5147483796701607
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.014578629999999999	0.5147483796701607
BENCZE SYNDROME	0.014578629999999999	0.5147483796701607
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.014578629999999999	0.5147483796701607
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.014578629999999999	0.5147483796701607
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.014578629999999999	0.5147483796701607
MORNING GLORY DISC ANOMALY	0.014578629999999999	0.5147483796701607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.014549274	0.5137118657155849
WEBB-DATTANI SYNDROME; WEDAS	0.014518483	0.5126246841794307
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.014514644	0.5124891351580513
ELEJALDE DISEASE	0.014509063	0.5122920788703933
RETINAL DYSTROPHY AND OBESITY; RDOB	0.014503519999999999	0.5120963643026656
LAND ISLANDS EYE DISEASE	0.014503519999999999	0.5120963643026656
EDICT SYNDROME	0.014503519999999999	0.5120963643026656
MEGALOCORNEA	0.014503519999999999	0.5120963643026656
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.014498680000000002	0.5119254715536485
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.014477714	0.5111851952363151
RETT SYNDROME; RTT	0.014473579	0.5110391949228471
RETINOPATHY OF PREMATURITY	0.014427460000000001	0.509410805936913
CHDIAK-HIGASHI SYNDROME	0.014420272999999999	0.5091570443279901
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.014420272999999999	0.5091570443279901
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.014394272999999999	0.5082390254283113
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5029385608436622
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5029385608436622
MEDULLOBLASTOMA	0.014244153999999998	0.5029385608436622
JOUBERT SYNDROME 35; JBTS35	0.014244153999999998	0.5029385608436622
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5029385608436622
SENIOR-LOKEN SYNDROME	0.014244153999999998	0.5029385608436622
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5029385608436622
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.014244153999999998	0.5029385608436622
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.014240018999999998	0.5027925605301939
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.014240018999999998	0.5027925605301939
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.014234453000000001	0.5025960338688243
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.014234319	0.5025913025406491
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.014163233	0.5000813682520888
BRITTLE CORNEA SYNDROME	0.01407841	0.49708640220872513
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.01396909	0.4932264858197681
CRANIOFRONTONASAL SYNDROME; CFNS	0.013967644000000001	0.4931754298455783
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.013967644000000001	0.4931754298455783
2Q23.1 MICRODUPLICATION SYNDROME	0.013964454	0.4930627959882715
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.013963509	0.4930294295321101
16Q24.3 MICRODELETION SYNDROME	0.013960318999999999	0.4929167956748033
WRINKLY SKIN SYNDROME	0.013933794	0.4919802398550349
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.013933794	0.4919802398550349
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.013932159999999999	0.491922545898032
CARNOSINASE DEFICIENCY	0.013932159999999999	0.491922545898032
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.013878854	0.49004039530317517
PFEIFFER SYNDROME TYPE 3	0.013874718999999999	0.489894394989707
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.013874718999999999	0.489894394989707
CLASSIC HOMOCYSTINURIA	0.013874718999999999	0.489894394989707
QAZI-MARKOUIZOS SYNDROME	0.013867059000000001	0.489623932498494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.013867059000000001	0.489623932498494
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.013766914	0.4860879708558658
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.483675911505379
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.483675911505379
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.483675911505379
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.483675911505379
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.013698599999999998	0.483675911505379
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.483675911505379
ANIRIDIA 3	0.013698599999999998	0.483675911505379
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.483675911505379
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.483675911505379
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.483675911505379
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.483675911505379
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.483675911505379
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.483675911505379
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.013698599999999998	0.483675911505379
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.483675911505379
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.483675911505379
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.013698599999999998	0.483675911505379
BEHR SYNDROME	0.013698599999999998	0.483675911505379
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.483675911505379
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.483675911505379
BASAL LAMINAR DRUSEN	0.013698599999999998	0.483675911505379
CHOROIDEREMIA	0.013698599999999998	0.483675911505379
BOUCHER-NEUHAUSER SYNDROME	0.013698599999999998	0.483675911505379
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.483675911505379
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.483675911505379
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.483675911505379
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.013688899000000001	0.4833333845305412
MICRO SYNDROME	0.013641863	0.48167261772418385
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013510793	0.47704474321722623
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.013510793	0.47704474321722623
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.013450318999999999	0.4749095018734117
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.013422090000000001	0.47391278050729513
X-LINKED RECESSIVE OCULAR ALBINISM	0.0134189	0.4738001466499883
OCULAR ALBINISM	0.0134189	0.4738001466499883
PELIZAEUS-MERZBACHER DISEASE	0.013336329000000001	0.4708846951667046
CATARACT 17, MULTIPLE TYPES	0.0133333	0.470777745964892
SPONDYLOOCULAR SYNDROME; SOS	0.0133333	0.470777745964892
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.0133333	0.470777745964892
ISOLATED ECTOPIA LENTIS	0.0133333	0.470777745964892
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.0133333	0.470777745964892
CATARACT, ANTERIOR POLAR, 2	0.0133333	0.470777745964892
CORNELIA DE LANGE SYNDROME	0.013311039	0.4699917452446709
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.013285183999999998	0.46907884606577877
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.013282073	0.4689690015735903
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013282073	0.4689690015735903
SHUKLA-VERNON SYNDROME; SHUVER	0.013282073	0.4689690015735903
PERLMAN SYNDROME	0.013266844	0.468431289657313
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.013233033000000002	0.4672374766951193
CHROMOSOME 5Q12 DELETION SYNDROME	0.013211193	0.46646634081938904
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.013211193	0.46646634081938904
COG5-CDG	0.013114649	0.46305752479436646
CANAVAN DISEASE	0.013010963	0.4593965360392858
TAY-SACHS DISEASE	0.013010963	0.4593965360392858
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.012993253	0.45877122393492775
SCHINDLER DISEASE, TYPE I	0.012993253	0.45877122393492775
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.012993253	0.45877122393492775
KRABBE DISEASE	0.012969374	0.45792809419241115
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.012921609	0.45624158754844363
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012856194000000001	0.45393188730527095
JOUBERT SYNDROME WITH RENAL DEFECT	0.012818553	0.4526028430974706
48,XXYY SYNDROME	0.012818553	0.4526028430974706
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012818553	0.4526028430974706
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.012818553	0.4526028430974706
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.012818553	0.4526028430974706
JOUBERT SYNDROME	0.012818553	0.4526028430974706
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01276962	0.45087509621985594
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.012749003	0.4501471425408299
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.012740654	0.4498523525487753
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012740654	0.4498523525487753
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012740654	0.4498523525487753
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.012740654	0.4498523525487753
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.012740654	0.4498523525487753
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012736519	0.44970635223530714
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.012730663000000001	0.4494995861323642
EPIDERMAL NEVUS SYNDROME	0.012719123999999998	0.44909216228300275
CORNELIA DE LANGE SYNDROME 1	0.012689698999999999	0.4480532120475009
RING CHROMOSOME 12 SYNDROME	0.012669774000000002	0.44734969179457407
JACOBSEN SYNDROME	0.012629603	0.4459313172861511
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.012621728999999998	0.44565329879322524
TEMPLE-BARAITSER SYNDROME	0.012621728999999998	0.44565329879322524
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.012515993	0.44191992777874695
KRABBE DISEASE	0.012465409	0.4401338867010027
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.012459654	0.4399306867484007
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.012441302999999999	0.4392827419473235
HELSMOORTEL-VAN DER AA SYNDROME	0.012441302999999999	0.4392827419473235
MICROPHTHALMIA, ISOLATED 5	0.01243895	0.4391996612369027
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.01243895	0.4391996612369027
MUCOPOLYSACCHARIDOSIS TYPE 1	0.01242382	0.438665444854128
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.012395433	0.4376631447577749
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012358719	0.43636683145459
4Q21 MICRODELETION SYNDROME	0.012315089000000001	0.43482632512409053
TARP SYNDROME	0.012240173	0.4321811595899238
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.0121951	0.43058970321049217
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.43058970321049217
LELIS SYNDROME	0.0121951	0.43058970321049217
FACIOCARDIOMELIC SYNDROME	0.0121951	0.43058970321049217
JUBERG-MARSIDI SYNDROME	0.0121951	0.43058970321049217
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.43058970321049217
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0121951	0.43058970321049217
CATARACT 48; CTRCT48	0.0121951	0.43058970321049217
RHYNS SYNDROME; RHYNS	0.0121951	0.43058970321049217
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.43058970321049217
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.43058970321049217
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0121951	0.43058970321049217
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.43058970321049217
LOEYS-DIETZ SYNDROME 3; LDS3	0.0121951	0.43058970321049217
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01217357	0.42982951294471966
LOWRY-WOOD SYNDROME	0.01217357	0.42982951294471966
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.012144023	0.4287862550820732
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012084049	0.42666866794786795
MICROFORM HOLOPROSENCEPHALY	0.012084049	0.42666866794786795
ROIFMAN SYNDROME; RFMN	0.012069844000000001	0.42616711185287043
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.012045363	0.4253027264419843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.42510821236051005
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.42510821236051005
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.42510821236051005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.42510821236051005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.42510821236051005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.42510821236051005
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.012026884	0.4246502621632472
PITT-HOPKINS SYNDROME	0.012022749000000001	0.42450426184977913
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011962653	0.42238236708842924
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.011959423	0.42226832089435373
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.011823753	0.41747802765899134
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.011766262999999999	0.4154481466381247
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.011766262999999999	0.4154481466381247
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011766262999999999	0.4154481466381247
SHPRINTZEN-GOLDBERG SYNDROME	0.01173158	0.41422354473437245
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.011639140000000001	0.4109596344618222
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.011591563	0.40927976580066766
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.011591563	0.40927976580066766
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.011573223	0.4086322093922019
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.011573223	0.4086322093922019
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.011573223	0.4086322093922019
DIAMOND-BLACKFAN ANEMIA 1	0.01154263	0.407552018923053
2P15P16.1 MICRODELETION SYNDROME	0.011522284	0.40683363382563503
EXUDATIVE VITREORETINOPATHY 4	0.011518610000000002	0.40670391069342665
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.011518610000000002	0.40670391069342665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.4061765088355612
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011503673	0.4061765088355612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011503673	0.4061765088355612
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.4061765088355612
PEHO SYNDROME; PEHO	0.011503673	0.4061765088355612
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.011503673	0.4061765088355612
HYPEREKPLEXIA 4; HKPX4	0.011503673	0.4061765088355612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.4061765088355612
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4058455630222269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4058455630222269
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4058455630222269
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4058455630222269
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011455493	0.4044753491976179
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.011448504	0.4042285786557004
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.40354062941564883
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011384273	0.40196068358088244
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.011384273	0.40196068358088244
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.011384273	0.40196068358088244
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.011384273	0.40196068358088244
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011341312999999999	0.40044383389125926
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.011341312999999999	0.40044383389125926
DESANTO-SHINAWI SYNDROME	0.011341312999999999	0.40044383389125926
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0113107	0.399362937253726
DUBOWITZ SYNDROME	0.0113107	0.399362937253726
KOOLEN-DE VRIES SYNDROME; KDVS	0.011170682999999999	0.3944191583200211
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0111532	0.3938018612268256
PRIMARY PULMONARY HYPOPLASIA	0.0111532	0.3938018612268256
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.011113389	0.3923961977493212
JOUBERT SYNDROME 21	0.011050144	0.39016311677585264
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011031804000000001	0.38951556036738694
RETT SYNDROME, CONGENITAL VARIANT	0.011028269	0.38939074510544985
HYPOPHOSPHATASIA, INFANTILE	0.011027669	0.38936956005391876
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.011027669	0.38936956005391876
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.010973033	0.38744044926150145
PIERPONT SYNDROME	0.010966703000000001	0.3872169469678489
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.010962254000000001	0.3870598598107462
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.386913859497278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.386913859497278
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.010958119	0.386913859497278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.010958119	0.386913859497278
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.386913859497278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.386913859497278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.386913859497278
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.010958119	0.386913859497278
ISOLATED COMPLEX I DEFICIENCY	0.010935914000000001	0.3861298360485332
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01090295	0.38496592931741724
MUSCLE-EYE-BRAIN DISEASE	0.010851198999999999	0.38313868331444506
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.010842854	0.38284403455606747
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010842854	0.38284403455606747
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.010842854	0.38284403455606747
PEDIATRIC-ONSET GRAVES DISEASE	0.010842854	0.38284403455606747
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.010799893999999999	0.38132718486644424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.010799893999999999	0.38132718486644424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.010799893999999999	0.38132718486644424
BARDET-BIEDL SYNDROME 1; BBS1	0.010799893999999999	0.38132718486644424
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.010799893999999999	0.38132718486644424
9Q33.3Q34.11 MICRODELETION SYNDROME	0.010795759	0.38118118455297617
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010788543000000001	0.3809263989998961
ADAMS-OLIVER SYNDROME 1; AOS1	0.010788543000000001	0.3809263989998961
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.010788543000000001	0.3809263989998961
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.010777419	0.3805336281445104
INFANTILE SIALIC ACID STORAGE DISEASE	0.010717323	0.3784117333831606
20P13 MICRODELETION SYNDROME	0.010708829	0.3781118236703193
COCKAYNE SYNDROME A; CSA	0.010625128999999999	0.37515650898173797
WOLCOTT-RALLISON SYNDROME	0.010606789	0.3745089525732723
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.010578423	0.37350739395372273
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.010550562999999999	0.37252370139429763
DISTAL MONOSOMY 10P	0.01054668	0.37238659880247255
MONOSOMY 5P	0.01052834	0.37173904239400685
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01052834	0.37173904239400685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.010520933	0.371477512932856
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.010520933	0.371477512932856
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010520933	0.371477512932856
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010520933	0.371477512932856
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010520933	0.371477512932856
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.010520933	0.371477512932856
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010520933	0.371477512932856
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010520933	0.371477512932856
GAUCHER DISEASE TYPE 3	0.01050459	0.3709004674375695
CAMPOMELIC DYSPLASIA	0.01048625	0.3702529110291038
STUVE-WIEDEMANN SYNDROME	0.01048625	0.3702529110291038
GENITOPATELLAR SYNDROME	0.010346233	0.36530913209539895
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.010346233	0.36530913209539895
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010346233	0.36530913209539895
PROPIONIC ACIDEMIA	0.010346233	0.36530913209539895
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.010346233	0.36530913209539895
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.010346233	0.36530913209539895
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010346233	0.36530913209539895
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.010346233	0.36530913209539895
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.010346233	0.36530913209539895
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0102973	0.36358138521778427
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0102973	0.36358138521778427
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.0102973	0.36358138521778427
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0102973	0.36358138521778427
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0102973	0.36358138521778427
RESTRICTIVE DERMOPATHY, LETHAL	0.0102973	0.36358138521778427
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.0102973	0.36358138521778427
PEMPHIGOID GESTATIONIS	0.0102973	0.36358138521778427
VACTERL/VATER ASSOCIATION	0.0102973	0.36358138521778427
TEMPLE SYNDROME	0.0102973	0.36358138521778427
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.010254339999999999	0.3620645355281611
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.010254339999999999	0.3620645355281611
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010254339999999999	0.3620645355281611
BRANCHIOGENIC DEAFNESS SYNDROME	0.010254339999999999	0.3620645355281611
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.010247124000000002	0.36180974997508114
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.010247124000000002	0.36180974997508114
OROFACIODIGITAL SYNDROME VI	0.010247124000000002	0.36180974997508114
ERMINE PHENOTYPE	0.010236	0.36141697911969545
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.010215159000000001	0.36068111635476446
MICROPHTHALMIA, SYNDROMIC 1	0.010215159000000001	0.36068111635476446
GAPO SYNDROME; GAPOS	0.010109289	0.35694301401211087
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.010095983	0.3564732001859906
16P12.1P12.3 TRIPLICATION SYNDROME	0.01008371	0.356039859956923
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.010065483	0.355396293399829
MULTIPLE SULFATASE DEFICIENCY	0.010065483	0.355396293399829
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.010065483	0.355396293399829
1Q44 MICRODELETION SYNDROME	0.010060124	0.35520707558123743
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.009979514	0.352360863908041
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009975379	0.3522148635945729
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.009975379	0.3522148635945729
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.009975379	0.3522148635945729
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009962314	0.3517535590974843
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.009958179	0.35160755878401617
CHROMOSOME 1P35 DELETION SYNDROME	0.009925353	0.35044852461475245
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0099044	0.34970870730686904
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.0099044	0.34970870730686904
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.009842769	0.34753261412201886
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009842769	0.34753261412201886
SECKEL SYNDROME 7; SCKL7	0.009842769	0.34753261412201886
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.346192483070584
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.346192483070584
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.009804814	0.346192483070584
OROFACIODIGITAL SYNDROME XVI; OFD16	0.009804814	0.346192483070584
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.346192483070584
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.346192483070584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.346192483070584
JOUBERT SYNDROME 33; JBTS33	0.009804814	0.346192483070584
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.346192483070584
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009804814	0.346192483070584
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.346192483070584
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009804814	0.346192483070584
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.346192483070584
TENORIO SYNDROME; TNORS	0.009800679	0.3460464827571158
HYPOADRENOCORTICISM, FAMILIAL	0.009800679	0.3460464827571158
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.009800679	0.3460464827571158
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.009800679	0.3460464827571158
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009800679	0.3460464827571158
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.009800679	0.3460464827571158
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3460464827571158
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.009800679	0.3460464827571158
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.009800679	0.3460464827571158
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3460464827571158
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00971991	0.34319465704526364
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00967374	0.34156446732994944
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009630350000000001	0.3400324350200624
CLASSICAL EHLERS-DANLOS SYNDROME	0.009630350000000001	0.3400324350200624
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009630350000000001	0.3400324350200624
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.009605869	0.3391680496091764
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.009583393000000003	0.33837445757882334
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009561553	0.3376033217030931
PMM2-CDG	0.009561553	0.3376033217030931
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009561553	0.3376033217030931
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009561553	0.3376033217030931
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009561553	0.3376033217030931
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009561553	0.3376033217030931
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009561553	0.3376033217030931
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009561553	0.3376033217030931
OKAMOTO SYNDROME	0.009554564	0.3373565511611756
PEROXISOME BIOGENESIS DISORDER 5B	0.009524064	0.336279644375014
PEROXISOME BIOGENESIS DISORDER 6B	0.009524064	0.336279644375014
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.009524064	0.336279644375014
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00951457	0.3359444262429543
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.009509789999999999	0.33577565199909026
NANCE-HORAN SYNDROME	0.009509789999999999	0.33577565199909026
15Q OVERGROWTH SYNDROME	0.009494639	0.3352406941395121
KAGAMI-OGATA SYNDROME	0.009490333	0.33508865608635763
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.33508865608635763
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.33508865608635763
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.33508865608635763
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.33508865608635763
KAGAMI-OGATA SYNDROME	0.009490333	0.33508865608635763
SUDANOPHILIC CEREBRAL SCLEROSIS	0.00943396	0.33309821456975786
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00943396	0.33309821456975786
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00943396	0.33309821456975786
POSTERIOR CORTICAL ATROPHY	0.00943396	0.33309821456975786
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.009383934	0.3313318755899375
SRD5A3-CDG	0.009351433	0.3301843166569197
PFEIFFER SYNDROME TYPE 2	0.009351433	0.3301843166569197
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009351433	0.3301843166569197
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009276742999999999	0.3275471308254963
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.009276742999999999	0.3275471308254963
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3269298337323008
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00925926	0.3269298337323008
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00925926	0.3269298337323008
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00925926	0.3269298337323008
AORTIC ARCH DEFECTS	0.00925926	0.3269298337323008
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.3269298337323008
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00925926	0.3269298337323008
PAINE SYNDROME	0.00925926	0.3269298337323008
GLYCINE ENCEPHALOPATHY	0.00925926	0.3269298337323008
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.3269298337323008
LARYNGOTRACHEAL ANGIOMA	0.00925926	0.3269298337323008
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3269298337323008
HYDROXYLYSINURIA	0.00925926	0.3269298337323008
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3269298337323008
BUTYRYLCHOLINESTERASE	0.00925926	0.3269298337323008
MERRF	0.00925926	0.3269298337323008
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.3269298337323008
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3269298337323008
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3269298337323008
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.3269298337323008
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3269298337323008
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00925926	0.3269298337323008
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3269298337323008
CARNOSINEMIA	0.00925926	0.3269298337323008
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00925926	0.3269298337323008
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.009194159	0.32463122033276276
INTELLECTUAL DISABILITY, WOLFF TYPE	0.009194159	0.32463122033276276
21Q22.11Q22.12 MICRODELETION SYNDROME	0.009194159	0.32463122033276276
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.009194159	0.32463122033276276
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.009194159	0.32463122033276276
RETINITIS PIGMENTOSA 27; RP27	0.009188660000000001	0.3244370593354807
CHROMOSOME XP11.3 DELETION SYNDROME	0.009188660000000001	0.3244370593354807
HENNEKAM-BEEMER SYNDROME	0.009175819	0.32398366392429706
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.009175819	0.32398366392429706
ADRENOMYODYSTROPHY	0.009175819	0.32398366392429706
CONO-SPONDYLAR DYSPLASIA	0.009175819	0.32398366392429706
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.009146503	0.32294856230649
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00914415	0.32286548159606904
COLOBOMA, OCULAR	0.00914415	0.32286548159606904
GM1 GANGLIOSIDOSIS	0.009037839	0.3191118082405402
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.009020134	0.3184866726782781
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.3184866726782781
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009020134	0.3184866726782781
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.3184866726782781
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009015999	0.31834067236480995
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.009015999	0.31834067236480995
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009015999	0.31834067236480995
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009015999	0.31834067236480995
PACHYGYRIA, FRONTOTEMPORAL	0.009015999	0.31834067236480995
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	0.31834067236480995
SIFRIM-HITZ-WEISS SYNDROME	0.00900901	0.31809390182289243
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.31809390182289243
VAN BOGAERT-HOZAY SYNDROME	0.00900901	0.31809390182289243
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00900901	0.31809390182289243
HYDRANENCEPHALY	0.009005013000000001	0.3179527740712765
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00897851	0.3170169950367308
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.3159720070615426
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3159720070615426
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.3159720070615426
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.31582600674807443
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.31582600674807443
OLIVER SYNDROME	0.00893619	0.3155227427354075
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008924432999999999	0.31510762165065653
MILLER-DIEKER SYNDROME	0.008863959000000001	0.31297238030684216
FONTAINE PROGEROID SYNDROME; FPS	0.00883838	0.31206922625165434
PELGER-HUET ANOMALY; PHA	0.008833134	0.31188399828443447
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.008810014	0.31106766763210475
ECTODERMAL DYSPLASIA SYNDROME	0.008805878999999999	0.3109216673186366
KNOBLOCH SYNDROME 1; KNO1	0.008805878999999999	0.3109216673186366
TYROSINEMIA TYPE 2	0.008805878999999999	0.3109216673186366
GLIOBLASTOMA	0.008805878999999999	0.3109216673186366
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.008805878999999999	0.3109216673186366
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.008805878999999999	0.3109216673186366
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.008794863	0.31053270977252656
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008735324	0.30843048180068133
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.008735324	0.30843048180068133
AARSKOG-SCOTT SYNDROME	0.008735324	0.30843048180068133
COFFIN-SIRIS SYNDROME 7; CSS7	0.008735324	0.30843048180068133
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.008735324	0.30843048180068133
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008735324	0.30843048180068133
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008735324	0.30843048180068133
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.008731188999999999	0.30828448148721316
MENTAL RETARDATION, X-LINKED 1	0.008731188999999999	0.30828448148721316
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.008716984	0.30778292539221563
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.008716984	0.30778292539221563
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00865907	0.3057380736016003
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00865907	0.3057380736016003
BLUE CONE MONOCHROMACY; BCM	0.00865907	0.3057380736016003
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00865907	0.3057380736016003
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00865907	0.3057380736016003
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00865907	0.3057380736016003
CONE DYSTROPHY 4	0.00865907	0.3057380736016003
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00865907	0.3057380736016003
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.008652739999999999	0.30551457130794774
CRANIOFACIAL DYSSYNOSTOSIS	0.008652739999999999	0.30551457130794774
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.2999232359657772
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.2999232359657772
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.2999232359657772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.2999232359657772
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.299224023339995
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00847458	0.299224023339995
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00847458	0.299224023339995
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.299224023339995
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.299224023339995
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.299224023339995
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00847458	0.299224023339995
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.299224023339995
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.299224023339995
TUFTED ANGIOMA	0.00847458	0.299224023339995
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00847458	0.299224023339995
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.29670935772325946
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.29670935772325946
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.29670935772325946
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.29670935772325946
NEMALINE MYOPATHY 10	0.00840336	0.29670935772325946
SCHISIS ASSOCIATION	0.00840336	0.29670935772325946
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.29670935772325946
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.29670935772325946
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.29670935772325946
DISTAL MONOSOMY 17Q	0.00840336	0.29670935772325946
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.29670935772325946
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.29670935772325946
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.29670935772325946
HYDROLETHALUS	0.00840336	0.29670935772325946
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.29670935772325946
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.29670935772325946
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.29670935772325946
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.29670935772325946
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.29670935772325946
EBSTEIN MALFORMATION	0.00840336	0.29670935772325946
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.29670935772325946
TEMPLE SYNDROME	0.00840336	0.29670935772325946
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.29670935772325946
FATCO SYNDROME	0.00840336	0.29670935772325946
GMS SYNDROME	0.00840336	0.29670935772325946
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.29670935772325946
OMPHALOCELE	0.00840336	0.29670935772325946
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.29670935772325946
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.29670935772325946
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.29670935772325946
HEC SYNDROME	0.00840336	0.29670935772325946
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.29670935772325946
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.29670935772325946
RENAL TUBULAR DYSGENESIS	0.00840336	0.29670935772325946
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.29670935772325946
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.29670935772325946
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.29670935772325946
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.29670935772325946
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.29670935772325946
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.29670935772325946
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.29670935772325946
FOUNTAIN SYNDROME	0.008378878999999999	0.2958449723123734
FLYNN-AIRD SYNDROME	0.008378878999999999	0.2958449723123734
CADASIL	0.008378878999999999	0.2958449723123734
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.008356403000000002	0.2950513802820204
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.008338063000000001	0.2944038238735546
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.008338063000000001	0.2944038238735546
GM2-GANGLIOSIDOSIS, AB VARIANT	0.008338063000000001	0.2944038238735546
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.008335249	0.294304465981874
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00828627	0.29257509491697525
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.2918050182938216
VON HIPPEL-LINDAU DISEASE	0.00826446	0.2918050182938216
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.2918050182938216
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00826446	0.2918050182938216
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00826446	0.2918050182938216
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.2918050182938216
NEUROMYELITIS OPTICA	0.00826446	0.2918050182938216
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.2918050182938216
SPONDYLO-OCULAR SYNDROME	0.00826446	0.2918050182938216
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.2918050182938216
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.2918050182938216
BLAU SYNDROME	0.00826446	0.2918050182938216
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.2918050182938216
CUSHING DISEASE	0.00826446	0.2918050182938216
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00826446	0.2918050182938216
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.2918050182938216
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00826446	0.2918050182938216
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.2918050182938216
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00826446	0.2918050182938216
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00826446	0.2918050182938216
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00826446	0.2918050182938216
NANCE-HORAN SYNDROME	0.00826446	0.2918050182938216
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00826446	0.2918050182938216
WEILL-MARCHESANI SYNDROME	0.00826446	0.2918050182938216
PEROXISOME BIOGENESIS DISORDER 11B	0.00826446	0.2918050182938216
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.2918050182938216
X-LINKED CORNEAL DERMOID	0.00826446	0.2918050182938216
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.2918050182938216
CATARACT 44; CTRCT44	0.00826446	0.2918050182938216
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00826446	0.2918050182938216
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.2918050182938216
LCAT DEFICIENCY	0.00826446	0.2918050182938216
ISOLATED ANIRIDIA	0.00826446	0.2918050182938216
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.2918050182938216
BRITTLE CORNEA SYNDROME	0.00826446	0.2918050182938216
STICKLER SYNDROME TYPE 1	0.00826446	0.2918050182938216
CONGENITAL GLAUCOMA	0.00826446	0.2918050182938216
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.008249309	0.2912700604342434
DILATED CARDIOMYOPATHY WITH ATAXIA	0.008249309	0.2912700604342434
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.008249309	0.2912700604342434
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.008232192999999999	0.290665721530901
HARTNUP DISEASE	0.008232192999999999	0.290665721530901
SMITH-MAGENIS SYNDROME	0.008232192999999999	0.290665721530901
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.008189769999999999	0.2891678324623982
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.008189769999999999	0.2891678324623982
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.008189769999999999	0.2891678324623982
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.008189769999999999	0.2891678324623982
FLOATING-HARBOR SYNDROME	0.008189769999999999	0.2891678324623982
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.008189769999999999	0.2891678324623982
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008146253	0.2876313159832704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.008146253	0.2876313159832704
CONGENITAL RUBELLA SYNDROME	0.008072239	0.2850179986432387
MAN1B1-CDG	0.008031413	0.28357649712022764
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2808065869409622
300270 ADRENOMYODYSTROPHY	0.007952964	0.2808065869409622
CROME SYNDROME	0.007948829	0.28066058662749405
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.28066058662749405
HALL-RIGGS SYNDROME	0.007948829	0.28066058662749405
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.28066058662749405
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.28066058662749405
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.28066058662749405
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.28066058662749405
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.28066058662749405
LISSENCEPHALY 5; LIS5	0.007948829	0.28066058662749405
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.28066058662749405
8P INVERTED DUPLICATION/DELETION SYNDROME	0.007948829	0.28066058662749405
FRYNS SYNDROME	0.007948829	0.28066058662749405
HEART AND BRAIN MALFORMATION SYNDROME	0.007901173	0.2789779286012213
BONNEMANN-MEINECKE-REICH SYNDROME	0.00783746	0.2767283232875584
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007826813	0.27635239454814
MOMO SYNDROME	0.007810849000000001	0.27578873094373724
ARIMA SYNDROME	0.007796644000000001	0.2752871748487396
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.007796644000000001	0.2752871748487396
JOUBERT SYNDROME 6	0.007796644000000001	0.2752871748487396
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.007792509	0.2751411745352714
TRISOMY 18P	0.00770789	0.27215341140942845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00770789	0.27215341140942845
6Q16 MICRODELETION SYNDROME	0.007690774	0.271549072506086
ANGELMAN SYNDROME	0.007686639	0.2714030721926179
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007686639	0.2714030721926179
KABUKI SYNDROME	0.007686639	0.2714030721926179
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0076048339999999996	0.26851466695845544
MALAN OVERGROWTH SYNDROME	0.007600699	0.2683686666449873
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2679133645791658
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2679133645791658
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2679133645791658
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.2679133645791658
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2679133645791658
HYPOTONIA-CYSTINURIA SYNDROME	0.007586494	0.2678671105499897
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.26776736426569764
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.26776736426569764
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007489994	0.2644598480954127
JOUBERT SYNDROME 24	0.007489994	0.2644598480954127
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007489994	0.2644598480954127
IMMUNODEFICIENCY 47	0.007485858999999999	0.2643138477819445
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007485858999999999	0.2643138477819445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2615439376026791
TRISOMY XQ28	0.00740741	0.2615439376026791
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2615439376026791
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2615439376026791
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.2615439376026791
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2615439376026791
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.2615439376026791
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2615439376026791
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007390803	0.2609575706847188
ABLEPHARON MACROSTOMIA SYNDROME	0.007359754	0.2598612795764063
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.007285394000000001	0.257235745523325
VITREORETINOCHOROIDOPATHY; VRCP	0.007269430000000001	0.2566720819189222
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.007269430000000001	0.2566720819189222
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.007269430000000001	0.2566720819189222
PIERSON SYNDROME	0.007251090000000001	0.25602452551045646
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.007251090000000001	0.25602452551045646
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.007251090000000001	0.25602452551045646
EHLERS-DANLOS SYNDROME, TYPE VI	0.007251090000000001	0.25602452551045646
RECOMBINANT CHROMOSOME 8 SYNDROME	0.007208933	0.2545360284814657
MUCOLIPIDOSIS TYPE IV	0.00714522	0.25228642316780286
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.007111073000000001	0.25108074657675167
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007111073000000001	0.25108074657675167
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.007111073000000001	0.25108074657675167
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.007111073000000001	0.25108074657675167
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.007111073000000001	0.25108074657675167
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.007108259	0.250981388685071
BANGSTAD SYNDROME	0.007108259	0.250981388685071
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00705928	0.24925201762017227
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.24865071524088267
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.24865071524088267
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.24865071524088267
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.24865071524088267
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.24865071524088267
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.24865071524088267
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.24865071524088267
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.24865071524088267
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.24865071524088267
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.24865071524088267
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.24865071524088267
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.24865071524088267
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.24865071524088267
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.24865071524088267
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.24865071524088267
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.24865071524088267
SCHIZENCEPHALY	0.007005203	0.24734264423409807
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.007005203	0.24734264423409807
KBG SYNDROME	0.007005203	0.24734264423409807
ISOLATED GLYCEROL KINASE DEFICIENCY	0.006986862999999999	0.2466950878256323
VICI SYNDROME	0.006986862999999999	0.2466950878256323
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.006986862999999999	0.2466950878256323
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.006986862999999999	0.2466950878256323
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.006986862999999999	0.2466950878256323
CRANIOECTODERMAL DYSPLASIA 4	0.00694444	0.2451971987571295
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00694444	0.2451971987571295
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00694444	0.2451971987571295
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.00694444	0.2451971987571295
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00694444	0.2451971987571295
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00694444	0.2451971987571295
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00694444	0.2451971987571295
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00694444	0.2451971987571295
BRACHYDACTYLY, TYPE B2	0.00694444	0.2451971987571295
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00694444	0.2451971987571295
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00694444	0.2451971987571295
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.006900923	0.24366068227800172
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006900923	0.24366068227800172
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006900923	0.24366068227800172
XQ28 (MECP2) DUPLICATION	0.006900923	0.24366068227800172
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.006900923	0.24366068227800172
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.006900923	0.24366068227800172
TETRASOMY 5P	0.006900923	0.24366068227800172
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006900923	0.24366068227800172
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006849384	0.24184092165990384
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.006845249	0.24169492134643572
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.006831044	0.24119336525143814
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006826909	0.24104736493797
CHYLOMICRON RETENTION DISEASE	0.006814199999999999	0.24059863023812314
INTESTINAL LYMPHANGIECTASIA	0.006814199999999999	0.24059863023812314
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.006814199999999999	0.24059863023812314
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00673984	0.23797309618504184
SPINOCEREBELLAR ATAXIA TYPE 25	0.00673984	0.23797309618504184
RETINOBLASTOMA	0.00673984	0.23797309618504184
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00673984	0.23797309618504184
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00673984	0.23797309618504184
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00673984	0.23797309618504184
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00673984	0.23797309618504184
LEBER CONGENITAL AMAUROSIS 16	0.00673984	0.23797309618504184
FOCAL DERMAL HYPOPLASIA; FDH	0.00673984	0.23797309618504184
INCONTINENTIA PIGMENTI	0.006723852999999999	0.237408620486997
CYCLIC VOMITING SYNDROME	0.006663379	0.23527337914318255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.006581483	0.23238176084287127
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.006581483	0.23238176084287127
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006569654000000001	0.23196409755193667
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.006569654000000001	0.23196409755193667
LIGNEOUS CONJUNCTIVITIS	0.006569654000000001	0.23196409755193667
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006569654000000001	0.23196409755193667
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.006569654000000001	0.23196409755193667
BEHET DISEASE	0.0065655190000000006	0.23181809723846852
SANDHOFF DISEASE	0.0065655190000000006	0.23181809723846852
TAY-SACHS DISEASE; TSD	0.0065655190000000006	0.23181809723846852
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0065655190000000006	0.23181809723846852
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.0065655190000000006	0.23181809723846852
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0065655190000000006	0.23181809723846852
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0064596490000000005	0.2280799948958149
PRIMARY CUTIS VERTICIS GYRATA	0.0064596490000000005	0.2280799948958149
COCKAYNE SYNDROME	0.006459649	0.2280799948958149
XERODERMA PIGMENTOSUM	0.006459649	0.2280799948958149
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.006441309	0.22743243848734918
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.006441309	0.22743243848734918
ZEBRA BODY MYOPATHY	0.006359504	0.22454403325318675
ALAZAMI-YUAN SYNDROME	0.006359504	0.22454403325318675
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.006359504	0.22454403325318675
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.006359504	0.22454403325318675
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.006359504	0.22454403325318675
HARTSFIELD SYNDROME; HRTFDS	0.006359504	0.22454403325318675
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.006359504	0.22454403325318675
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006359504	0.22454403325318675
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.006355369	0.22439803293971858
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.006355369	0.22439803293971858
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.006355369	0.22439803293971858
47,XYY SYNDROME	0.006355369	0.22439803293971858
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.006355369	0.22439803293971858
MUCOLIPIDOSIS IV; ML4	0.006182434	0.218291971462182
COFFIN-SIRIS SYNDROME 4; CSS4	0.006145473	0.2169869369794502
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.006145473	0.2169869369794502
COFFIN-SIRIS SYNDROME 3; CSS3	0.006145473	0.2169869369794502
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.006145473	0.2169869369794502
SENGERS SYNDROME	0.00612196	0.21615673011836758
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00612196	0.21615673011836758
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.006040064	0.21326511181805627
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.006040064	0.21326511181805627
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.006040064	0.21326511181805627
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.006035929000000001	0.21311911150458815
EPISODIC ATAXIA TYPE 6	0.006035929000000001	0.21311911150458815
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.006035929000000001	0.21311911150458815
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.006035929000000001	0.21311911150458815
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.006035929000000001	0.21311911150458815
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.006024100000000001	0.2127014482136535
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.006024100000000001	0.2127014482136535
FRASER SYNDROME	0.006024100000000001	0.2127014482136535
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.006024100000000001	0.2127014482136535
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.006024100000000001	0.2127014482136535
STICKLER SYNDROME, TYPE I	0.006024100000000001	0.2127014482136535
CYSTINOSIS, NEPHROPATHIC; CTNS	0.006024100000000001	0.2127014482136535
FLECK RETINA OF KANDORI	0.006024100000000001	0.2127014482136535
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.006024100000000001	0.2127014482136535
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.006024100000000001	0.2127014482136535
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.006024100000000001	0.2127014482136535
SANDHOFF DISEASE	0.006024100000000001	0.2127014482136535
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006024100000000001	0.2127014482136535
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.006024100000000001	0.2127014482136535
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.006024100000000001	0.2127014482136535
TEMPORAL ARTERITIS	0.006024100000000001	0.2127014482136535
MUSK, INABILITY TO SMELL	0.006024100000000001	0.2127014482136535
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.006024100000000001	0.2127014482136535
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.006024100000000001	0.2127014482136535
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.006024100000000001	0.2127014482136535
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.006024100000000001	0.2127014482136535
WEILL-MARCHESANI SYNDROME 1; WMS1	0.006024100000000001	0.2127014482136535
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.006024100000000001	0.2127014482136535
USHER SYNDROME, TYPE IID; USH2D	0.006024100000000001	0.2127014482136535
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.006024100000000001	0.2127014482136535
SORSBY FUNDUS DYSTROPHY; SFD	0.006024100000000001	0.2127014482136535
RETINITIS PIGMENTOSA 71; RP71	0.006024100000000001	0.2127014482136535
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.006024100000000001	0.2127014482136535
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.006024100000000001	0.2127014482136535
RETINITIS PIGMENTOSA 35; RP35	0.006024100000000001	0.2127014482136535
RETINITIS PIGMENTOSA	0.006024100000000001	0.2127014482136535
ALBERS-SCHNBERG OSTEOPETROSIS	0.006024100000000001	0.2127014482136535
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.006024100000000001	0.2127014482136535
HERPES SIMPLEX VIRUS STROMAL KERATITIS	0.006024100000000001	0.2127014482136535
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.006024100000000001	0.2127014482136535
RODRIGUES BLINDNESS	0.006024100000000001	0.2127014482136535
LEBER CONGENITAL AMAUROSIS, TYPE II	0.006024100000000001	0.2127014482136535
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.006024100000000001	0.2127014482136535
RETINITIS PIGMENTOSA 29; RP29	0.006024100000000001	0.2127014482136535
SARCOIDOSIS	0.006024100000000001	0.2127014482136535
FREESIA FLOWERS, INABILITY TO SMELL	0.006024100000000001	0.2127014482136535
IDIOPATHIC PANUVEITIS	0.006024100000000001	0.2127014482136535
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.006024100000000001	0.2127014482136535
WEILL-MARCHESANI SYNDROME 2; WMS2	0.006024100000000001	0.2127014482136535
NON-24-HOUR SLEEP-WAKE SYNDROME	0.006024100000000001	0.2127014482136535
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.006024100000000001	0.2127014482136535
MUCOUS MEMBRANE PEMPHIGOID	0.006024100000000001	0.2127014482136535
COGAN SYNDROME	0.006024100000000001	0.2127014482136535
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.006024100000000001	0.2127014482136535
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.006024100000000001	0.2127014482136535
GLYCEROL KINASE DEFICIENCY; GKD	0.005981943	0.2112129511846628
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005981943	0.2112129511846628
COACH SYNDROME	0.005963603	0.21056539477619704
2P21 MICRODELETION SYNDROME	0.005963603	0.21056539477619704
VICI SYNDROME; VICIS	0.005963603	0.21056539477619704
KLEEFSTRA SYNDROME 2; KLEFS2	0.005963603	0.21056539477619704
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00581395	0.2052813839149036
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00581395	0.2052813839149036
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00581395	0.2052813839149036
GERMAN SYNDROME	0.00581395	0.2052813839149036
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00581395	0.2052813839149036
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00581395	0.2052813839149036
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.00581395	0.2052813839149036
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00581395	0.2052813839149036
EMERY-NELSON SYNDROME	0.00581395	0.2052813839149036
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00581395	0.2052813839149036
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00581395	0.2052813839149036
BETHLEM MYOPATHY 1	0.00581395	0.2052813839149036
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00581395	0.2052813839149036
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00581395	0.2052813839149036
AMISH NEMALINE MYOPATHY	0.00581395	0.2052813839149036
NEMALINE MYOPATHY 3; NEM3	0.00581395	0.2052813839149036
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.00581395	0.2052813839149036
BETHLEM MYOPATHY	0.00581395	0.2052813839149036
RADICULONEUROPATHY, FATAL NEONATAL	0.00581395	0.2052813839149036
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00581395	0.2052813839149036
TYPICAL NEMALINE MYOPATHY	0.00581395	0.2052813839149036
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00581395	0.2052813839149036
FG SYNDROME 2; FGS2	0.00581395	0.2052813839149036
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00581395	0.2052813839149036
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00581395	0.2052813839149036
MYOPATHY AND DIABETES MELLITUS	0.00581395	0.2052813839149036
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00581395	0.2052813839149036
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00581395	0.2052813839149036
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00581395	0.2052813839149036
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00581395	0.2052813839149036
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00581395	0.2052813839149036
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00581395	0.2052813839149036
ARGININEMIA	0.0057598729999999996	0.20337201052882933
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.0057598729999999996	0.20337201052882933
CENTRAL BILATERAL MACROGYRIA	0.0057598729999999996	0.20337201052882933
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0057598729999999996	0.20337201052882933
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.0057598729999999996	0.20337201052882933
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0057598729999999996	0.20337201052882933
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0057598729999999996	0.20337201052882933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0057598729999999996	0.20337201052882933
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0057598729999999996	0.20337201052882933
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0057598729999999996	0.20337201052882933
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.0056368799999999995	0.19902932212389882
MOEBIUS SYNDROME	0.0056368799999999995	0.19902932212389882
PETERS PLUS SYNDROME	0.005604054	0.19787028795463518
FILIPPI SYNDROME; FLPIS	0.005599919	0.19772428764116703
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.005599919	0.19772428764116703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00554358	0.19573504661082075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00554358	0.19573504661082075
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.005496862999999999	0.19408554319019403
RETINITIS PIGMENTOSA 60; RP60	0.00549451	0.19400246247977312
PSEUDOXANTHOMA ELASTICUM; PXE	0.00549451	0.19400246247977312
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00549451	0.19400246247977312
RAMOS-ARROYO SYNDROME	0.00549451	0.19400246247977312
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00549451	0.19400246247977312
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.00549451	0.19400246247977312
RETINITIS PIGMENTOSA 76; RP76	0.00549451	0.19400246247977312
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00549451	0.19400246247977312
RETINITIS PIGMENTOSA 77; RP77	0.00549451	0.19400246247977312
DERMOCHONDROCORNEAL DYSTROPHY	0.00549451	0.19400246247977312
STARGARDT DISEASE 3; STGD3	0.00549451	0.19400246247977312
PRIMARY HYPEROXALURIA	0.00549451	0.19400246247977312
CORNEAL DYSTROPHY, MEESMANN	0.00549451	0.19400246247977312
NANOPHTHALMOS 4; NNO4	0.00549451	0.19400246247977312
CONE-ROD DYSTROPHY 21; CORD21	0.00549451	0.19400246247977312
INTERMEDIATE UVEITIS	0.00549451	0.19400246247977312
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.00549451	0.19400246247977312
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00549451	0.19400246247977312
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00549451	0.19400246247977312
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00549451	0.19400246247977312
KERATOCONUS 9; KTCN9	0.00549451	0.19400246247977312
RETINITIS PIGMENTOSA 56; RP56	0.00549451	0.19400246247977312
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.00549451	0.19400246247977312
CONE-ROD DYSTROPHY 5; CORD5	0.00549451	0.19400246247977312
OCULOCUTANEOUS ALBINISM TYPE 5	0.00549451	0.19400246247977312
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.00549451	0.19400246247977312
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00549451	0.19400246247977312
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.00549451	0.19400246247977312
MADRAS MOTOR NEURON DISEASE	0.00549451	0.19400246247977312
IRVAN SYNDROME	0.00549451	0.19400246247977312
RETINITIS PIGMENTOSA 51; RP51	0.00549451	0.19400246247977312
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.00549451	0.19400246247977312
RETINITIS PIGMENTOSA 85; RP85	0.00549451	0.19400246247977312
OCULOCUTANEOUS ALBINISM TYPE 6	0.00549451	0.19400246247977312
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00549451	0.19400246247977312
SENIOR-LOKEN SYNDROME 8; SLSN8	0.00549451	0.19400246247977312
FRIEDREICH ATAXIA	0.00549451	0.19400246247977312
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00549451	0.19400246247977312
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00549451	0.19400246247977312
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00549451	0.19400246247977312
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.00549451	0.19400246247977312
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00549451	0.19400246247977312
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.005478523	0.19343798678172833
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.005478523	0.19343798678172833
RFT1-CDG	0.005478523	0.19343798678172833
SMITH-LEMLI-OPITZ SYNDROME	0.005453233	0.19254503685969462
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005453233	0.19254503685969462
EMANUEL SYNDROME	0.005453233	0.19254503685969462
WOLF-HIRSCHHORN SYNDROME	0.005453233	0.19254503685969462
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.005453233	0.19254503685969462
BOHRING-OPITZ SYNDROME	0.005453233	0.19254503685969462
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005453233	0.19254503685969462
COFFIN-SIRIS SYNDROME	0.005453233	0.19254503685969462
COHEN SYNDROME	0.005453233	0.19254503685969462
19P13.12 MICRODELETION SYNDROME	0.005453233	0.19254503685969462
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.005453233	0.19254503685969462
22Q11.2 DELETION SYNDROME	0.005453233	0.19254503685969462
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.005440524	0.1920963021598478
JOUBERT SYNDROME 14	0.005440524	0.1920963021598478
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.005440524	0.1920963021598478
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005440524	0.1920963021598478
NEPHRONOPHTHISIS 11; NPHP11	0.005440524	0.1920963021598478
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.005440524	0.1920963021598478
DUPLICATION/INVERSION 15Q11	0.005436389	0.19195030184637962
ACROCALLOSAL SYNDROME; ACLS	0.005436389	0.19195030184637962
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005422184	0.19144874575138204
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005422184	0.19144874575138204
THYROID HEMIAGENESIS	0.005422184	0.19144874575138204
GALACTOSE EPIMERASE DEFICIENCY	0.005422184	0.19144874575138204
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.005422184	0.19144874575138204
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.005422184	0.19144874575138204
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.005422184	0.19144874575138204
FAMILIAL DYSAUTONOMIA	0.005418049	0.1913027454379139
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.005418049	0.1913027454379139
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.005418049	0.1913027454379139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.005418049	0.1913027454379139
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.005418049	0.1913027454379139
14Q12 MICRODELETION SYNDROME	0.005418049	0.1913027454379139
LATHOSTEROLOSIS	0.005418049	0.1913027454379139
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.18425536150401436
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.005218454	0.18425536150401436
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.005218454	0.18425536150401436
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.18410936119054622
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.18410936119054622
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.18410936119054622
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.005214319	0.18410936119054622
HUNTINGTON DISEASE-LIKE 1	0.005214319	0.18410936119054622
NEUROCUTANEOUS MELANOCYTOSIS	0.005214319	0.18410936119054622
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.005214319	0.18410936119054622
PARTINGTON SYNDROME	0.005214319	0.18410936119054622
RETT SYNDROME	0.005214319	0.18410936119054622
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005214319	0.18410936119054622
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.18410936119054622
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.18410936119054622
DERMOTRICHIC SYNDROME	0.005214319	0.18410936119054622
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.005214319	0.18410936119054622
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.18410936119054622
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.18410936119054622
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.18410936119054622
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.18410936119054622
AUTISM	0.005214319	0.18410936119054622
EPILEPSY, READING	0.005214319	0.18410936119054622
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.005214319	0.18410936119054622
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.18410936119054622
ATYPICAL RETT SYNDROME	0.005214319	0.18410936119054622
ZLOTOGORA-OGUR SYNDROME	0.005214319	0.18410936119054622
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.18410936119054622
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.005214319	0.18410936119054622
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.18410936119054622
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.18410936119054622
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.18410936119054622
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.18410936119054622
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.005214319	0.18410936119054622
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.18410936119054622
SUPRABULBAR PARESIS, CONGENITAL	0.005214319	0.18410936119054622
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.18410936119054622
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.18410936119054622
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.18410936119054622
OSTEOGENESIS IMPERFECTA	0.0050585	0.178607638616352
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0050585	0.178607638616352
TREACHER-COLLINS SYNDROME	0.004955444	0.17496889416537903
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004955444	0.17496889416537903
HYPERTRYPTOPHANEMIA; HYPTRP	0.004955444	0.17496889416537903
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004951309	0.1748228938519109
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.004951309	0.1748228938519109
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004951309	0.1748228938519109
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0049371039999999995	0.1743213377569133
TRIPLE A SYNDROME	0.004932969	0.17417533744344518
KALLMANN SYNDROME	0.004932969	0.17417533744344518
INFANTILE NEUROAXONAL DYSTROPHY	0.004932969	0.17417533744344518
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0049118140000000005	0.17342838783487963
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.004911814	0.1734283878348796
TRISOMY 17P	0.004911814	0.1734283878348796
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004907679	0.17328238752141145
MARDEN-WALKER SYNDROME	0.004907679	0.17328238752141145
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00489497	0.17283365282156463
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00487663	0.17218609641309887
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00487663	0.17218609641309887
ESOPHAGEAL ATRESIA	0.00487663	0.17218609641309887
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00487663	0.17218609641309887
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00487663	0.17218609641309887
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00487663	0.17218609641309887
GLYCOGEN STORAGE DISEASE IXC	0.00487663	0.17218609641309887
HYPOTONIA-CYSTINURIA SYNDROME	0.00487663	0.17218609641309887
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004736613	0.16724231747939408
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004736613	0.16724231747939408
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004736613	0.16724231747939408
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.004736613	0.16724231747939408
RING CHROMOSOME 22 SYNDROME	0.004736613	0.16724231747939408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.004736613	0.16724231747939408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.004736613	0.16724231747939408
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004736613	0.16724231747939408
CLASSIC PHENYLKETONURIA	0.004736613	0.16724231747939408
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004736613	0.16724231747939408
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.004736613	0.16724231747939408
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004736613	0.16724231747939408
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004736613	0.16724231747939408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.16499271216573122
HUNTINGTON DISEASE	0.0046729	0.16499271216573122
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.16499271216573122
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.0046729	0.16499271216573122
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.16499271216573122
ISAAC SYNDROME	0.0046729	0.16499271216573122
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.16499271216573122
ARGININOSUCCINIC ACIDURIA	0.0046729	0.16499271216573122
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.0046729	0.16499271216573122
SCHIZOPHRENIA	0.0046729	0.16499271216573122
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.16499271216573122
SACCHAROPINURIA	0.0046729	0.16499271216573122
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.16499271216573122
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0046729	0.16499271216573122
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.16499271216573122
OCULOCUTANEOUS ALBINISM TYPE 4	0.00440989	0.15570624482709589
X-LINKED RETINAL DYSPLASIA	0.00440989	0.15570624482709589
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00440989	0.15570624482709589
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00440989	0.15570624482709589
APERT SYNDROME	0.00440989	0.15570624482709589
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00440989	0.15570624482709589
RENAL COLOBOMA SYNDROME	0.00440989	0.15570624482709589
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00440989	0.15570624482709589
BUSCHKE-OLLENDORFF SYNDROME	0.00440989	0.15570624482709589
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00440989	0.15570624482709589
SPASTIC PARAPLEGIA 16, X-LINKED	0.00440989	0.15570624482709589
ACRO-RENAL-OCULAR SYNDROME	0.00440989	0.15570624482709589
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00440989	0.15570624482709589
OCULOCUTANEOUS ALBINISM TYPE 2	0.00440989	0.15570624482709589
HALLERMANN-STREIFF SYNDROME	0.00440989	0.15570624482709589
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00439155	0.15505868841863016
MARFAN SYNDROME	0.00439155	0.15505868841863016
FETAL METHYLMERCURY SYNDROME	0.00439155	0.15505868841863016
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00439155	0.15505868841863016
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00439155	0.15505868841863016
ABETALIPOPROTEINEMIA	0.00439155	0.15505868841863016
GOLDENHAR SYNDROME	0.00439155	0.15505868841863016
JOHANSON-BLIZZARD SYNDROME; JBS	0.00436626	0.15416573849659646
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.15011490948492537
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.15011490948492537
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.15011490948492537
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.15011490948492537
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.15011490948492537
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.15011490948492537
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.15011490948492537
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004251533	0.15011490948492537
COFFIN-SIRIS SYNDROME 2; CSS2	0.004251533	0.15011490948492537
JABERI-ELAHI SYNDROME; JABELS	0.004251533	0.15011490948492537
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004251533	0.15011490948492537
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004251533	0.15011490948492537
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.15011490948492537
BOHRING-OPITZ SYNDROME	0.004226243	0.14922195956289167
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.004226243	0.14922195956289167
MATERNAL PHENYLKETONURIA	0.004226243	0.14922195956289167
15Q24 MICRODELETION SYNDROME	0.004226243	0.14922195956289167
DISTAL MONOSOMY 15Q	0.004226243	0.14922195956289167
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.004226243	0.14922195956289167
8P23.1 MICRODELETION SYNDROME	0.004226243	0.14922195956289167
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.004207903	0.1485744031544259
LATHOSTEROLOSIS	0.004207903	0.1485744031544259
FILIPPI SYNDROME	0.004207903	0.1485744031544259
WOLMAN DISEASE	0.004195194	0.14812566845457908
LIG4 SYNDROME	0.004195194	0.14812566845457908
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	0.14812566845457908
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.004195194	0.14812566845457908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.004195194	0.14812566845457908
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.004195194	0.14812566845457908
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.004195194	0.14812566845457908
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.004195194	0.14812566845457908
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	0.14812566845457908
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.004195194	0.14812566845457908
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004195194	0.14812566845457908
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.004195194	0.14812566845457908
JOUBERT SYNDROME 10	0.004195194	0.14812566845457908
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004195194	0.14812566845457908
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.004195194	0.14812566845457908
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	0.14812566845457908
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	0.14812566845457908
MONOSOMY 13Q34	0.004195194	0.14812566845457908
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004195194	0.14812566845457908
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0041910590000000005	0.14797966814111096
ZIMMERMANN-LABAND SYNDROME	0.0041910590000000005	0.14797966814111096
HEREDITARY FRUCTOSE INTOLERANCE	0.0041910590000000005	0.14797966814111096
THREONINEMIA	0.0041910590000000005	0.14797966814111096
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.0041910590000000005	0.14797966814111096
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0041910590000000005	0.14797966814111096
20Q13.33 MICRODELETION SYNDROME	0.0041910590000000005	0.14797966814111096
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.0041910590000000005	0.14797966814111096
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0041910590000000005	0.14797966814111096
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0041910590000000005	0.14797966814111096
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.13099826046011034
CRANIOTELENCEPHALIC DYSPLASIA	0.0037101139999999996	0.13099826046011034
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.13099826046011034
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0037101139999999996	0.13099826046011034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.13099826046011034
N SYNDROME	0.0037101139999999996	0.13099826046011034
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.13099826046011034
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003705979	0.13085226014664222
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.13085226014664222
PAPILLOMA OF CHOROID PLEXUS	0.003705979	0.13085226014664222
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003705979	0.13085226014664222
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.13085226014664222
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.13085226014664222
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0036848239999999997	0.13010531053807664
FLOATING-HARBOR SYNDROME	0.0036848239999999997	0.13010531053807664
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0036848239999999997	0.13010531053807664
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.0036848239999999997	0.13010531053807664
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0036848239999999997	0.13010531053807664
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0036848239999999997	0.13010531053807664
DISTAL TRISOMY 6P	0.0036848239999999997	0.13010531053807664
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0036848239999999997	0.13010531053807664
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0036848239999999997	0.13010531053807664
FETAL TRIMETHADIONE SYNDROME	0.0036848239999999997	0.13010531053807664
FETAL HYDANTOIN SYNDROME	0.0036848239999999997	0.13010531053807664
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036848239999999997	0.13010531053807664
SECKEL SYNDROME 1; SCKL1	0.003680689	0.1299593102246085
BRANCHIOOCULOFACIAL SYNDROME	0.003680689	0.1299593102246085
DUBOWITZ SYNDROME	0.003680689	0.1299593102246085
MARDEN-WALKER SYNDROME	0.0036664840000000002	0.1294577541296109
TRISOMY 18	0.0036664840000000002	0.1294577541296109
RITSCHER-SCHINZEL SYNDROME 1	0.0036664840000000002	0.1294577541296109
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.0036664840000000002	0.1294577541296109
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0036664840000000002	0.1294577541296109
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0036664840000000002	0.1294577541296109
COLE-CARPENTER SYNDROME	0.0036664840000000002	0.1294577541296109
XQ27.3Q28 DUPLICATION SYNDROME	0.0036664840000000002	0.1294577541296109
12Q14 MICRODELETION SYNDROME	0.0036664840000000002	0.1294577541296109
20Q11.2 MICRODELETION SYNDROME	0.0036664840000000002	0.1294577541296109
CUTIS LAXA	0.0036664840000000002	0.1294577541296109
DISTAL MONOSOMY 3P	0.0036623489999999996	0.12931175381614277
RING CHROMOSOME 10 SYNDROME	0.0036623489999999996	0.12931175381614277
WIEDEMANN-STEINER SYNDROME	0.0036623489999999996	0.12931175381614277
THANATOPHORIC DYSPLASIA	0.0036623489999999996	0.12931175381614277
ACROCARDIOFACIAL SYNDROME	0.0036623489999999996	0.12931175381614277
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0036623489999999996	0.12931175381614277
DISTAL TRISOMY 15Q	0.0036623489999999996	0.12931175381614277
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	0.12886301911629594
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	0.12886301911629594
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00364964	0.12886301911629594
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	0.12886301911629594
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00364964	0.12886301911629594
3MC SYNDROME 3	0.00364964	0.12886301911629594
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	0.12886301911629594
HARDIKAR SYNDROME	0.00364964	0.12886301911629594
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	0.12886301911629594
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	0.12886301911629594
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	0.12886301911629594
MAJEED SYNDROME	0.00364964	0.12886301911629594
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	0.12886301911629594
CRYPTOSPORIDIOSIS	0.00364964	0.12886301911629594
AXENFELD-RIEGER SYNDROME	0.00364964	0.12886301911629594
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	0.12886301911629594
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	0.12886301911629594
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	0.12886301911629594
CERNUNNOS-XLF DEFICIENCY	0.00364964	0.12886301911629594
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	0.12886301911629594
FRANK-TER HAAR SYNDROME; FTHS	0.00364964	0.12886301911629594
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00364964	0.12886301911629594
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	0.12886301911629594
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	0.12886301911629594
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00364964	0.12886301911629594
AROMATASE DEFICIENCY	0.00364964	0.12886301911629594
CUSHING SYNDROME	0.00364964	0.12886301911629594
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00364964	0.12886301911629594
JUVENILE POLYPOSIS SYNDROME	0.00364964	0.12886301911629594
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	0.12886301911629594
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	0.12886301911629594
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	0.12886301911629594
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	0.12886301911629594
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	0.12886301911629594
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	0.12886301911629594
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	0.12886301911629594
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00364964	0.12886301911629594
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	0.12886301911629594
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	0.12886301911629594
T-SUBSTANCE ANOMALY	0.00364964	0.12886301911629594
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	0.12886301911629594
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	0.12886301911629594
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	0.12886301911629594
NEPHRONOPHTHISIS 1	0.00364964	0.12886301911629594
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	0.12886301911629594
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	0.12886301911629594
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00364964	0.12886301911629594
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00364964	0.12886301911629594
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	0.12886301911629594
CINCA SYNDROME; CINCA	0.00364964	0.12886301911629594
BARTH SYNDROME; BTHS	0.00364964	0.12886301911629594
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	0.12886301911629594
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	0.12886301911629594
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	0.12886301911629594
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00364964	0.12886301911629594
SERKAL SYNDROME	0.00364964	0.12886301911629594
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	0.12886301911629594
LYSINE MALABSORPTION SYNDROME	0.00364964	0.12886301911629594
FAMILIAL HYPOALDOSTERONISM	0.00364964	0.12886301911629594
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	0.12886301911629594
RING CHROMOSOME 13 SYNDROME	0.00364964	0.12886301911629594
NATHALIE SYNDROME	0.00364964	0.12886301911629594
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	0.12886301911629594
HEREDITARY SPHEROCYTOSIS	0.00364964	0.12886301911629594
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	0.12886301911629594
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	0.12886301911629594
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00364964	0.12886301911629594
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	0.12886301911629594
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	0.12886301911629594
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	0.12886301911629594
CHYLOMICRON RETENTION DISEASE	0.00364964	0.12886301911629594
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	0.12886301911629594
NEPHRONOPHTHISIS 4	0.00364964	0.12886301911629594
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	0.12886301911629594
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	0.12886301911629594
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00364964	0.12886301911629594
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00364964	0.12886301911629594
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	0.12886301911629594
GLYCOGEN STORAGE DISEASE IXA	0.00364964	0.12886301911629594
CITRULLINE TRANSPORT DEFECT	0.00364964	0.12886301911629594
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	0.12886301911629594
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	0.12886301911629594
ALPHA-HEAVY CHAIN DISEASE	0.00364964	0.12886301911629594
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	0.12886301911629594
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003559293	0.12567300936516979
CHROMOSOME 16P13.3 DELETION SYNDROME	0.003559293	0.12567300936516979
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.003559293	0.12567300936516979
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.003559293	0.12567300936516979
MONOSOMY 9Q22.3	0.003559293	0.12567300936516979
KABUKI SYNDROME 1	0.003559293	0.12567300936516979
2Q31.1 MICRODELETION SYNDROME	0.003559293	0.12567300936516979
MONOSOMY 9P	0.003559293	0.12567300936516979
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.003559293	0.12567300936516979
15Q13.3 MICRODELETION SYNDROME	0.003559293	0.12567300936516979
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.003559293	0.12567300936516979
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.003559293	0.12567300936516979
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.003559293	0.12567300936516979
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.003559293	0.12567300936516979
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.003559293	0.12567300936516979
C SYNDROME	0.003559293	0.12567300936516979
49,XXXXY SYNDROME	0.003559293	0.12567300936516979
WEAVER SYNDROME	0.003559293	0.12567300936516979
1Q21.1 MICRODUPLICATION SYNDROME	0.003559293	0.12567300936516979
48,XXXY SYNDROME	0.003559293	0.12567300936516979
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.003559293	0.12567300936516979
CHROMOSOME 10Q26 DELETION SYNDROME	0.003559293	0.12567300936516979
WIEDEMANN-STEINER SYNDROME; WDSTS	0.003559293	0.12567300936516979
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11173561112182721
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11173561112182721
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00316456	0.11173561112182721
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.11173561112182721
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11173561112182721
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11173561112182721
JALILI SYNDROME	0.00316456	0.11173561112182721
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11173561112182721
PROLIDASE DEFICIENCY	0.00316456	0.11173561112182721
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00316456	0.11173561112182721
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11173561112182721
FISH-EYE DISEASE	0.00316456	0.11173561112182721
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11173561112182721
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11173561112182721
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11173561112182721
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11173561112182721
CONE ROD DYSTROPHY	0.00316456	0.11173561112182721
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11173561112182721
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11173561112182721
WAGR SYNDROME	0.00316456	0.11173561112182721
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11173561112182721
BRADYOPSIA	0.00316456	0.11173561112182721
GAPO SYNDROME	0.00316456	0.11173561112182721
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11173561112182721
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11173561112182721
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11173561112182721
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11173561112182721
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11173561112182721
GMEZ-LPEZ-HERNNDEZ SYNDROME	0.00316456	0.11173561112182721
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11173561112182721
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.11173561112182721
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11173561112182721
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11173561112182721
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11173561112182721
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11173561112182721
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11173561112182721
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.11173561112182721
BETA-THALASSEMIA MAJOR	0.00316456	0.11173561112182721
CYSTINOSIS	0.00316456	0.11173561112182721
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11173561112182721
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11173561112182721
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11173561112182721
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11173561112182721
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11173561112182721
GILLESPIE SYNDROME; GLSP	0.00316456	0.11173561112182721
TANGIER DISEASE; TGD	0.00316456	0.11173561112182721
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11173561112182721
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11173561112182721
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.11173561112182721
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00316456	0.11173561112182721
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.11173561112182721
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11173561112182721
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11173561112182721
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11173561112182721
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.11173561112182721
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11173561112182721
MMEP SYNDROME	0.00316456	0.11173561112182721
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11173561112182721
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11173561112182721
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11173561112182721
ERDHEIM-CHESTER DISEASE	0.00316456	0.11173561112182721
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11173561112182721
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11173561112182721
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11173561112182721
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11173561112182721
BLUE CONE MONOCHROMATISM	0.00316456	0.11173561112182721
MUCOLIPIDOSIS TYPE III	0.00316456	0.11173561112182721
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11173561112182721
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11173561112182721
ASCHER SYNDROME	0.00316456	0.11173561112182721
N SYNDROME	0.00316456	0.11173561112182721
MALT LYMPHOMA	0.00316456	0.11173561112182721
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.11173561112182721
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11173561112182721
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11173561112182721
ALBINISM, OCULAR, TYPE I	0.00316456	0.11173561112182721
MANGANESE POISONING	0.00316456	0.11173561112182721
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00313927	0.1108426611997935
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00313927	0.1108426611997935
MOSAIC MONOSOMY X	0.00313927	0.1108426611997935
ELLIS VAN CREVELD SYNDROME	0.00313927	0.1108426611997935
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00313927	0.1108426611997935
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00313927	0.1108426611997935
PROGEROID SYNDROME, PETTY TYPE	0.00313927	0.1108426611997935
BRANCHIO-OCULO-FACIAL SYNDROME	0.00313927	0.1108426611997935
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00313927	0.1108426611997935
MONOSOMY X	0.00313927	0.1108426611997935
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00313927	0.1108426611997935
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00313927	0.1108426611997935
LAMBOTTE SYNDROME	0.00313927	0.1108426611997935
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00313927	0.1108426611997935
ALAGILLE SYNDROME	0.00313927	0.1108426611997935
TURNER SYNDROME	0.00313927	0.1108426611997935
MEIER-GORLIN SYNDROME 1; MGORS1	0.00313927	0.1108426611997935
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00312093	0.11019510479132776
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00312093	0.11019510479132776
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00312093	0.11019510479132776
THAKKER-DONNAI SYNDROME	0.00312093	0.11019510479132776
MONOSOMY 13Q14	0.00312093	0.11019510479132776
DIASTROPHIC DWARFISM	0.00312093	0.11019510479132776
CAT-EYE SYNDROME	0.00312093	0.11019510479132776
LAMBERT SYNDROME	0.00312093	0.11019510479132776
IMAGE SYNDROME	0.00312093	0.11019510479132776
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00312093	0.11019510479132776
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00312093	0.11019510479132776
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00312093	0.11019510479132776
JOHANSON-BLIZZARD SYNDROME	0.00312093	0.11019510479132776
PEARSON SYNDROME	0.00312093	0.11019510479132776
MATTHEW-WOOD SYNDROME	0.00312093	0.11019510479132776
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00312093	0.11019510479132776
NEUROFACIODIGITORENAL SYNDROME	0.00312093	0.11019510479132776
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0030178740000000003	0.10655636034035482
TOLUENE EMBRYOPATHY	0.0030178740000000003	0.10655636034035482
HADZISELIMOVIC SYNDROME	0.0030178740000000003	0.10655636034035482
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.0030178740000000003	0.10655636034035482
CRANIOSYNOSTOSIS 6; CRS6	0.0030178740000000003	0.10655636034035482
GERMAN SYNDROME	0.0030178740000000003	0.10655636034035482
MARINESCO-SJGREN SYNDROME	0.0030178740000000003	0.10655636034035482
2Q32Q33 MICRODELETION SYNDROME	0.0030178740000000003	0.10655636034035482
ARTERIAL TORTUOSITY SYNDROME	0.0030178740000000003	0.10655636034035482
CODAS SYNDROME	0.0030178740000000003	0.10655636034035482
MOWAT-WILSON SYNDROME	0.003013739	0.10641036002688666
5Q14.3 MICRODELETION SYNDROME	0.003013739	0.10641036002688666
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003013739	0.10641036002688666
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.003013739	0.10641036002688666
CHROMOSOME 18Q DELETION SYNDROME	0.003013739	0.10641036002688666
PALLISTER-KILLIAN SYNDROME	0.003013739	0.10641036002688666
FRAGILE X SYNDROME	0.003013739	0.10641036002688666
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.003013739	0.10641036002688666
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003013739	0.10641036002688666
NOONAN SYNDROME 7; NS7	0.003013739	0.10641036002688666
LEIGH SYNDROME	0.003013739	0.10641036002688666
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.002980913	0.10525132585762295
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002980913	0.10525132585762295
STT3B-CDG	0.002980913	0.10525132585762295
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002980913	0.10525132585762295
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.002980913	0.10525132585762295
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.002980913	0.10525132585762295
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002980913	0.10525132585762295
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002980913	0.10525132585762295
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.002980913	0.10525132585762295
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.002980913	0.10525132585762295
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002980913	0.10525132585762295
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002980913	0.10525132585762295
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.002980913	0.10525132585762295
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002980913	0.10525132585762295
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.002980913	0.10525132585762295
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.002980913	0.10525132585762295
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002980913	0.10525132585762295
CATEL-MANZKE SYNDROME; CATMANS	0.002980913	0.10525132585762295
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002980913	0.10525132585762295
AL KAISSI SYNDROME; ALKAS	0.002980913	0.10525132585762295
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002980913	0.10525132585762295
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.002980913	0.10525132585762295
RUVALCABA SYNDROME	0.002980913	0.10525132585762295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002980913	0.10525132585762295
COFFIN-SIRIS SYNDROME 5	0.002980913	0.10525132585762295
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002980913	0.10525132585762295
PETERS-PLUS SYNDROME; PTRPLS	0.002980913	0.10525132585762295
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002980913	0.10525132585762295
MACDERMOT-WINTER SYNDROME	0.002980913	0.10525132585762295
PALLISTER-HALL SYNDROME	0.002980913	0.10525132585762295
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00247232	0.08729371100207164
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00247232	0.08729371100207164
STEINERT MYOTONIC DYSTROPHY	0.00247232	0.08729371100207164
TRISOMY 20P	0.00247232	0.08729371100207164
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00247232	0.08729371100207164
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00247232	0.08729371100207164
TRISOMY 4P	0.00247232	0.08729371100207164
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00247232	0.08729371100207164
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00247232	0.08729371100207164
NON-DISTAL MONOSOMY 10Q	0.00247232	0.08729371100207164
8Q21.11 MICRODELETION SYNDROME	0.00247232	0.08729371100207164
NOONAN SYNDROME	0.00247232	0.08729371100207164
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00247232	0.08729371100207164
TETRASOMY 12P	0.00247232	0.08729371100207164
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00247232	0.08729371100207164
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00247232	0.08729371100207164
6P22 MICRODELETION SYNDROME	0.00247232	0.08729371100207164
COOPER-JABS SYNDROME	0.00247232	0.08729371100207164
REVESZ SYNDROME	0.002439494	0.08613467683280795
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002439494	0.08613467683280795
MOSAIC TRISOMY 9	0.002439494	0.08613467683280795
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.002439494	0.08613467683280795
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002439494	0.08613467683280795
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002439494	0.08613467683280795
DYSKERATOSIS CONGENITA	0.002439494	0.08613467683280795
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.002439494	0.08613467683280795
DIAPHANOSPONDYLODYSOSTOSIS	0.002439494	0.08613467683280795
BRESEK SYNDROME	0.002439494	0.08613467683280795
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.002439494	0.08613467683280795
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002439494	0.08613467683280795
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.002439494	0.08613467683280795
HOYERAAL-HREIDARSSON SYNDROME	0.002439494	0.08613467683280795
SYNDROMIC DIARRHEA	0.002439494	0.08613467683280795
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.002439494	0.08613467683280795
SAUL-WILSON SYNDROME; SWILS	0.002439494	0.08613467683280795
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.002439494	0.08613467683280795
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.002439494	0.08613467683280795
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002439494	0.08613467683280795
%300712 CRANIOFACIOSKELETAL SYNDROME	0.002439494	0.08613467683280795
RABSON-MENDENHALL SYNDROME	0.002439494	0.08613467683280795
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.002439494	0.08613467683280795
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.002439494	0.08613467683280795
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.002439494	0.08613467683280795
SECKEL SYNDROME 9; SCKL9	0.002439494	0.08613467683280795
OCULO-PALATO-CEREBRAL SYNDROME	0.002439494	0.08613467683280795
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.002439494	0.08613467683280795
CONGENITAL VARICELLA SYNDROME	0.002439494	0.08613467683280795
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.002439494	0.08613467683280795
DE BARSY SYNDROME	0.002439494	0.08613467683280795
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.002439494	0.08613467683280795
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.002439494	0.08613467683280795
SILVER-RUSSELL SYNDROME; SRS	0.002439494	0.08613467683280795
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.002439494	0.08613467683280795
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.002439494	0.08613467683280795
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.002439494	0.08613467683280795
WARSAW BREAKAGE SYNDROME; WABS	0.002439494	0.08613467683280795
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002439494	0.08613467683280795
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.002439494	0.08613467683280795
TARP SYNDROME; TARPS	0.002439494	0.08613467683280795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.002439494	0.08613467683280795
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.002439494	0.08613467683280795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.002439494	0.08613467683280795
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002439494	0.08613467683280795
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002439494	0.08613467683280795
EAR-PATELLA-SHORT STATURE SYNDROME	0.002439494	0.08613467683280795
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002439494	0.08613467683280795
LOWRY-MACLEAN SYNDROME	0.002439494	0.08613467683280795
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.002439494	0.08613467683280795
RETINITIS PIGMENTOSA 59; RP59	0.002435359	0.08598867651933981
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002435359	0.08598867651933981
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002435359	0.08598867651933981
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.002435359	0.08598867651933981
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002435359	0.08598867651933981
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002435359	0.08598867651933981
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.002435359	0.08598867651933981
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002435359	0.08598867651933981
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002435359	0.08598867651933981
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002435359	0.08598867651933981
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002435359	0.08598867651933981
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.002435359	0.08598867651933981
KAPUR-TORIELLO SYNDROME	0.002435359	0.08598867651933981
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.002435359	0.08598867651933981
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.002435359	0.08598867651933981
HARROD SYNDROME	0.002435359	0.08598867651933981
3-HYDROXYISOBUTYRIC ACIDURIA	0.002435359	0.08598867651933981
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.002435359	0.08598867651933981
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.002435359	0.08598867651933981
MENKES DISEASE	0.002435359	0.08598867651933981
11Q22.2Q22.3 MICRODELETION SYNDROME	0.002332303	0.08234993206836684
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002332303	0.08234993206836684
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002332303	0.08234993206836684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.002332303	0.08234993206836684
PONTINE TEGMENTAL CAP DYSPLASIA	0.002332303	0.08234993206836684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08234993206836684
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002332303	0.08234993206836684
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002332303	0.08234993206836684
RUBINSTEIN-TAYBI SYNDROME	0.002332303	0.08234993206836684
POTOCKI-SHAFFER SYNDROME	0.002332303	0.08234993206836684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.002332303	0.08234993206836684
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002332303	0.08234993206836684
CK SYNDROME	0.002332303	0.08234993206836684
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002332303	0.08234993206836684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.002332303	0.08234993206836684
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.002332303	0.08234993206836684
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.002332303	0.08234993206836684
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.002332303	0.08234993206836684
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08234993206836684
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.002332303	0.08234993206836684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002332303	0.08234993206836684
ADAMS-OLIVER SYNDROME 2; AOS2	0.002332303	0.08234993206836684
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002332303	0.08234993206836684
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002332303	0.08234993206836684
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.002332303	0.08234993206836684
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.002332303	0.08234993206836684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002332303	0.08234993206836684
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.002332303	0.08234993206836684
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.002332303	0.08234993206836684
MEHMO SYNDROME; MEHMO	0.002332303	0.08234993206836684
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002332303	0.08234993206836684
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.002332303	0.08234993206836684
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002332303	0.08234993206836684
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.002332303	0.08234993206836684
MENTAL RETARDATION, X-LINKED 90	0.002332303	0.08234993206836684
SSR4-CDG	0.002332303	0.08234993206836684
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002332303	0.08234993206836684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002332303	0.08234993206836684
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002332303	0.08234993206836684
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.002332303	0.08234993206836684
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002332303	0.08234993206836684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.002332303	0.08234993206836684
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002332303	0.08234993206836684
19P13.13 MICRODELETION SYNDROME	0.002332303	0.08234993206836684
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.002332303	0.08234993206836684
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.002332303	0.08234993206836684
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08234993206836684
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002332303	0.08234993206836684
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002332303	0.08234993206836684
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002332303	0.08234993206836684
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002332303	0.08234993206836684
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.002332303	0.08234993206836684
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.002313963	0.08170237565990111
MAPLE SYRUP URINE DISEASE	0.002313963	0.08170237565990111
DPAGT1-CDG	0.002313963	0.08170237565990111
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.002313963	0.08170237565990111
GRISCELLI SYNDROME	0.002313963	0.08170237565990111
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002313963	0.08170237565990111
SIMPSON-GOLABI-BEHMEL SYNDROME	0.002313963	0.08170237565990111
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002313963	0.08170237565990111
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002313963	0.08170237565990111
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002313963	0.08170237565990111
KLEEFSTRA SYNDROME	0.002313963	0.08170237565990111
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.002313963	0.08170237565990111
15Q11Q13 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990111
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002313963	0.08170237565990111
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990111
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002313963	0.08170237565990111
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.08170237565990111
CODAS SYNDROME	0.002313963	0.08170237565990111
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002313963	0.08170237565990111
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.002313963	0.08170237565990111
FOLATE MALABSORPTION, HEREDITARY	0.002313963	0.08170237565990111
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002313963	0.08170237565990111
2Q37 MICRODELETION SYNDROME	0.002313963	0.08170237565990111
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.08170237565990111
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.002313963	0.08170237565990111
FUCOSIDOSIS	0.002313963	0.08170237565990111
METHYLMALONIC ACIDURIA, CBLA TYPE	0.002313963	0.08170237565990111
MEVALONIC ACIDURIA	0.002313963	0.08170237565990111
PELIZAEUS-MERZBACHER DISEASE	0.002313963	0.08170237565990111
TRISOMY X	0.002313963	0.08170237565990111
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002313963	0.08170237565990111
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002313963	0.08170237565990111
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002313963	0.08170237565990111
3Q29 MICRODUPLICATION SYNDROME	0.002313963	0.08170237565990111
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002313963	0.08170237565990111
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.002313963	0.08170237565990111
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002313963	0.08170237565990111
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002313963	0.08170237565990111
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.002313963	0.08170237565990111
20P12.3 MICRODELETION SYNDROME	0.002313963	0.08170237565990111
FREE SIALIC ACID STORAGE DISEASE	0.002313963	0.08170237565990111
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002313963	0.08170237565990111
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.002313963	0.08170237565990111
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002313963	0.08170237565990111
PYRUVATE CARBOXYLASE DEFICIENCY	0.002313963	0.08170237565990111
KETOADIPICACIDURIA	0.002313963	0.08170237565990111
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002313963	0.08170237565990111
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002313963	0.08170237565990111
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.002313963	0.08170237565990111
GRISCELLI SYNDROME, TYPE 1	0.002313963	0.08170237565990111
DISTAL MONOSOMY 19P13.3	0.002313963	0.08170237565990111
WALKER-WARBURG SYNDROME	0.002313963	0.08170237565990111
HOLOPROSENCEPHALY 2; HPE2	0.002313963	0.08170237565990111
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.002313963	0.08170237565990111
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002313963	0.08170237565990111
HOLOPROSENCEPHALY	0.002313963	0.08170237565990111
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00189394	0.0668720274945248
MECKEL SYNDROME, TYPE 4; MKS4	0.00189394	0.0668720274945248
PHOCOMELIA, SCHINZEL TYPE	0.00189394	0.0668720274945248
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00189394	0.0668720274945248
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00189394	0.0668720274945248
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00189394	0.0668720274945248
FETAL AKINESIA DEFORMATION SEQUENCE	0.00189394	0.0668720274945248
CEREBROCOSTOMANDIBULAR SYNDROME	0.00189394	0.0668720274945248
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00189394	0.0668720274945248
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00189394	0.0668720274945248
ENG-STROM SYNDROME	0.00189394	0.0668720274945248
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00189394	0.0668720274945248
BLOOM SYNDROME	0.00189394	0.0668720274945248
MECKEL SYNDROME, TYPE 1; MKS1	0.00189394	0.0668720274945248
PHAVER SYNDROME	0.00189394	0.0668720274945248
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00189394	0.0668720274945248
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00189394	0.0668720274945248
ACROFACIAL DYSOSTOSIS, RODRGUEZ TYPE	0.00189394	0.0668720274945248
3M SYNDROME	0.00189394	0.0668720274945248
TETRALOGY OF FALLOT	0.00189394	0.0668720274945248
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00189394	0.0668720274945248
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00189394	0.0668720274945248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00189394	0.0668720274945248
LETHAL FACIOCARDIOMELIC DYSPLASIA	0.00189394	0.0668720274945248
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00189394	0.0668720274945248
TETRAPLOIDY	0.00189394	0.0668720274945248
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00189394	0.0668720274945248
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00189394	0.0668720274945248
MULIBREY NANISM	0.00189394	0.0668720274945248
MARTINEZ-FRIAS SYNDROME	0.00189394	0.0668720274945248
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00189394	0.0668720274945248
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00189394	0.0668720274945248
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00189394	0.0668720274945248
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00189394	0.0668720274945248
TRIPLOIDY	0.00189394	0.0668720274945248
TRANSALDOLASE DEFICIENCY	0.00189394	0.0668720274945248
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00189394	0.0668720274945248
VACTERL WITH HYDROCEPHALUS	0.00189394	0.0668720274945248
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00189394	0.0668720274945248
CRANE-HEISE SYNDROME	0.00189394	0.0668720274945248
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.00189394	0.0668720274945248
HYDROLETHALUS SYNDROME 1	0.00189394	0.0668720274945248
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00189394	0.0668720274945248
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00189394	0.0668720274945248
BALLER-GEROLD SYNDROME	0.00189394	0.0668720274945248
JUBERG-HAYWARD SYNDROME	0.00189394	0.0668720274945248
ACRORENAL-MANDIBULAR SYNDROME	0.00189394	0.0668720274945248
MEIER-GORLIN SYNDROME 8; MGORS8	0.00189394	0.0668720274945248
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00189394	0.0668720274945248
MECKEL SYNDROME 12; MKS12	0.00189394	0.0668720274945248
19Q13.11 MICRODELETION SYNDROME	0.00189394	0.0668720274945248
NEU-LAXOVA SYNDROME 2; NLS2	0.00189394	0.0668720274945248
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00189394	0.0668720274945248
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00189394	0.0668720274945248
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00189394	0.0668720274945248
MITCHELL-RILEY SYNDROME; MTCHRS	0.00189394	0.0668720274945248
IMMUNODEFICIENCY 55; IMD55	0.00189394	0.0668720274945248
NIJMEGEN BREAKAGE SYNDROME	0.00189394	0.0668720274945248
VERVERI-BRADY SYNDROME; VERBRAS	0.00189394	0.0668720274945248
HOLZGREVE SYNDROME	0.00189394	0.0668720274945248
BLOOM SYNDROME	0.00189394	0.0668720274945248
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00189394	0.0668720274945248
ACRO-RENAL-MANDIBULAR SYNDROME	0.00189394	0.0668720274945248
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00189394	0.0668720274945248
METHIMAZOLE EMBRYOFETOPATHY	0.00189394	0.0668720274945248
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00189394	0.0668720274945248
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00189394	0.0668720274945248
BARTSOCAS-PAPAS SYNDROME; BPS	0.00189394	0.0668720274945248
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00189394	0.0668720274945248
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00189394	0.0668720274945248
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00189394	0.0668720274945248
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00189394	0.0668720274945248
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00189394	0.0668720274945248
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00189394	0.0668720274945248
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00189394	0.0668720274945248
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00189394	0.0668720274945248
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00189394	0.0668720274945248
LEPRECHAUNISM	0.00189394	0.0668720274945248
NEU-LAXOVA SYNDROME	0.00189394	0.0668720274945248
ATRESIA OF SMALL INTESTINE	0.00189394	0.0668720274945248
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00189394	0.0668720274945248
ROIFMAN SYNDROME	0.00189394	0.0668720274945248
HEMOCHROMATOSIS, NEONATAL	0.00189394	0.0668720274945248
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00189394	0.0668720274945248
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00189394	0.0668720274945248
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00189394	0.0668720274945248
AREDYLD SYNDROME	0.00189394	0.0668720274945248
FRAXE INTELLECTUAL DISABILITY	0.00189394	0.0668720274945248
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00189394	0.0668720274945248
GENITOPALATOCARDIAC SYNDROME	0.00189394	0.0668720274945248
SECKEL SYNDROME 4	0.00189394	0.0668720274945248
MEIER-GORLIN SYNDROME 2; MGORS2	0.00189394	0.0668720274945248
APPARENT MINERALOCORTICOID EXCESS	0.00189394	0.0668720274945248
MEIER-GORLIN SYNDROME 3; MGORS3	0.00189394	0.0668720274945248
MODY	0.00189394	0.0668720274945248
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00189394	0.0668720274945248
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00189394	0.0668720274945248
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00189394	0.0668720274945248
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00189394	0.0668720274945248
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00189394	0.0668720274945248
HARTSFIELD SYNDROME	0.00189394	0.0668720274945248
BRADDOCK SYNDROME	0.00189394	0.0668720274945248
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00189394	0.0668720274945248
TRICHOHEPATOENTERIC SYNDROME 2	0.00189394	0.0668720274945248
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00189394	0.0668720274945248
STIMMLER SYNDROME	0.00189394	0.0668720274945248
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00189394	0.0668720274945248
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00189394	0.0668720274945248
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00189394	0.0668720274945248
GRACILE SYNDROME	0.00189394	0.0668720274945248
RUSSELL-SILVER SYNDROME, X-LINKED	0.00189394	0.0668720274945248
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	0.06323328304355184
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.06323328304355184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	0.06323328304355184
MIETENS SYNDROME	0.001790884	0.06323328304355184
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.06323328304355184
CHAR SYNDROME	0.001790884	0.06323328304355184
SENIOR-LOKEN SYNDROME 9	0.001790884	0.06323328304355184
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.06323328304355184
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.001790884	0.06323328304355184
LAMB-SHAFFER SYNDROME	0.001790884	0.06323328304355184
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	0.06323328304355184
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001790884	0.06323328304355184
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.06323328304355184
MEIER-GORLIN SYNDROME 7	0.001790884	0.06323328304355184
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.06323328304355184
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.06323328304355184
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001790884	0.06323328304355184
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.06323328304355184
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001790884	0.06323328304355184
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.06323328304355184
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.001790884	0.06323328304355184
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.06323328304355184
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	0.06323328304355184
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	0.06323328304355184
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	0.06323328304355184
3MC SYNDROME 2	0.001790884	0.06323328304355184
ROTHMUND-THOMSON SYNDROME	0.001790884	0.06323328304355184
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.06323328304355184
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001790884	0.06323328304355184
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001790884	0.06323328304355184
MARINESCO-SJOGREN SYNDROME; MSS	0.001790884	0.06323328304355184
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.06323328304355184
FRONTOOCULAR SYNDROME	0.001790884	0.06323328304355184
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001790884	0.06323328304355184
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.06323328304355184
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001790884	0.06323328304355184
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.001790884	0.06323328304355184
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	0.06323328304355184
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	0.06323328304355184
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001790884	0.06323328304355184
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.06323328304355184
CHAR SYNDROME	0.001790884	0.06323328304355184
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.06323328304355184
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001790884	0.06323328304355184
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.001790884	0.06323328304355184
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.06323328304355184
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.06323328304355184
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.06308728273008368
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001786749	0.06308728273008368
INCONTINENTIA PIGMENTI; IP	0.001786749	0.06308728273008368
CHIME SYNDROME	0.001786749	0.06308728273008368
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001786749	0.06308728273008368
ATAXIA-TELANGIECTASIA	0.001786749	0.06308728273008368
SMITH-KINGSMORE SYNDROME; SKS	0.001786749	0.06308728273008368
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.06308728273008368
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.001786749	0.06308728273008368
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001786749	0.06308728273008368
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.001786749	0.06308728273008368
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.001786749	0.06308728273008368
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.06308728273008368
PROTEUS SYNDROME	0.001786749	0.06308728273008368
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.001786749	0.06308728273008368
BRANCHIOSKELETOGENITAL SYNDROME	0.001786749	0.06308728273008368
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.001786749	0.06308728273008368
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001786749	0.06308728273008368
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001786749	0.06308728273008368
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.06308728273008368
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.06308728273008368
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001786749	0.06308728273008368
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.06308728273008368
CONGENITAL HYDROCEPHALUS	0.001786749	0.06308728273008368
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.06308728273008368
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001786749	0.06308728273008368
MENTAL RETARDATION, X-LINKED 21	0.001786749	0.06308728273008368
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001786749	0.06308728273008368
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001786749	0.06308728273008368
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001772544	0.06258572663508612
GENITOPATELLAR SYNDROME; GTPTS	0.001772544	0.06258572663508612
LATERAL MENINGOCELE SYNDROME	0.001772544	0.06258572663508612
17P13.3 MICRODUPLICATION SYNDROME	0.001772544	0.06258572663508612
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001772544	0.06258572663508612
LARSEN-LIKE SYNDROME	0.001772544	0.06258572663508612
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06258572663508612
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001772544	0.06258572663508612
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001772544	0.06258572663508612
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001772544	0.06258572663508612
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001772544	0.06258572663508612
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001772544	0.06258572663508612
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001772544	0.06258572663508612
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.001772544	0.06258572663508612
FRIED SYNDROME	0.001772544	0.06258572663508612
PEROXISOME BIOGENESIS DISORDER 3B	0.001772544	0.06258572663508612
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.001772544	0.06258572663508612
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001772544	0.06258572663508612
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.001772544	0.06258572663508612
WAARDENBURG-SHAH SYNDROME	0.001772544	0.06258572663508612
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.001772544	0.06258572663508612
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001772544	0.06258572663508612
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001772544	0.06258572663508612
3C SYNDROME	0.001772544	0.06258572663508612
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001772544	0.06258572663508612
ALG6-CDG	0.001772544	0.06258572663508612
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06258572663508612
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001772544	0.06258572663508612
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001772544	0.06258572663508612
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508612
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.001772544	0.06258572663508612
MEVALONIC ACIDURIA; MEVA	0.001772544	0.06258572663508612
NIEMANN-PICK DISEASE, TYPE A	0.001772544	0.06258572663508612
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001772544	0.06258572663508612
ATHYREOSIS	0.001772544	0.06258572663508612
TRANSKETOLASE DEFICIENCY	0.001772544	0.06258572663508612
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001772544	0.06258572663508612
MONOSOMY 18P	0.001772544	0.06258572663508612
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.001772544	0.06258572663508612
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001772544	0.06258572663508612
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001772544	0.06258572663508612
THYROID ECTOPIA	0.001772544	0.06258572663508612
MICROPHTHALMIA, SYNDROMIC 3	0.001772544	0.06258572663508612
FAMILIAL THYROID DYSHORMONOGENESIS	0.001772544	0.06258572663508612
DISTAL MONOSOMY 9P	0.001772544	0.06258572663508612
THYROID HYPOPLASIA	0.001772544	0.06258572663508612
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.001772544	0.06258572663508612
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06258572663508612
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001772544	0.06258572663508612
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001772544	0.06258572663508612
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508612
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06258572663508612
14Q22Q23 MICRODELETION SYNDROME	0.001772544	0.06258572663508612
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001772544	0.06258572663508612
CHROMOSOME 9P DELETION SYNDROME	0.001772544	0.06258572663508612
OCCIPITAL HORN SYNDROME	0.001772544	0.06258572663508612
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001772544	0.06258572663508612
HURLER SYNDROME	0.001772544	0.06258572663508612
ALPHA-MANNOSIDOSIS	0.001772544	0.06258572663508612
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06258572663508612
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06258572663508612
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06258572663508612
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06258572663508612
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06258572663508612
17Q21.31 MICRODUPLICATION SYNDROME	0.001772544	0.06258572663508612
JOUBERT SYNDROME 8	0.001772544	0.06258572663508612
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06243972632161796
HYPOPHOSPHATASIA	0.001768409	0.06243972632161796
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06243972632161796
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.001768409	0.06243972632161796
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001768409	0.06243972632161796
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001768409	0.06243972632161796
FETAL GAUCHER DISEASE	0.001768409	0.06243972632161796
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.001768409	0.06243972632161796
CAMOS SYNDROME	0.001768409	0.06243972632161796
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06243972632161796
ISOLATED SPINA BIFIDA	0.001768409	0.06243972632161796
CENTRONUCLEAR MYOPATHY	0.001768409	0.06243972632161796
SJGREN-LARSSON SYNDROME	0.001768409	0.06243972632161796
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06243972632161796
METACHROMATIC LEUKODYSTROPHY	0.001768409	0.06243972632161796
ALG9-CDG	0.001768409	0.06243972632161796
ACUTE ADRENAL INSUFFICIENCY	0.001768409	0.06243972632161796
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.001768409	0.06243972632161796
L-2-HYDROXYGLUTARIC ACIDURIA	0.001768409	0.06243972632161796
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001768409	0.06243972632161796
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.001768409	0.06243972632161796
ONDINE SYNDROME	0.001768409	0.06243972632161796
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06243972632161796
2Q23.1 MICRODELETION SYNDROME	0.001768409	0.06243972632161796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001768409	0.06243972632161796
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.001768409	0.06243972632161796
POTOCKI-SHAFFER SYNDROME	0.001768409	0.06243972632161796
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06243972632161796
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06243972632161796
METACHROMATIC LEUKODYSTROPHY	0.001768409	0.06243972632161796
OHDO SYNDROME	0.001768409	0.06243972632161796
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.001768409	0.06243972632161796
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001768409	0.06243972632161796
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001768409	0.06243972632161796
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.001768409	0.06243972632161796
BETA-KETOTHIOLASE DEFICIENCY	0.001768409	0.06243972632161796
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.001768409	0.06243972632161796
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001768409	0.06243972632161796
ASPARTYLGLUCOSAMINURIA; AGU	0.001768409	0.06243972632161796
HYPERLYSINEMIA, TYPE I	0.001768409	0.06243972632161796
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.001768409	0.06243972632161796
GLYCINE ENCEPHALOPATHY; GCE	0.001768409	0.06243972632161796
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06243972632161796
GLUTARIC ACIDEMIA I; GA1	0.001768409	0.06243972632161796
VISCERAL STEATOSIS, CONGENITAL	0.001768409	0.06243972632161796
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.001768409	0.06243972632161796
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001768409	0.06243972632161796
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.001768409	0.06243972632161796
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001768409	0.06243972632161796
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001768409	0.06243972632161796
THANATOPHORIC DYSPLASIA TYPE 1	0.001768409	0.06243972632161796
1P36 MICRODELETION SYNDROME	0.001768409	0.06243972632161796
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001768409	0.06243972632161796
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06243972632161796
COFFIN-LOWRY SYNDROME; CLS	0.001768409	0.06243972632161796
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.001768409	0.06243972632161796
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.001768409	0.06243972632161796
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00124533	0.043970633705268686
ODONTOCHONDRODYSPLASIA	0.00124533	0.043970633705268686
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.043970633705268686
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.043970633705268686
ANTLEY-BIXLER SYNDROME	0.00124533	0.043970633705268686
SCARF SYNDROME	0.00124533	0.043970633705268686
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.043970633705268686
PETERS ANOMALY	0.00124533	0.043970633705268686
GLUTATHIONURIA	0.00124533	0.043970633705268686
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.043970633705268686
MELNICK-NEEDLES SYNDROME	0.00124533	0.043970633705268686
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.043970633705268686
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.043970633705268686
WOOLLY HAIR	0.00124533	0.043970633705268686
FANCONI ANEMIA	0.00124533	0.043970633705268686
AASE-SMITH SYNDROME	0.00124533	0.043970633705268686
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.043970633705268686
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.043970633705268686
SCARF SYNDROME	0.00124533	0.043970633705268686
MASA SYNDROME	0.00124533	0.043970633705268686
PELVISCAPULAR DYSPLASIA	0.00124533	0.043970633705268686
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.043970633705268686
IVIC SYNDROME	0.00124533	0.043970633705268686
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.043970633705268686
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.043970633705268686
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.043970633705268686
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00124533	0.043970633705268686
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.043970633705268686
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.043970633705268686
FEMORAL-FACIAL SYNDROME	0.00124533	0.043970633705268686
HYPERTELORISM, TEEBI TYPE	0.00124533	0.043970633705268686
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.043970633705268686
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00124533	0.043970633705268686
CHANARIN-DORFMAN SYNDROME	0.00124533	0.043970633705268686
JACKSON-WEISS SYNDROME	0.00124533	0.043970633705268686
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.043970633705268686
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.043970633705268686
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00124533	0.043970633705268686
SUMMITT SYNDROME	0.00124533	0.043970633705268686
OTOMANDIBULAR SYNDROME	0.00124533	0.043970633705268686
COATS DISEASE	0.00124533	0.043970633705268686
FREEMAN-SHELDON SYNDROME	0.00124533	0.043970633705268686
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00124533	0.043970633705268686
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	0.043970633705268686
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.043970633705268686
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.043970633705268686
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.043970633705268686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.043970633705268686
FOCAL DERMAL HYPOPLASIA	0.00124533	0.043970633705268686
CEREBROFACIOTHORACIC DYSPLASIA	0.00124533	0.043970633705268686
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.043970633705268686
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.043970633705268686
FETAL IODINE SYNDROME	0.00124533	0.043970633705268686
MCDONOUGH SYNDROME	0.00124533	0.043970633705268686
PROXIMAL SYMPHALANGISM	0.00124533	0.043970633705268686
GASTROCUTANEOUS SYNDROME	0.00124533	0.043970633705268686
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.043970633705268686
PETERS ANOMALY	0.00124533	0.043970633705268686
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.043970633705268686
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.043970633705268686
ALAGILLE SYNDROME 1; ALGS1	0.00124533	0.043970633705268686
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.043970633705268686
GORLIN SYNDROME	0.00124533	0.043970633705268686
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.043970633705268686
MOSAIC TRISOMY 8	0.00124533	0.043970633705268686
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.043970633705268686
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00124533	0.043970633705268686
SECKEL SYNDROME 5; SCKL5	0.00124533	0.043970633705268686
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00124533	0.043970633705268686
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.043970633705268686
FRONTORHINY	0.00124533	0.043970633705268686
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	0.043970633705268686
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.043970633705268686
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00124533	0.043970633705268686
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.043970633705268686
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.043970633705268686
ROBINOW-SORAUF SYNDROME	0.00124533	0.043970633705268686
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.043970633705268686
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.043970633705268686
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.043970633705268686
IVIC SYNDROME	0.00124533	0.043970633705268686
HEMIFACIAL MICROSOMIA	0.00124533	0.043970633705268686
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.043970633705268686
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.043970633705268686
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.043970633705268686
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00124533	0.043970633705268686
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00124533	0.043970633705268686
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.043970633705268686
CROSSED POLYSYNDACTYLY	0.00124533	0.043970633705268686
MULTIMINICORE MYOPATHY	0.00124533	0.043970633705268686
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00124533	0.043970633705268686
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.043970633705268686
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.043970633705268686
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.043970633705268686
COSTELLO SYNDROME	0.00124533	0.043970633705268686
MCDONOUGH SYNDROME	0.00124533	0.043970633705268686
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.043970633705268686
15Q26 OVERGROWTH SYNDROME	0.00124533	0.043970633705268686
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.043970633705268686
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.043970633705268686
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.043970633705268686
ABDUCENS PALSY	0.00124533	0.043970633705268686
MEIER-GORLIN SYNDROME 6; MGORS6	0.00124533	0.043970633705268686
BASAL CELL NEVUS SYNDROME	0.00124533	0.043970633705268686
LERI PLEONOSTEOSIS	0.00124533	0.043970633705268686
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.043970633705268686
STIFF SKIN SYNDROME	0.00124533	0.043970633705268686
MLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.043970633705268686
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.043970633705268686
LAURENCE-MOON SYNDROME	0.00124533	0.043970633705268686
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.043970633705268686
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00124533	0.043970633705268686
NATIVE AMERICAN MYOPATHY	0.00122699	0.04332307729680296
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00122699	0.04332307729680296
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.04332307729680296
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.04332307729680296
KENNEDY DISEASE	0.00122699	0.04332307729680296
PRADER-WILLI SYNDROME (TYPE 1)	0.00122699	0.04332307729680296
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00122699	0.04332307729680296
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00122699	0.04332307729680296
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.04332307729680296
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00122699	0.04332307729680296
3Q13 MICRODELETION SYNDROME	0.00122699	0.04332307729680296
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.04332307729680296
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00122699	0.04332307729680296
B4GALT1-CDG	0.00122699	0.04332307729680296
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.04332307729680296
WARBURG MICRO SYNDROME 1	0.00122699	0.04332307729680296
KEARNS-SAYRE SYNDROME	0.00122699	0.04332307729680296
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.04332307729680296
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.04332307729680296
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.04332307729680296
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00122699	0.04332307729680296
SPINOCEREBELLAR ATAXIA 13	0.00122699	0.04332307729680296
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.04332307729680296
PORPHYRIA, ACUTE HEPATIC	0.00122699	0.04332307729680296
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.04332307729680296
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00122699	0.04332307729680296
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.04332307729680296
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.04332307729680296
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00122699	0.04332307729680296
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00122699	0.04332307729680296
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00122699	0.04332307729680296
POLYMYOSITIS	0.00122699	0.04332307729680296
NEMALINE MYOPATHY 4	0.00122699	0.04332307729680296
NEMALINE MYOPATHY 7; NEM7	0.00122699	0.04332307729680296
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00122699	0.04332307729680296
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00122699	0.04332307729680296
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.04332307729680296
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00122699	0.04332307729680296
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00122699	0.04332307729680296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00122699	0.04332307729680296
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00122699	0.04332307729680296
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00122699	0.04332307729680296
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.04332307729680296
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.04332307729680296
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.04332307729680296
MACS SYNDROME	0.00122699	0.04332307729680296
CENTRAL CORE DISEASE	0.00122699	0.04332307729680296
CAREY-FINEMAN-ZITER SYNDROME	0.00122699	0.04332307729680296
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.04332307729680296
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00122699	0.04332307729680296
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.04332307729680296
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.04332307729680296
ANTISYNTHETASE SYNDROME	0.00122699	0.04332307729680296
PIEBALDISM	0.00122699	0.04332307729680296
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00122699	0.04332307729680296
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.04332307729680296
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00122699	0.04332307729680296
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00122699	0.04332307729680296
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00122699	0.04332307729680296
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00122699	0.04332307729680296
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00122699	0.04332307729680296
DERMATOMYOSITIS	0.00122699	0.04332307729680296
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00122699	0.04332307729680296
INFANTILE SYSTEMIC HYALINOSIS	0.00122699	0.04332307729680296
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00122699	0.04332307729680296
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680296
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00122699	0.04332307729680296
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680296
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680296
CEREBELLAR HYPOPLASIA	0.00122699	0.04332307729680296
HAWKINSINURIA	0.00122699	0.04332307729680296
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00122699	0.04332307729680296
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00122699	0.04332307729680296
GRANT SYNDROME	0.00122699	0.04332307729680296
FRYNS-SMEETS-THIRY SYNDROME	0.00122699	0.04332307729680296
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00122699	0.04332307729680296
GLYCOGEN STORAGE DISEASE IV	0.00122699	0.04332307729680296
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.04332307729680296
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.04332307729680296
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.04332307729680296
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.04332307729680296
MYOTONIC DYSTROPHY 1	0.00122699	0.04332307729680296
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.04332307729680296
JUVENILE DERMATOMYOSITIS	0.00122699	0.04332307729680296
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.04332307729680296
JUNG SYNDROME	0.00122699	0.04332307729680296
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.04332307729680296
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00122699	0.04332307729680296
ISOTRETINOIN SYNDROME	0.00122699	0.04332307729680296
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.04332307729680296
SPONASTRIME DYSPLASIA	0.00122699	0.04332307729680296
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00122699	0.04332307729680296
SPINOCEREBELLAR ATAXIA 1	0.00122699	0.04332307729680296
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00122699	0.04332307729680296
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00122699	0.04332307729680296
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00122699	0.04332307729680296
SHPRINTZEN OMPHALOCELE SYNDROME	0.00122699	0.04332307729680296
OPSISMODYSPLASIA	0.00122699	0.04332307729680296
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00122699	0.04332307729680296
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.04332307729680296
DESBUQUOIS DYSPLASIA 1	0.00122699	0.04332307729680296
OPSISMODYSPLASIA; OPSMD	0.00122699	0.04332307729680296
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.04332307729680296
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00122699	0.04332307729680296
OSTEOPENIA AND SPARSE HAIR	0.00122699	0.04332307729680296
MENTAL RETARDATION, X-LINKED 93	0.00122699	0.04332307729680296
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00122699	0.04332307729680296
ARTERIAL TORTUOSITY SYNDROME	0.00122699	0.04332307729680296
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.04332307729680296
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.04332307729680296
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.04332307729680296
CHIARI MALFORMATION TYPE II	0.00122699	0.04332307729680296
KYPHOMELIC DYSPLASIA	0.00122699	0.04332307729680296
INTESTINAL BOTULISM	0.00122699	0.04332307729680296
PRADER-WILLI SYNDROME (TYPE 2)	0.00122699	0.04332307729680296
INFANT BOTULISM	0.00122699	0.04332307729680296
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.04332307729680296
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00122699	0.04332307729680296
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00122699	0.04332307729680296
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00122699	0.04332307729680296
ACID PHOSPHATASE DEFICIENCY	0.00122699	0.04332307729680296
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.04332307729680296
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00122699	0.04332307729680296
NEONATAL MARFAN SYNDROME	0.00122699	0.04332307729680296
VELOCARDIOFACIAL SYNDROME	0.00122699	0.04332307729680296
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00122699	0.04332307729680296
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00122699	0.04332307729680296
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00122699	0.04332307729680296
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00122699	0.04332307729680296
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00122699	0.04332307729680296
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00122699	0.04332307729680296
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00122699	0.04332307729680296
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00122699	0.04332307729680296
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00122699	0.04332307729680296
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00122699	0.04332307729680296
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00122699	0.04332307729680296
LESCH-NYHAN SYNDROME; LNS	0.00122699	0.04332307729680296
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00122699	0.04332307729680296
LAURIN-SANDROW SYNDROME	0.00122699	0.04332307729680296
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00122699	0.04332307729680296
SMITH-MAGENIS SYNDROME	0.00122699	0.04332307729680296
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00122699	0.04332307729680296
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00122699	0.04332307729680296
AICARDI-GOUTIRES SYNDROME	0.001086973	0.03837929836309815
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03837929836309815
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03837929836309815
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03837929836309815
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.03837929836309815
LISSENCEPHALY 4	0.001086973	0.03837929836309815
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03837929836309815
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.03837929836309815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03837929836309815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03837929836309815
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.03837929836309815
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.03837929836309815
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03837929836309815
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.03837929836309815
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03837929836309815
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03837929836309815
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03837929836309815
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.03837929836309815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.03837929836309815
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.03837929836309815
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03837929836309815
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.03837929836309815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.03837929836309815
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.03837929836309815
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.03837929836309815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03837929836309815
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03837929836309815
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.001086973	0.03837929836309815
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03837929836309815
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03837929836309815
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.03837929836309815
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03837929836309815
KBG SYNDROME	0.001086973	0.03837929836309815
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03837929836309815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.03837929836309815
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03837929836309815
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03837929836309815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03837929836309815
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03837929836309815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03837929836309815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03837929836309815
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.03837929836309815
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03837929836309815
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.03837929836309815
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03837929836309815
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03837929836309815
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.03837929836309815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03837929836309815
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.03837929836309815
KEUTEL SYNDROME	0.001086973	0.03837929836309815
SULFOCYSTEINURIA	0.001086973	0.03837929836309815
TIMOTHY SYNDROME; TS	0.001086973	0.03837929836309815
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03837929836309815
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.03837929836309815
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03837929836309815
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03837929836309815
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.03837929836309815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03837929836309815
SIALIDOSIS TYPE 2	0.001086973	0.03837929836309815
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03837929836309815
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03837929836309815
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03837929836309815
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03837929836309815
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03837929836309815
LANDAU-KLEFFNER SYNDROME	0.001086973	0.03837929836309815
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.03837929836309815
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03837929836309815
BAND HETEROTOPIA; BH	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03837929836309815
MEND SYNDROME; MEND	0.001086973	0.03837929836309815
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.03837929836309815
PETTIGREW SYNDROME	0.001086973	0.03837929836309815
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.03837929836309815
GRISCELLI SYNDROME TYPE 1	0.001086973	0.03837929836309815
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.03837929836309815
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03837929836309815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03837929836309815
WAISMAN SYNDROME; WSMN	0.001086973	0.03837929836309815
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.03837929836309815
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.03837929836309815
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.03837929836309815
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03837929836309815
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03837929836309815
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03837929836309815
XQ25 DUPLICATION SYNDROME	0.001086973	0.03837929836309815
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.03837929836309815
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03837929836309815
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03837929836309815
GLASS SYNDROME	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.03837929836309815
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.03837929836309815
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.03837929836309815
HARTNUP DISORDER	0.001086973	0.03837929836309815
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03837929836309815
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.03837929836309815
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03837929836309815
NETHERTON SYNDROME	0.001086973	0.03837929836309815
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03837929836309815
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.03837929836309815
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03837929836309815
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03837929836309815
CITRULLINEMIA, CLASSIC	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03837929836309815
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03837929836309815
PHACE ASSOCIATION	0.001086973	0.03837929836309815
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03837929836309815
LISSENCEPHALY 1; LIS1	0.001086973	0.03837929836309815
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.03837929836309815
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03837929836309815
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.03837929836309815
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.03837929836309815
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03837929836309815
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.03837929836309815
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.03837929836309815
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.03837929836309815
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03837929836309815
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.03837929836309815
HOLOPROSENCEPHALY 7	0.001086973	0.03837929836309815
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03837929836309815
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309815
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03837929836309815
DYSTONIA-APHONIA SYNDROME	0.001086973	0.03837929836309815
15Q14 MICRODELETION SYNDROME	0.001086973	0.03837929836309815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.03837929836309815
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309815
17Q12 MICRODELETION SYNDROME	0.001086973	0.03837929836309815
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03837929836309815
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.03837929836309815
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03837929836309815
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03837929836309815
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03837929836309815
L1 SYNDROME	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.03837929836309815
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.03837929836309815
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03837929836309815
MEND SYNDROME	0.001086973	0.03837929836309815
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03837929836309815
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.03837929836309815
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03837929836309815
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03837929836309815
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03837929836309815
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03837929836309815
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03837929836309815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03837929836309815
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309815
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03837929836309815
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03837929836309815
EAST SYNDROME	0.001086973	0.03837929836309815
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.03837929836309815
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.03837929836309815
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03837929836309815
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.03837929836309815
ISOVALERIC ACIDEMIA	0.001086973	0.03837929836309815
MOSAIC TRISOMY 14	0.001086973	0.03837929836309815
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.03837929836309815
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.03837929836309815
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03837929836309815
DISTAL TRISOMY 17Q	0.001086973	0.03837929836309815
WILSON-TURNER SYNDROME	0.001086973	0.03837929836309815
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03837929836309815
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.03837929836309815
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03837929836309815
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.03837929836309815
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03837929836309815
CITRULLINEMIA TYPE II	0.001086973	0.03837929836309815
DISTAL MONOSOMY 1Q	0.001086973	0.03837929836309815
8P11.2 DELETION SYNDROME	0.001086973	0.03837929836309815
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03837929836309815
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.03837929836309815
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03837929836309815
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.03837929836309815
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.03837929836309815
STT3A-CDG	0.001086973	0.03837929836309815
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.03837929836309815
COWDEN SYNDROME	0.001086973	0.03837929836309815
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.03837929836309815
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.03837929836309815
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03837929836309815
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.03837929836309815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03837929836309815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03837929836309815
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03837929836309815
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.03837929836309815
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.03837929836309815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.019262649338283148
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.019262649338283148
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.019262649338283148
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.019262649338283148
NOONAN SYNDROME 5; NS5	0.000545554	0.019262649338283148
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.019262649338283148
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.019262649338283148
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.019262649338283148
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.019262649338283148
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.019262649338283148
NOONAN SYNDROME 11; NS11	0.000545554	0.019262649338283148
OGDEN SYNDROME; OGDNS	0.000545554	0.019262649338283148
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.019262649338283148
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.019262649338283148
AUSTRALIA ANTIGEN	0.000545554	0.019262649338283148
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.019262649338283148
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.019262649338283148
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.019262649338283148
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.019262649338283148
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.019262649338283148
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.019262649338283148
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.019262649338283148
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.019262649338283148
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.019262649338283148
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.019262649338283148
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.019262649338283148
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.019262649338283148
FRIAS SYNDROME	0.000545554	0.019262649338283148
NOONAN SYNDROME 3; NS3	0.000545554	0.019262649338283148
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.019262649338283148
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.019262649338283148
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.019262649338283148
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.019262649338283148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.019262649338283148
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.019262649338283148
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.019262649338283148
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.019262649338283148
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.019262649338283148
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.019262649338283148
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.019262649338283148
OTOFACIOCERVICAL SYNDROME	0.000545554	0.019262649338283148
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.019262649338283148
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.019262649338283148
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.019262649338283148
JAWAD SYNDROME	0.000545554	0.019262649338283148
EVEN-PLUS SYNDROME	0.000545554	0.019262649338283148
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.019262649338283148
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.019262649338283148
NOONAN SYNDROME 6; NS6	0.000545554	0.019262649338283148
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.019262649338283148
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.019262649338283148
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.019262649338283148
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.019262649338283148
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.019262649338283148
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.019262649338283148
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.019262649338283148
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.019262649338283148
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.019262649338283148
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.019262649338283148
JOUBERT SYNDROME 27	0.000545554	0.019262649338283148
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.019262649338283148
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.019262649338283148
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.019262649338283148
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.019262649338283148
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.019262649338283148
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.019262649338283148
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.019262649338283148
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.019262649338283148
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.019262649338283148
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.019262649338283148
TEMTAMY SYNDROME	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.019262649338283148
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.019262649338283148
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.019262649338283148
WEAVER SYNDROME	0.000545554	0.019262649338283148
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.019262649338283148
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.019262649338283148
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.019262649338283148
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.019262649338283148
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.019262649338283148
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.019262649338283148
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.019262649338283148
ICF SYNDROME	0.000545554	0.019262649338283148
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.019262649338283148
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.019262649338283148
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.019262649338283148
CURRY-JONES SYNDROME	0.000545554	0.019262649338283148
HYDROXYKYNURENINURIA	0.000545554	0.019262649338283148
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.019262649338283148
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.019262649338283148
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.019262649338283148
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.019262649338283148
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.019262649338283148
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.019262649338283148
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.019262649338283148
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.019262649338283148
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.019262649338283148
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.019262649338283148
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.019262649338283148
HYPERTRICHOSIS CUBITI	0.000545554	0.019262649338283148
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.019262649338283148
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.019262649338283148
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.019262649338283148
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.019262649338283148
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.019262649338283148
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.019262649338283148
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.019262649338283148
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.019262649338283148
TRISOMY 12P	0.000545554	0.019262649338283148
SAY-BARBER-MILLER SYNDROME	0.000545554	0.019262649338283148
HEREDITARY OROTIC ACIDURIA	0.000545554	0.019262649338283148
ZECHI-CEIDE SYNDROME	0.000545554	0.019262649338283148
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.019262649338283148
HOLMES-GANG SYNDROME	0.000545554	0.019262649338283148
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.019262649338283148
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.019262649338283148
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.019262649338283148
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.019262649338283148
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.019262649338283148
LIG4 SYNDROME	0.000545554	0.019262649338283148
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.019262649338283148
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.019262649338283148
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.019262649338283148
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.019262649338283148
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.019262649338283148
TRISOMY 8Q	0.000545554	0.019262649338283148
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.019262649338283148
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.019262649338283148
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.019262649338283148
NOONAN SYNDROME 2; NS2	0.000545554	0.019262649338283148
3Q29 MICRODELETION SYNDROME	0.000545554	0.019262649338283148
CDAGS SYNDROME	0.000545554	0.019262649338283148
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.019262649338283148
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.019262649338283148
MICROVILLUS INCLUSION DISEASE	0.000545554	0.019262649338283148
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.019262649338283148
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.019262649338283148
OXOGLUTARIC ACIDURIA	0.000545554	0.019262649338283148
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.019262649338283148
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.019262649338283148
DISTAL TRISOMY 18Q	0.000545554	0.019262649338283148
TRISOMY 9P	0.000545554	0.019262649338283148
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.019262649338283148
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.019262649338283148
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.019262649338283148
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.019262649338283148
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.019262649338283148
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.019262649338283148
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.019262649338283148
SEPTOOPTIC DYSPLASIA	0.000545554	0.019262649338283148
SECKEL SYNDROME 8; SCKL8	0.000545554	0.019262649338283148
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.019262649338283148
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.019262649338283148
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.019262649338283148
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.019262649338283148
OGDEN SYNDROME	0.000545554	0.019262649338283148
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.019262649338283148
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.019262649338283148
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.019262649338283148
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.019262649338283148
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.019262649338283148
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.019262649338283148
CULLER-JONES SYNDROME; CJS	0.000545554	0.019262649338283148
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.019262649338283148
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.019262649338283148
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.019262649338283148
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.019262649338283148
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.019262649338283148
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.019262649338283148
STEEL SYNDROME; STLS	0.000545554	0.019262649338283148
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.019262649338283148
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.019262649338283148
JOUBERT SYNDROME 25	0.000545554	0.019262649338283148
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.019262649338283148
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.019262649338283148
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.019262649338283148
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.019262649338283148
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.019262649338283148
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.019262649338283148
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.019262649338283148
8P23.1 DUPLICATION SYNDROME	0.000545554	0.019262649338283148
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.019262649338283148
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.019262649338283148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.019262649338283148
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.019262649338283148
JOUBERT SYNDROME 26	0.000545554	0.019262649338283148
48,XYYY SYNDROME	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.019262649338283148
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.019262649338283148
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.019262649338283148
NOONAN SYNDROME 9; NS9	0.000545554	0.019262649338283148
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.019262649338283148
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.019262649338283148
CHOPS SYNDROME; CHOPS	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.019262649338283148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.019262649338283148
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.019262649338283148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.019262649338283148
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.019262649338283148
AL-RAQAD SYNDROME; ARS	0.000545554	0.019262649338283148
MECKEL SYNDROME 13; MKS13	0.000545554	0.019262649338283148
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.019262649338283148
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.019262649338283148
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.019262649338283148
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.019262649338283148
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.019262649338283148
AU-KLINE SYNDROME; AUKS	0.000545554	0.019262649338283148
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.019262649338283148
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.019262649338283148
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.019262649338283148
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 2	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.019262649338283148
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.019262649338283148
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.019262649338283148
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.019262649338283148
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.019262649338283148
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.019262649338283148
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.019262649338283148
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.019262649338283148
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.019262649338283148
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.019262649338283148
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.019262649338283148
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.019262649338283148
RIDDLE SYNDROME	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.019262649338283148
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.019262649338283148
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.019262649338283148
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.019262649338283148
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.019262649338283148
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.019262649338283148
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.019262649338283148
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.019262649338283148
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.019262649338283148
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.019262649338283148
ALAZAMI SYNDROME; ALAZS	0.000545554	0.019262649338283148
JOUBERT SYNDROME 28	0.000545554	0.019262649338283148
OROTIC ACIDURIA	0.000545554	0.019262649338283148
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.019262649338283148
RIGID SPINE SYNDROME	0.000545554	0.019262649338283148
HOLOPROSENCEPHALY 11	0.000545554	0.019262649338283148
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.019262649338283148
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.019262649338283148
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.019262649338283148
ABETAL34V AMYLOIDOSIS	0.000545554	0.019262649338283148
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.019262649338283148
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.019262649338283148
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.019262649338283148
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.019262649338283148
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.019262649338283148
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.019262649338283148
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.019262649338283148
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.019262649338283148
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.019262649338283148
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.019262649338283148
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.019262649338283148
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.019262649338283148
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.019262649338283148
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.019262649338283148
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.019262649338283148
ATELOSTEOGENESIS TYPE III	0.000545554	0.019262649338283148
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.019262649338283148
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.019262649338283148
DEXTROCARDIA	0.000545554	0.019262649338283148
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.019262649338283148
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.019262649338283148
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.019262649338283148
PELLAGRA-LIKE SYNDROME	0.000545554	0.019262649338283148
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.019262649338283148
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.019262649338283148
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.019262649338283148
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.019262649338283148
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.019262649338283148
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.019262649338283148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.019262649338283148
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.019262649338283148
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.019262649338283148
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.019262649338283148
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.019262649338283148
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.019262649338283148
JOUBERT SYNDROME 15	0.000545554	0.019262649338283148
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.019262649338283148
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.019262649338283148
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.019262649338283148
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.019262649338283148
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.019262649338283148
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.019262649338283148
RAINE SYNDROME	0.000545554	0.019262649338283148
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.019262649338283148
OPITZ G/BBB SYNDROME	0.000545554	0.019262649338283148
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.019116649024815004
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.019116649024815004
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.019116649024815004
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.019116649024815004
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.019116649024815004
HYPER-BETA-ALANINEMIA	0.000541419	0.019116649024815004
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.019116649024815004
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.019116649024815004
EBOLA HEMORRHAGIC FEVER	0.000541419	0.019116649024815004
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.019116649024815004
KIFAFA SEIZURE DISORDER	0.000541419	0.019116649024815004
LUJO HEMORRHAGIC FEVER	0.000541419	0.019116649024815004
RAMON SYNDROME	0.000541419	0.019116649024815004
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.019116649024815004
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.019116649024815004
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.019116649024815004
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.019116649024815004
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.019116649024815004
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.019116649024815004
CYSTATHIONINURIA	0.000541419	0.019116649024815004
HEREDITARY HYPEREKPLEXIA	0.000541419	0.019116649024815004
HENNEKAM SYNDROME	0.000541419	0.019116649024815004
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.019116649024815004
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.019116649024815004
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.019116649024815004
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.019116649024815004
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.019116649024815004
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.019116649024815004
GITELMAN SYNDROME	0.000541419	0.019116649024815004
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.019116649024815004
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.019116649024815004
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.019116649024815004
HYPERPROLINEMIA, TYPE II	0.000541419	0.019116649024815004
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.019116649024815004
SYSTEMIC SCLEROSIS	0.000541419	0.019116649024815004
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.019116649024815004
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.019116649024815004
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.019116649024815004
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.019116649024815004
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.019116649024815004
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.019116649024815004
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.019116649024815004
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.019116649024815004
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.019116649024815004
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.019116649024815004
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019116649024815004
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000541419	0.019116649024815004
PARIETAL FORAMINA	0.000541419	0.019116649024815004
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019116649024815004
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.019116649024815004
SNEDDON SYNDROME	0.000541419	0.019116649024815004
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.019116649024815004
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.019116649024815004
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.019116649024815004
STURGE-WEBER SYNDROME	0.000541419	0.019116649024815004
MOYAMOYA DISEASE	0.000541419	0.019116649024815004
RAMON SYNDROME	0.000541419	0.019116649024815004
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.019116649024815004
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.019116649024815004
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.019116649024815004
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.019116649024815004
LASSA FEVER	0.000541419	0.019116649024815004
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.019116649024815004
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.019116649024815004
CRONKHITE-CANADA SYNDROME	0.000541419	0.019116649024815004
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.019116649024815004
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.019116649024815004
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.019116649024815004
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.019116649024815004
PAPILLORENAL SYNDROME	0.000541419	0.019116649024815004
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.019116649024815004
DARIER-WHITE DISEASE; DAR	0.000541419	0.019116649024815004
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.019116649024815004
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.019116649024815004
FLYNN-AIRD SYNDROME	0.000541419	0.019116649024815004
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.019116649024815004
NASU-HAKOLA DISEASE	0.000541419	0.019116649024815004
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.019116649024815004
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.019116649024815004
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.019116649024815004
PORENCEPHALY	0.000541419	0.019116649024815004
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.019116649024815004
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.019116649024815004
ISOLATED BILIARY ATRESIA	0.000541419	0.019116649024815004
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.019116649024815004
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.019116649024815004
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.019116649024815004
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.019116649024815004
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.019116649024815004
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.019116649024815004
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.019116649024815004
DIAMINOPENTANURIA	0.000541419	0.019116649024815004
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.019116649024815004
2Q33.1 DELETION SYNDROME	0.000541419	0.019116649024815004
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.019116649024815004
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.019116649024815004
ASPARTYLGLUCOSAMINURIA	0.000541419	0.019116649024815004
EPILEPSY-TELANGIECTASIA	0.000541419	0.019116649024815004
FOUNTAIN SYNDROME	0.000541419	0.019116649024815004
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.019116649024815004
FRYNS SYNDROME; FRNS	0.000541419	0.019116649024815004
BERNARD-SOULIER SYNDROME	0.000541419	0.019116649024815004
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.019116649024815004
SECONDARY SYRINGOMYELIA	0.000541419	0.019116649024815004
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.019116649024815004
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.019116649024815004
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.000541419	0.019116649024815004
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.019116649024815004
ALEXANDER DISEASE	0.000541419	0.019116649024815004
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.019116649024815004
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.019116649024815004
SUBEPENDYMOMA	0.000541419	0.019116649024815004
EPENDYMOMA	0.000541419	0.019116649024815004
NIPAH VIRUS DISEASE	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.019116649024815004
JUVENILE HUNTINGTON DISEASE	0.000541419	0.019116649024815004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.019116649024815004
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.019116649024815004
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.019116649024815004
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.019116649024815004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.019116649024815004
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.019116649024815004
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.019116649024815004
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.019116649024815004
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.019116649024815004
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.019116649024815004
MOYNAHAN SYNDROME	0.000541419	0.019116649024815004
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.019116649024815004
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.019116649024815004
MYASTHENIA GRAVIS	0.000541419	0.019116649024815004
RECURRENT ACUTE PANCREATITIS	0.000541419	0.019116649024815004
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.019116649024815004
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.019116649024815004
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.019116649024815004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.019116649024815004
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.019116649024815004
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.019116649024815004
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.019116649024815004
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.019116649024815004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.019116649024815004
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.019116649024815004
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.019116649024815004
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.019116649024815004
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.019116649024815004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.019116649024815004
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019116649024815004
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.019116649024815004
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.019116649024815004
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.019116649024815004
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.019116649024815004
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.019116649024815004
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.019116649024815004
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.019116649024815004
PERRAULT SYNDROME 3	0.000541419	0.019116649024815004
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.019116649024815004
NEVUS COMEDONICUS SYNDROME	0.000541419	0.019116649024815004
EPISODIC ATAXIA, TYPE 6	0.000541419	0.019116649024815004
LHERMITTE-DUCLOS DISEASE	0.000541419	0.019116649024815004
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.019116649024815004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.019116649024815004
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.019116649024815004
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.019116649024815004
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.019116649024815004
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.019116649024815004
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.019116649024815004
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.019116649024815004
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.019116649024815004
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.019116649024815004
KLEEFSTRA SYNDROME	0.000541419	0.019116649024815004
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.019116649024815004
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.019116649024815004
ADIPOSIS DOLOROSA	0.000541419	0.019116649024815004
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.019116649024815004
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.019116649024815004
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.019116649024815004
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.019116649024815004
LISSENCEPHALY 3; LIS3	0.000541419	0.019116649024815004
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.019116649024815004
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.019116649024815004
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.019116649024815004
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.019116649024815004
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.019116649024815004
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.019116649024815004
HYPERPROLINEMIA TYPE 1	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.019116649024815004
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.019116649024815004
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.019116649024815004
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.019116649024815004
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.019116649024815004
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.019116649024815004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.019116649024815004
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.019116649024815004
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.019116649024815004
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.019116649024815004
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.019116649024815004
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.019116649024815004
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.019116649024815004
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.019116649024815004
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.019116649024815004
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.019116649024815004
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.019116649024815004
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.019116649024815004
PSEUDO-TORCH SYNDROME 2	0.000541419	0.019116649024815004
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.019116649024815004
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.019116649024815004
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.019116649024815004
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.019116649024815004
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.019116649024815004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.019116649024815004
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.019116649024815004
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.019116649024815004
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.019116649024815004
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.019116649024815004
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.019116649024815004
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.019116649024815004
LIPOID PROTEINOSIS	0.000541419	0.019116649024815004
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.019116649024815004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.019116649024815004
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.019116649024815004
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.019116649024815004
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.019116649024815004
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.019116649024815004
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.019116649024815004
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.019116649024815004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.019116649024815004
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.019116649024815004
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.019116649024815004
COWDEN SYNDROME 5; CWS5	0.000541419	0.019116649024815004
COWDEN SYNDROME 6; CWS6	0.000541419	0.019116649024815004
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.019116649024815004
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.019116649024815004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.019116649024815004
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.019116649024815004
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.019116649024815004
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.019116649024815004
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.019116649024815004
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.019116649024815004
PORPHYRIA	0.000541419	0.019116649024815004
ALZHEIMER DISEASE 3; AD	0.000541419	0.019116649024815004
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.019116649024815004
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.019116649024815004
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.019116649024815004
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.019116649024815004
ENCEPHALITIS LETHARGICA	0.000541419	0.019116649024815004
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.019116649024815004
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.019116649024815004
SCRUB TYPHUS	0.000541419	0.019116649024815004
CENTRAL DIABETES INSIPIDUS	0.000541419	0.019116649024815004
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.019116649024815004
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.019116649024815004
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.019116649024815004
MERCURY POISONING	0.000541419	0.019116649024815004
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.019116649024815004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.019116649024815004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.019116649024815004
FABRY DISEASE	0.000541419	0.019116649024815004
TETRASOMY 18P	0.000541419	0.019116649024815004
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.019116649024815004
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.019116649024815004
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.019116649024815004
GRISCELLI SYNDROME TYPE 2	0.000541419	0.019116649024815004
PORPHYRIA VARIEGATA	0.000541419	0.019116649024815004
HHHH SYNDROME	0.000541419	0.019116649024815004
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.019116649024815004
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.019116649024815004
THYROCEREBRORENAL SYNDROME	0.000541419	0.019116649024815004
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.019116649024815004
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.019116649024815004
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.019116649024815004
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.019116649024815004
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.019116649024815004
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.019116649024815004
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.019116649024815004
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.019116649024815004
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.019116649024815004
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.019116649024815004
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.019116649024815004
THYROCEREBRORETINAL SYNDROME	0.000541419	0.019116649024815004
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.019116649024815004
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.019116649024815004
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.019116649024815004
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.019116649024815004
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.019116649024815004
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.019116649024815004
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.019116649024815004
FRONTAL ENCEPHALOCELE	0.000541419	0.019116649024815004
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.019116649024815004
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.019116649024815004
ATKIN-FLAITZ SYNDROME	0.000541419	0.019116649024815004
ADDISON DISEASE	0.000541419	0.019116649024815004
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.019116649024815004
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.019116649024815004
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.019116649024815004
CLARK-BARAITSER SYNDROME	0.000541419	0.019116649024815004
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.019116649024815004
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.019116649024815004
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.019116649024815004
EPISODIC ATAXIA TYPE 3	0.000541419	0.019116649024815004
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.019116649024815004
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.019116649024815004
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.019116649024815004
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.019116649024815004
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.019116649024815004
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.019116649024815004
GALACTOSIALIDOSIS	0.000541419	0.019116649024815004
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.019116649024815004
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.019116649024815004
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.019116649024815004
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.019116649024815004
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.019116649024815004
BETA-MANNOSIDOSIS	0.000541419	0.019116649024815004
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.019116649024815004
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.019116649024815004
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.019116649024815004
RABIES	0.000541419	0.019116649024815004
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.019116649024815004
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.019116649024815004
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.019116649024815004
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.019116649024815004
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.019116649024815004
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.019116649024815004
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.019116649024815004
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.019116649024815004
WORSTER-DROUGHT SYNDROME	0.000541419	0.019116649024815004
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.019116649024815004
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019116649024815004
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.019116649024815004
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.019116649024815004
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.019116649024815004
ROSA-DORFMAN DISEASE	0.000541419	0.019116649024815004
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.019116649024815004
MOGS-CDG	0.000541419	0.019116649024815004
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.019116649024815004
ALG2-CDG	0.000541419	0.019116649024815004
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.019116649024815004
VIRAL HEMORRHAGIC FEVER	0.000541419	0.019116649024815004
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.019116649024815004
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.019116649024815004
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.019116649024815004
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.019116649024815004
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.019116649024815004
CRISPONI SYNDROME	0.000541419	0.019116649024815004
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.019116649024815004
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.019116649024815004
HEREDITARY COPROPORPHYRIA	0.000541419	0.019116649024815004
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.019116649024815004
GURRIERI SYNDROME	0.000541419	0.019116649024815004
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.019116649024815004
WHIPPLE DISEASE	0.000541419	0.019116649024815004
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.019116649024815004
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.019116649024815004
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.019116649024815004
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.019116649024815004
